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Ill

ABSTRACT
Bartonella henselae is a zoonotic agent in which the domestic cat serves as the
natural reservoir, and humans acquire potentially serious infections associated with this
microorganism. The purpose o f this research is to contribute to the understanding o f the
pathogenesis o f B. henselae in the domestic cat using a molecular approach.
Using sequence differences in a portion o f thel6S rRNA gene between B. henselae
genotype I, and B. henselae genotype II, a nested polymerase chain reaction (nPCR)
was designed and used to investigate various phases of feline bartonellosis. The nPCR
detected 3.2 organisms per milliliter of blood which is below the detection limits o f
standard bacterial culture. Bartonella henselae LSU 16 genotype II, Bartonella
henselae Baby genotype II, Bartonella henselae 87-66 genotype I, and Bartonella
henselae Houston-1 genotype I were used in this study to infect cats. The PCR assay
detected Bartonella DNA in 40 blood samples that were culture negative. The
bacteremia as determined by PCR lasted for a period of 1 to 9 weeks longer than
determined by culture methods in 10 of the 16 cats. An episode o f relapsing bacteremia
occurred in two cats during the infection. O f the twenty-three cats examined,
Bartonella DNA was detected in various tissues from 10 o f the 23 cats. The spleen of
nine o f the 10 cats was positive for Bartonella DNA. The other tissues in which
Bartonella DNA was detected included bone marrow, lymph node, kidney, lung, liver,
brain, and heart valve. Histopathological lesions associated with nonspecific antigenic
stimulation were seen in the cats but organisms could not be visualized in tissue. RNA
expression analysis using the RT-PCR assay with primers specific for the 16S rRNA
and the citrate synthase gene (gitA) of Bartonella detected no Bartonella RNA
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expression in the tissue o f infected cats. Bartonella genotypes remained the same
throughout the period o f the acute bacteremia and in the recurring bacteremia in two
cats as determined by the PCR assay. The persistent Bartonella DNA detected in tissue
was B. henselae genotype II. B. henselae genotype I was not detected in any o f the
infected cats.
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CHAPTER ONE
REVIEW OF LITERATURE
Description and History of the Genus
Bartonella
Taxonomy. The genus Bartonella is named for A. L. Barton who described
Bartonella bacilliformis in 1909 as an intraerythrocytic bacterium. Bartonella
bacilliformis was at one time the only species in the genus Bartonella. The genus
Bartonella and Grahamella were the only two genera in the family Bartonellaceae that
were in the Order Rickettsiales. With DNA-DNA hybridization techniques, the
taxonomy and classification o f the family Bartonellaceae was changed and the current
Bartonella species, other than B. bacilliformis, changed names and taxonomy several
times before being finally placed into the current order o f Bartonellaceae. The 1984
edition o f Bergey’s Manual o f Systematic Bacteriology divided the order Rickettsiales
into three families namely, Rickettsiaceae, Bartonellaceae, and Anaplasmataceae
(Weiss 1984). Bartonella bacilliformis was the only member o f the genus Bartonella,
and Grahamella was the other genus in the family Bartonellaceae. The Rickettsiaceae
family initially included three genera, Rickettsia, Coxiella, and Rochalimaea. The first
and current Bartonella species (other than B. bacilliformis), B. quintana, was first
named Rickettsia quintana in 1917 as proposed by Schmincke, and is the causative
agent o f trench fever (Maurin 1996). Rickettsia quintana was then transferred to the
genus Rochalimaea by Krieg in 1961 (Maruin 1996). The next Rochalimaea named
was R. vinsonii isolated from voles (Microtus pennsylvanicus) in Canada (Weiss et al.
1978). The third Rochalimaea species, R. henselae had been visualized in tissue
sections o f lesions with Warthin-Starry staining but had not been successfully cultured

l

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

or identified (Angritt et al.1988; Leboit et al. 1988). Using the polymerase chain
reaction(PCR) and oligonucleotide primers complementary to 16S ribosomal RNA
genes of eubacteria, Reiman amplified the 16S ribosomal gene fragment o f
Rochalimaea henselae directly from tissue samples o f patients with bacillary
angiomatosis (Reiman et al. 1990). Slater et al. (1990) and Welch et al. (1992) then
isolated the organism on solid medium supplemented with horse or human blood from
the blood of patients infected with the human immunodeficiency vims (HIV), transplant
recipients, immunocompetent patients with bacteremia and a patient with peliosis
hepatis (Slater et al. 1990; Welch et al. 1992). Based on DNA-DNA hybridization data
and comparison o f existing 16S rRNA gene sequences, Rochalimaea and Coxiella were
removed from the Rickettsiaceae family, and the genus Rochalimaea were renamed
Bartonella (Brenner et al. 1993). The genus Rochalimaea was transferred from the
family Rickettsiaceae to the family Bartonellaceae and united with the genus
Bartonella. The family Bartonellaceae was removed from the order Rickettsiales
(Brenner et al. 1993). The current genus Bartonella was created. Bartonella species
were removed from the order Rickettsiales, and the genus Bartonella and Grahamella
were combined. Closely related genera based on the sequence homology o f the 16S
rRNA gene are the Brucella and the Agrobacterium (Regnery et al.1992; Anderson and
Neuman 1997). The genus Bartonella is in the family Bartonellaceae and belongs to
the alpha-2-subdivision o f the class Proteobacteria. There are presently 14 recognized
species of Bartonella. Included in the group is B. henselae, B. bacilliformis, B.
quintana, B. elizabethae (all human pathogens), B. vinsonii, (B. vinsonii subspecies
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berkhoffi), B. grahamii, B. taylorii, B. doshiae, B. talpae, B. peromysci, B. clarridgeae,
B. koehlerae, B. alsatica, B. tribocorum.
Description of the genus. Bartonella species are small (0.6 by 1.0 um) gram
negative rods that are often slightly curved. Bartonella species in general are
biochemically inert (Bergy’s Manual, Ninth edition). They are oxidase, catalase, and
urease negative, aerobic, and highly fastidious. They do not produce acid from
carbohydrates. B. bacilliformis possesses polar flagella whereas B. henselae and B.
quintana display twitching motility due to the presence o f pili (Welch and Slater, 1999).
The genome sizes have been estimated to be 1.5 x 106 bp for B. quintana and 2 xI06bp
for B. vinsonii (Meyers et al. 1980) and the guanine plus cytosine content o f the
genomes for Bartonella species is estimated at 39 to 40% (Weiss et al. 1978; Tyeryar et
al. 1973; Welch et al. 1992). Plasmids have not been described (Kreuger et al. 1995). A
bacteriophage particle has been identified in both B. bacilliformis (Umemori et al. 1992)
and B. henselae (Anderson et al.1994). Gene sequences o f B. henselae published are
those encoding the citrate synthase, 16S rRNA (Daly et al. 1993; Regnery et al. 1993),
5S rRNA, 23S rRNA genes, intergenic regions between rRNA genes (Minnick 1994), a
60-kDa antigen in B. henselae (Anderson et al.1993) and a unique 17-kDA gene
(Anderson et al. 1995).
Bartonella species and hum an disease. The disease syndrome attributed to B.
bacilliformis is bartonellosis or Carrion’s disease. Carrion’s disease is geographically
confined to the South American Andes region. Its regional occurrence is the result of
the limited distribution o f the sand fly (Lutzomyia verrucarum), the vector. Carrion’s
disease is a biphasic disease consisting of an acute hemolytic anemia (Oroya fever) and
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a chronic form (verruga peruana) that presents with vascular proliferative skin lesions.
Evidence from the artifacts o f pre-Columbian culture suggests that the verruga peruana
form o f Carrion's disease was present in Ecuador at least 1,000 years before the arrival
o f Europeans (Anderson and Neuman 1997).
Bartonella quintana, the causative agent o f trench fever was first identified among
battlefield troops in World War I (Review by Anderson and Neuman 1997). It was
estimated that over 1 million troops were affected. The disease was characterized by a
5-day relapsing fever, with severe and persistent pain in the shins, and although rarely
fatal, it resulted in prolonged disability. The disease also affected troops in World War
II. Trench fever was a debilitating febrile illness characterized by fever, rash, bone pain
and splenomegaly. The disease is often associated with poor sanitation and personal
hygiene, and is communicable by means o f the body louse (Pediculus humanus).
Infection is thought to be transmitted from lice to humans via the arthropod excreta,
which enters the body through broken skin (Maurin and Raoult 1996). Since World
War II infections associated with B. quintana were rare until the description of
infections in human immunodeficiency virus (HIV)-infected patients. The reason for
the reemergence o f B. quintana infections after many years o f apparent absence is
unclear (Reiman 1998).
In addition to causing diseases with which Bartonella has been historically
connected, members o f the genus Bartonella have been isolated from a range o f
emerging diseases with a wide array o f clinical syndromes. B. henselae is associated
with diseases with granulomatous features such as cat scratch disease, and vascular
proliferative disease, such as bacillary angiomatosis, peliosis, and epidemics of
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bacteremic illness. B. quintana is associated with bacteremic illness, endocarditis, and
bacillary angiomatosis and peliosis, but not cat scratch disease. B. quintana infection is
epidemiologically associated with homelessness, low income, and exposure to lice
(Koehler et al. 1997). B. quintana infections are seen in HIV-infected patients, chronic
alcoholics, and homeless individuals (Drancourt et al. 1993; Koehler et al.1992; Spach
et al. 1993).
B. henselae is associated with bacteremic illness, endocarditis, bacillary
angiomatosis, peliosis, and cat scratch disease. B. henselae infections are
epidemiologically linked to cat and flea exposure (Koehler et al. 1997). The most
common Bartonella infection in humans is cat scratch disease (CSD). In the United
States the number o f CSD cases is estimated to be approximately 25,000 annually
(Welch and Slater 1999). Typical CSD occurs in about 89% o f the cases and is usually
a self-limiting disease with fever and lymphadenopathy, usually preceded by an
erythematous papule at the inoculation site (Welch and Slater 1999). Most cases o f
CSD are resolved within 2-6 months (Margilith et al.1992). About one-third of the
patients have a fever, and about one-sixth develop lymph node suppuration (Welch and
Slater 1999). Inflammatory reactions include granulomata and stellate necrosis seen on
histopathological examination o f the nodes (Welch and Slater 1999). Atypical CSD
occurs in about 11% o f the cases. Complications resulting from atypical CSD include
encephalitis, retinitis, hepatic and splenic abscesses, pneumonia osteomyelitis, lytic
bone lesions, conjunctivitis, and central nervous system involvement (Anderson 1997).
Other Bartonella species involved in human disease include B. elizabethae, which
was isolated from a single patient with endocarditis (Daly et al. 1993), and B.
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clarridgeiae, which has been isolated from a patient with cat scratch disease (Kordick et
al. 1997a). Bartonella vinsonii subsp. berkhoffii was reported in a case o f endocarditis
in a human that was blood culture-negative and afebrile (Roux et al. 2000). In that case,
Bartonella DNA was detected by PCR from valvular material removed during aortic
valve replacement. The bacterium was never cultured.
Bartonella species not related to hum an disease. Bartonella vinosonii, B.
grahamii, B. taylorii, B. doshiae, B. talpae, B. koehlerae, and B. peromysci have all
been identified in a wide range of mammalian species, including felines and rodents
(Birtles et al. 1995; Heller et al. 1997; Chomel et al. 1995; Droz et al. 1999) but are all
presently considered nonpathogenic to humans. B. vinsonii has been isolated from vole
and canines and designated B. vinsonii subsp. vinsonii and B. vinsonii subsp. berkhoffii,
respectively (Kordick and Breitschwerdt 1998). B. vinsonii subsp. vinsonii was first
isolated in 1946 from the spleen of a vole and was not described again until 1995 when
B. vinsonii subsp. berkhoffi was isolated from a dog with vascular endocarditis
(Breitschwerdt and Kordick 1995). In North Carolina and Virginia 3.6% o f 1,920 dogs
were seropositive for B. vinsonii subsp. berkhoffii (Pappalardo et al. 1997). A study by
Chang et al. (1998) demonstrated the prevalence o f antibodies (7% to 51%) to B.
vinsonii subsp. berkhoffii in coyotes (Canis latrans) from parts of northern California.
The seroprevlaence o f Bartonella in coyotes in California was from the coastal counties
and thought to be vector transmitted from wildlife to domestic dogs (Chang et al. 1998).
Bartonella henselae
Background and history. Bartonella henselae, a member o f the family
Bartonellaceae has emerged as an important microorganism in the last 5 years.
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Bartonella henselae is a zoonotic agent causing a wide array o f human disease
syndromes with the domestic cat as a major reservoir for the organism. In humans, B.
henselae is associated with cat scratch disease, bacillary angiomatosis, and bacillary
peliosis. The search for the infectious agent responsible for these new emerging
diseases and the connection to the domestic cat evolved slowly and involved clinical
medicine, traditional microbiology, and genetic approaches. The various manifestations
of CSD have been recognized for over 100 years but “la maladies des griffes du chat”
was not identified as a syndrome until 1950 (Debre et al, 1950). The search for the
etiologic agent o f CSD has been long with the first described clinical cases in 1931 by
Debre and Semelaigne and published in 1950 (Shinall 1990). Organisms that have been
reported as the potential etiologic agent o f the disease included a herpes-like virus
(Kalter et al. 1969), a hemagglutinating virus (Turner et al. 1959), Chlamydia (Emmons
et al. 1976), and an acid-fast bacillus (Boyd 1961). Despite the unknown etiology, a
clinical diagnosis o f CSD was based on the presence of three criteria: 1) history of
animal contact with the presence o f a scratch or an inoculation lesion o f the skin, eye or
mucous membrane; 2) a positive CSD skin test (CSD antigen); 3) regional
lymphadenopathy with negative laboratory results for other causes o f
lymphadenopathy; and 4) characteristic histopathologic changes consistent with CSD in
a biopsied lymph node (Margileth 1988).
In 1988, the Armed Forces Institute o f Pathology named Ajipia felis as the agent o f
CSD (Regnery and Tappero 1995). Wear et al. (1983), reported finding bacteria in
lymph nodes of cat scratch disease patients meeting the criteria by using the WarthinStarry silver stain. Then in 1988, English et al. (1988) reported the isolation, o f a
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bacterial agent from a lymph node of a CSD patient’s. The isolate, Afipia felis, was
named after the Armed Forces Institute of Pathology (Afipia), the source o f the original
isolate, and felis referring to the presumed vertebrate vector o f CSD (Wear et al.1983;
English et al. 1988; Regnery and Tappero 1995). Upon further investigation, other
laboratories could not recover isolates of A. felis from CSD patients, and a serological
link between A. felis and cats could not be demonstrated (Bergmans et al. 1995;
Regnery and Tappero 1995).
The next part of the story and the true etiologic agent o f CSD emerged when patients
infected with human immunodeficiency virus (HIV) developed cutaneous and
subcutaneous vascular lesions containing baciilary organisms seen on W arthin-Stany
silver stain described as indistinguishable from baciilary organisms seen in CSD
patients (Stoler et al. 1983, Koehler et al. 1993; Tappero et al. 1993). Zangwill et
al.(1993), reported that patients with baciilary angiomatosis had a household kitten
under the age o f 1year and reported traumatic contact with a cat. Reiman (1990)
identified DNA from baciilary angiomatosis skin lesions that was not necessarily
identical to but was related to Rochalimaea quintana. Independently but about the same
time in Houston, Texas, Rochalimaea-Yike organisms were isolated from the blood o f
HIV-infected patients with relapsing fever of unknown origin. In Oklahoma, Welch et
al. (1992) isolated a similar organism and coined the new species designation R.
henselae in recognition o f the contribution of Diane Hensel, who initially isolated
several o f the organisms in Oklahoma (Regnery et al. 1992a). Regnery et al. (1992b)
then developed an indirect fluorescence antibody (IFA) using the Houston-1 isolate o f
R. henselae and found high antibody titers to R. henselae in patients identified with
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HIV-infected baciilary angiomatosis and later in CSD patients (Tappero et al. 1992;
Regnery et al. 1992). This was the first laboratory evidence that R. henselae was
associated with CSD. R. henselae was isolated directly from the lymph nodes of two
CSD patients and identified in 1993 by Dolan et al. Using archival sources 93% o f the
skin-test positive CSD patients tested positive by IFA to Rochalimaea antigen (Szelc et
al. 1992). Also, pasteurized exudate collected from suppurative CSD lymph nodes used
in the skin test as antigen was shown by PCR to contain Rochalimaea nucleic acid
sequences and R. henselae sequences in particular (Perkins et al. 1992; Anderson et al.
1993).
A role for the cat in the life cycle o f R. henselae was proposed following the
discovery o f R. henselae as the etiologic agent o f CSD. Involvement o f the cat in the
life cycle o f B. henselae was demonstrated by Bartonella-specific IFA antibodies in 39
o f 48 cats living in households reporting human CSD in a study by Zangwill, 1993.
After detecting anti -Bartonella henselae antibodies in a cat by IFA, Regnery et al.
(1992a) isolated B. henselae from the blood o f a single cat not linked to human illness.
R. henselae was isolated from the blood o f cats whose owners were diagnosed with
baciilary angiomatosis established the cat as a reservoir for R. henselae infection
(Koehler et al. 1994) Cat ownership was then considered a risk factor for diagnosis of
CSD and baciilary angiomatosis. In the last decade the reservoir, the possible vectors,
the diseases, the epidemiology, the genetic characteristics, and many other aspects of B.
henselae have been studied. Despite all these years, many aspects o f feline
bartonellosis are still unclear.
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B. henselae, the causative agent o f cat scratch disease (CSD), has been linked by
epidemiologic and serologic studies to cats (Zangwill, et al.1993; Childs et al.1994;
Chomel et al.1995; Demers et al.1995; Koehler et al. 1994). Contact with cats,
especially kittens, has been shown to be a significant risk factor (Zangwill et al. 1993).
In the vast majority o f CSD cases, patients have been bitten or scratched by a cat. In a
small percentage o f CSD patients, no history o f animal contact was reported (Caithers et
al.1969).
The role of the flea (Ctenocephalides felis) as a vector for transmission has been
explored. B. henselae has been amplified by PCR from the flea gut after 24 hours and
nine days after feeding on cat blood seeded with B. henselae (Higgins et al. 1996).
Using an IFA assay Higgins et al. (1996) were able to observe B. henselae in dissected
guts o f fleas after3 hours and at 9 days after infectious feeding. Qualitatively the
number of fluorescing bacteria were more plentiful in flea guts at 9 days. Experimental
transmission of B. henselae between cats by way of a cat flea vector has been
demonstrated (Chomel et al. 1996). The route o f the exposure from cat to cat was not
clear until an experimental infection o f domestic cats with B. henselae by inoculation o f
flea feces alone (Foil et al. 1998). Direct transmission of B. henselae from cat fleas to
humans has not been demonstrated. Reports of tick bites before infection with B.
henselae have been reported (Lucey et al.1992).
Cat scratch disease accounts for approximately 24,000 cases annually in the United
States, with an estimated 2,000 hospital admissions (Jackson et al. 1993). The estimated
health-care cost of CSD in 1992 in the U.S. is $12 million per year (Jackson et al.
1993). The peak incidence o f cases of CSD is in persons between ages 2 and 14
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(Caithers 1985; Zangwill et al. 1993). The incidence is reported to be higher in males
(60%) and in whites (Klein et al. 1994) and is seasonal with most cases recognized in
the second half o f the year (Carithers 1985). Individual reports from numerous
countries suggest a worldwide distribution o f CSD (Flexman et al.1995; Ueno et al.
1995; Waldvogel et al.1995).
Bartonella henselae and C ats
Prevalence. Prevalence studies performed in both cats and human patients to
determine seroprevalence o f B. henselae use the indirect fluorescent-antibody test
(IFA), the enzyme-linked immunoabsorbent assay (ELISA), and the western blot
analysis. Several prevalence studies done in cats have shown the sensitivity (86.2 %
ELISA versus 88% IFA) and specificity (95.9% ELISA versus 94% IFA) when
measuring IgG between the IFA and ELISA to be similar (Guptill et al. 1997; Regnery
et al. 1996). Other studies, done by Bergmans et al, (1997) on human patients have
pointed out the pitfalls and fallacies o f serological tests and showed preparation of
Bartonella-specific antigen influenced the outcome o f the test, and measurement o f IgM
(71%) was shown to have a greater sensitivity than that o f IgG (40.9%) serology. In
other studies B. quintana and B. clarridgeiae have been shown to serologically crossreact with B. henselae antigens thus influencing seroprevalence o f B. henselae in cats
(Childs et al. 1995; Kordick et al. 1997a; Freeland et al. 1999). Nevertheless, the
prevalence o f B. henselae in cats as determined by serologic evidence using Bartonellaspecific antigens and by the presence o f bacteremia in cats has been reported and varies
according to the type o f cat population (pet or stray), age o f the animal, gender, region
of the country as influenced by weather patterns and flea infestation of cats. Chomel et
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al. (1995) found impounded and former stray cats were 2.86 times more likely to be
bacteremic than pet cats and young cats (<1 year old) were 1.64 times more likely than
adult cats to be bacteremic, and bacteremic cats were more likely than nonbacteremic
cats to be infested with fleas. In a study by Zangwill et al. (1993) in Connecticut, 46%
o f the pet cats not associated with human disease and 81% o f cats living in households
reporting human CSD were seropositive. Childs et al. (1995) found 44.4% (n=9) of
feral cats, 11.8% o f stray cats (n=195), and 12.5% of cats (n=24) in veterinary hospitals
were seropositive in Baltimore, Maryland and that cats are more likely to acquire and
transmit B. henselae in the first year o f their life. Childs et al. (1995) found that 28% of
the cats in a group o f 1,370 cats from an animal shelter in Maryland had antibodies to B.
henselae. Jamerson et al, (1995) found a higher seroprevalence in southeastern United
States, Hawaii, coastal California, the Pacific Northwest and the south central plains
54.6%, 47.4%, 40.0%, 34.3%, and 36.7%, respectively. Alaska, the Rocky MountainGreat Plains region, and the Midwest had low average prevalence o f 5.0%, 3.7%, and
6.7%, respectively. The overall seroprevelance throughout these regions was 27.9%
(n=628) (Jameson et al. 1995). The seroprevalence of B. henselae in cats in this study
appeared to be influenced by climate. Foley et al. (1998) surveyed a group o f 11
catteries from diverse geographical locations in North America and found a
seroprevalence o f 35.8%.
Bartonella henselae has a worldwide distribution. The seroprevalence varies widely
among different countries and geographic regions within countries. Seroprevalence of
B. henselae ranges from 3.7% to 65.4% in the United States, and from 6 to 22% in
Japan (Yoshida et al. 1996; Breitschwerdt and Kordick 1995; Childs, et al. 1994;
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Chomel et al.1995; Jamerson et al.1995). In Autstralia the seroprevalence is 33%, in
Egypt 12%, and in Portugal 7% (Ueno et al. 1995; von Alleerberger et al. 1995). In a
study in the Netherlands by Bergman et al. (1997), using the enzyme-linked
immunoassay 50% (n=l 13) o f sheltered cats were seropositive, 56% (n=50) o f pet cats
were seropositive, and 22% o f sheltered cats were bacteremic; none o f the specificpathogen free cats were seropositive. In an Indonesian cat population Marston et al.
(1999) found 54% (n=70) were positive by IFA and 43% (n=14) of feral cats were
culture positive for B. henselae. The prevalence o f B. henselae in Germany determined
by blood culture from household cats was 13% (n=l00) (Sander et al. 1997). In this
study young, female cats (24 months of age or younger) were more likely to be found
positive for B. henselae.
S train variability. B. henselae is a zoonotic agent and has adapted to survive and
replicate in the human host (incidental host) and the feline host (natural host) (Reiman
1998). Both the diversity o f strains within cat reservoirs and that cause various human
clinical syndromes has not been compared extensively. B. henselae genotype
differences have been described using various genotypic methods. B. henselae causes a
diverse spectrum o f diseases in humans that range from self-limiting to severe. Because
o f the diverse pathology and different host adaptation, strain variability would be
expected with B. henselae. The difference in the clinical presentation o f B. henselae in
humans and cats suggest that different strains may exist. It is expected that there will be
greater strain diversity in the natural host (cat) than within the incidental human host
(Reiman 1998). The majority o f available clinically relevant B. henselae strains have
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been isolated in the United States (Dolan et al.1993; Koehler et al. 1992; Lucey et al.
1992).
The first isolate of B. henselae was named B. henselae Houston-1 and was isolated
from an HIV-infected patient in Houston and identified as the prototype strain (Regnery
et al. 1992). The next human strain was isolated from the blood o f febrile patients with
AIDS in Oklahoma and designated B. henselae ATCC 49793 (Slater et al. 1990). These
two strains were identified by genotypic methods including ribosomal RNA gene
analysis and were similar. Arvand et al. (1997) isolated the first B. henselae from
Europe. This group isolated B. henselae from the baciilary angiomatosis lesions o f an
HIV-infected patient in Germany and named it B. henselae Berlin-1. Using pulsed-field
gel electrophoresis o f endonuclease-restricted chromosomal DNA, the Berlin-1 isolated
was compare to the B. henselae strains isolated from patients in the United States
(Arvand et al. 1997). The two strains were indiscernible suggesting that these strains
might represent one clone. The Berlin-1 strain was similar to the ATCC 49793
(Oklahoma strain) but did have one differing band, indicating a close relationship
between the strains. A feline blood isolate named Berlin-2 was also compared in the
Germany study and displayed a digestion profile with at least eight different bands
which would be a distinct clone (Arvand et al. 1997). Using the 16S rRNA gene
sequence analysis, Bergmans et al. (1994) found a difference of 3 bp located at
positions 172 to 175 o f the 16S rRNA gene o f B. henselae from CSD patients. The B.
henselae isolates were then divided into 2 groups, genotype I and genotype II according
to 16S rRNA gene sequence. B. henselae genotype I has a TAG sequence and B.
henselae genotype II has a ATT sequence between the 172 and 175 region o f the 16S
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rRNA gene (Bergman et al. 1994). Genotype I was identical to the sequence describe
by Regnery et al. (1992) as Houston-1 and genotype II was identical to the so called
“BA-TF sequence found by Reiman et al. (1990) in patients with baciilary
angiomatosis. Using two type-specific PCRs that could discriminate between B.
henselae variants, Bergman et al.(1996) investigated the B. henselae strains in samples
from cat-scratch disease patients in The Netherlands. Bergmans et al. (1996) found 32
of 41 Bartonella DNA-positive samples from Dutch patients with CSD contained B
henselae genotype I , seven samples contained B. henselae genotype II and 2 samples
were found to be negative in both type-specific PCRs. Similarly, Sander et al. (1999)
found 23 of 39 of the PCR-positive patients in Switzerland were infected with B.
henselae genotype I, and 9 o f 39 were infected with B. henselae genotype II. Heller et
al. (1999) found genotype I in 59% of Dutch patients and genotype II in 23% o f these
patients with cat scratch disease.
Further work was done to investigate the genotypes isolated from cats. Several
studies suggest that B. henselae genotype II is more common among cats than B.
henselae genotype I (Bergmans et al. 1997; Heller et al. 1997). Heller et al. (1997)
characterized B. henselae isolates from cats in France and found 34% o f the isolates
were B. henselae genotype I and 36% of the isolates were B. henselae genotype II.
Bergmans et al. (1997) found typed strains of B. henselae isolates from cats in the
Netherlands using Bartonella-specific PCR and hybridization assay and by 16S-23S
spacer PCR-restriction fragment length polymorphism (RFLP). Three B. henselae types
were found according to the RFLP patterns and were labeled A, B, and G (Bergmans et
al.1997). RFLP pattern A corresponds to 16S rRNA genotype I, while RFLP pattern B
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corresponds to genotype II. RFLP pattern G did not correspond to either 16S rRNA
genotype I or genotype II. RFLP pattern B (genotype II) was found more common
within the cats that typed as A or G. The various strains o f B. henselae have been
shown to influence the immunological response o f the host. Drancourt et al. (1996),
have documented CSD patients who were seronegative on a standard IFA diagnostic
test for B. henselae Houston-1 antigen but were seropositive for a Marseille strain of B.
henselae (Drancourt et al. 1996). Other studies have shown that up to 60% o f CSD
patients may test negative in conventional B. henselae seroassays (Dupon et al.1996;
Yoshida et al. 1996). Yamamoto et al. (1998) has shown the lack o f cross protection
between B. henselae genotype I and genotype II. Freeland et al. (1999) demonstrated at
least three antigenic differences between genotype I strain (Houston-1) and a genotype
II strain LSU 16.
Pathogenesis. The pathogenesis o f B. henselae in cats is not clearly understood.
The pathogenesis o f an infectious disease is influenced by many factors involving the
host and the infectious agent. The immunological response o f the host, the age, feline
genetic differences, additional infections, the dose, the route o f entry into the host,
virulence factors o f the microorganism, and the strain of the microorganism, are some
of the factors that influence the pathogenesis of an infectious agent. Clinical signs in
experimentally infected animals range from no overt clinical signs to fever, mild
anorexia, lymphadenopathy, central nervous signs including abnormal behavior and
vacant staring, signs of focal motor seizures, nystagmus, and rigidity (Kordick et
al.1999; O’Reilly et al. 1999a). Numerous experimental B. henselae infections have
been induced in cats and a wide range o f clinical responses seen (Green et al. 1996;
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Kordick et al.1995; Regnery et al. 1996; Guptill et al. 1997; O ’Reilly et al. 1999a).
Regnery et al. (1996) established a bacteremia and a Bartonella-specific IgG antibody
response in 31 cats inoculated with B. henselae Houston-1 strain and did not observe
clinical disease in any o f the animals. In a study by O ’Reilly et al. (1999a), acute
clinical disease with bacteremia, antibody response, and adverse clinical signs were
established in cats using a pathogenic strain of B. henselae called LSU 16. Bacteremia
can be established in most cats within 1 to 2 weeks after inoculation (Regnery et al.
1996; Guptill et al. 1997; O ’Reilly et al. 1999a). The magnitude and duration o f the
bacteremia is varied. The magnitude o f bacteremia in experimental infection is reported
to be significant and sometimes exceeds 106CFU/ml o f blood (O’Reilly et al. 1999a).
Bacteremia can persist for weeks to months, and in some cats, a relapsing bacteremia
occurs in both experimental and naturally occurring Bartonella infections (Regnery et
al. 1996; Guptill et al. 1997; Kordick et al. 1999a). Intervals o f culture-negative cats
can be random and vary in duration. Kordick et al. (1999) reported intervals o f 1 to 4
months o f culture negative results before recurrent bacteremia could be detected.
Pathogenesis o f B. henselae at the cellular and molecular levels is poorly
characterized. Bartonella are most closely related to Brucella based on the
phylogenetic relationships o f the 16S rRNA gene sequence analysis. Bartonella, like
Brucella are considered intracellular pathogens and can cause chronic bacteremia
probably because o f the ability to survive in macrophages and because o f the relative
low virulence of these organisms. Several studies have shown attachment and entry o f
Bartonella into several types o f cells. Batterman et al. (1995) has shown attachment to
and entry of B. henselae into human epithelial cells. Bundle-forming pili have been
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demonstrated by electron microscopy in B. henselae and are thought to be an important
virulence factor. A strong correlation between degree o f attachment to epithelial cells
and degree of piliation has been shown (Batterman et al. 1995). Batterman et al. (1995)
demonstrated a relationship between piliation and phase variation. The two phases o f
the colonies noted were dry colonies embedded in the agar and mucoid colonies. B.
henselae 87-66 (ATCC 49793) produced dry colonies which deeply embedded in the
agar where as B. henselae ATCC 49793 colonies were mucoid and did not pit the agar.
The heterogeneity in colony types suggests a phase variation and is seen in multiple
passages on laboratory media. Batterman et al. (1995) demonstrated that the rough
adherent colony type B. henselae 87-66 expressed pili and that most o f the smooth
colony type of B. henselae ATCC 49793 had few pili (Batterman et al.1995). Zbinden
et al (1995) demonstrated intracellular location within the Vero cells mainly around the
nuclei. Presently however, mechanisms of entry have not been discovered. Clarridge
(1996) demonstrated a cohesive factor in B. henselae associated with organisms existing
in a tightly packed array. Clarridge suggested that the cohesive growth factor o f B.
henselae might help in resistance to antibiotic penetration and contribute to the
recurrence of infection (Clarridge 1996).
Species of Bartonella have been shown to have a positive tropism for endothelial
cells and red blood cells. Entry o f B. henselae into the human endothelial cells has been
demonstrated by Dehio et al. (1997). In vitro studies have shown B. henselae to
colonize the vascular tissue with vascular uptake o f large bacterial aggregates by
engulfment (Dehio et al. 1997). The organism first accumulates and aggregates on the
endothelial surface and then enters and forms a structure called an invasome, which
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contains large and completely internalized bacterial aggregates (Dehio et al. 1997).
Histological analysis demonstrates the presence o f bacterial clumps in close association
within proliferating endothelial cells (Dehio et al. 1997). In other human studies it has
been shown that B. henselae attaches and enters pericytes, macrophages and neutrophils
(Anderson et al. 1997; Maurin and Raoult 1996).
Evaluation o f bacteremic cats during natural and experimental infections suggests
the presence of intracellular, epicellular, and extracellular bacteria in the blood, with
erythrocytes invasion being limited to a small percentage o f the bacterial population
(Mehock et al. 1998). Intracellular location within the cat has been limited to the feline
erythrocytes (Kordick and Breitschwerdt 1995). In these studies erythrocytes of
persistently bacteremic cats, were studied, and identified 2.9% o f the erythrocytes in cat
A were infected whereas 6.2% of the erythrocytes in cat B were infected with B.
henselae. Epicellular or extracellular organisms were not found in the blood o f either
cat A or B in this study. Kordick and Breitschwerdt (1995) speculated that engulfrnent
o f the bacteria by the erythrocyte membrane was a bacterium-induced or that forced
endocytosis was involved in the engulfrnent. In vitro studies have suggested a
intracellular location o f B. henselae in the feline erythrocytes (Mehock et al. 1998).
Mehock et al. (1998) demonstrated invasion rates o f the feline erythrocytes to be from 2
to 20% o f the inoculum. Using laser scanning confocal microscopy to discriminate
between intracellular and epicellular B. henselae cells, less than 1% o f the erythrocytes
were determined to be infected. The role that invasion o f feline red blood cells plays in
the pathogenesis o f B. henselae has been speculated to have at least four potential
benefits: 1) immune evasion, 2) hemin acquisition, 3) survival in the cat flea, and
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4) spread to other anatomical sites such as the liver or spleen (Mehock et al. 1998).
Identification o f antigenic proteins and subunits of specific virulence factors o f B.
henselae has been limited. Burgess (1998) found that a 43 k-Da outer membrane
protein was a major adhesin for human umbilical vein endothelial cells. A 17-kDa
outer membrane protein from B. henselae was shown reactive with human sera from
CSD patients (Anderson et al. 1995; Sweger et al. 2000). Freeland et al. (1999) showed
the 11.3, 13.3, and 16.9/18.0 k-Da antigens, to be immunodominant in 83% (n=482) o f
seropositive cats naturally infected with B. henselae.
In vivo studies have demonstrated low endotoxin potency and diminished induction
of neutrophilic oxidative metabolism, degranulation, and cheomtaxis by B. henselae
when compared to E. coli and S. typhi (Fumarola et al. 1994).
M ode o f transm ission, vector. Several Bartonella species have been shown to
require an ectoparasite for transmission. B. bacilliformis is transmitted by the
Phlebotomus sand fly, (Schultz et al. 1968), and B. quintana, the etiological for trench
fever is transmitted by the human body louse, Pediculus humanus (Strong et al. 1918).
The association o f B. henselae with the cat flea, Ctenocephalides felis, has been shown
in several studies (Foil et al. 1998; Higgins et al. 1996; Chomel et al. 1996). In an
epidemiological study by Zangwill et al. (1993), the risk factors associated with the
development o f cat scratch disease were established. Ownership o f a kitten was the
most significant risk factor noted. The finding o f one kitten with fleas helped establish
the role o f the flea as a biologic or mechanical vector in the transmission o f B. henselae
in cats. Studies have detected B. henselae DNA by PCR from fleas o f infected cats
(Koehler et al.1994; Bergmans et al.1997). Higgins et al. (1996) demonstrated that B.
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henselae was viable after 9 days in flea feces o f fleas feed on infected cats. Tompkins
(1997) suggested that infection with B. henselae could occur by means o f flea feces
inoculated into a cutaneous site. Chomel et al. (1996) demonstrated that the cat flea
transmits B. henselae from infected cats to noninfected cats by removing fleas from one
group to the other. In the study by Foil et al. (1998), experimental infection o f cats with
B. henselae was established by inoculation o f flea feces that had been collected from
infected cats.
Clinical m anifestations. B. henselae infections in humans result in a wide array of
diseases. Because clinical infection in cats can be asymptomatic, natural infections may
have gone unnoticed for many years. Early reports suggested that cases o f regional and
generalized feline lymphadenopathies of unknown cause were associated with
Bartonella infections in cats (Kirkpatrick et al. 1989). Argyrophilic bacteria were seen
in the lymph nodes o f cats with persistent idiopathic lymphadenopathy (Kirkpathrick et
al. 1989). Epidemiological studies indicate that a large number o f cats have been
exposed to B. henselae or are infected with the organism (Childs et al. 1995; Chomel et
al. 1995; Jameson et al. 1995; Koehler et al. 1994). Naturally infected cats appear to
tolerate chronic infections without obvious clinical abnormalities. Cats can remain
asymptomatic and bacteremic for many months (Koehler et al. 1994; Kordick et al.
1995). Several experimental infections have attempted to establish the clinical signs in
cats. Clinical presentations in experimentally infected cats have varied from no clinical
signs (Regnery et al. 1996; Abbott et al. 1997) to mild clinical signs with fever and
histopathologic lesions (Guptill et al.1997) to acute clinical disease with fever, anorexia,
and neurological signs (Kordick et al. 1997b; O ’Reilly et al. 1999a). Lappin and Black
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(1999) have reported a case o f anterior uvetis in a cat in which antibodies to Bartonella
species could be detected in serum and aqueous humor. Bacteremia in cats is a clinical
presentation that is consistent with infection with B. henselae. Bacteremia can be of
significant magnitude with counts ranging from 999 to 33,300 CFU/ml (Greene et al.
1996). Bacteremia can last for weeks to years and then relapse (Kordick et al. 1999).
In studies by Greene et al. (1996), recrudescent bacteremia in infected cats with lower
magnitude (6 to 3,300 CFU/ml) was seen. In the acute phase o f the infection in cats,
bacteremia was associated with febrile signs, whereas in recurrent episodes o f
bacteremia, fever not a usual clinical sign (Kordick et al. 1999).
Persistent infections. Persistent infections are known to occur in association with
many bacteria, viruses, and protozoa. Examples o f microorganisms involved in
persistent infections include Salmonella typhi which can persist in the gall bladder and
urinary tract and is intermittently shed in urine and feces; Mycobacterium tuberculosis;
Herpes simplex; Varicella-Zoster; Plasmodium vivax; and Toxoplasma gondii. In
general, one way o f explaining persistent infections is to regard them as a failure o f the
host’s antimicrobial forces to eliminate the invading microorganism from tissue.
Persistent infections cannot by definition be acutely lethal and in fact, they tend to cause
only mild tissue damage or disease to the host. In certain acute infections, the patient
appears to recover, but there is a later relapse. Persistent infections are not usually
significant causes o f acute illness but can be o f particular importance because 1) They
enable the infectious agent to persist in the community. 2) They can be activated in
immunosuppressed patients. 3) Some are associated with immunopathological disease
i.e. feline leukemia virus, hepatitis B virus, malaria. 4) Some are associated with
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neoplasms. 5) Some are immunosuppressive and permit disease caused by other
normally harmless persistent microorganisms. The persistent organism can then
continue to cause pathological changes or to be shed from the body. Bartonellosis in
humans causes a persistent bacteremic illness in patients infected with B. henselae and
B. quintana (Lucey et al. 1992; Welch, and Slater 1999). Fever with bacteremia is a
common clinical presentation o f Bartonella infection. Relapsing fever with bacteremia
can occur in both immunocompromised and immunocompetent patients (Lucey et al.
1992). Prolonged and recurring episodes o f bacteremia are associated with Bartonella
infections in cats. Kordick and Breitschwerdt (1997) demonstrated relapsing
bacteremia in experimentally infected cats in a study where the cats were observed for
213 days. Eleven of these cats were inoculated via blood transfusion and developed
relapsing bacteremia. The reasons for relapsing bacteremia are unclear. Possible
reasons for relapsing bacteremia in cats may result from repetitive evasion o f the
immune system through antigenic variation by the organism via alteration o f surface
antigens, escape from the phagocytic cell, location in an immunologically privileged
site, or sequestration in the host with intermittent release into the general circulation.
The bacteremia in these cats persisted in the presence o f variable antibody titers,
suggesting that B. henselae antibodies are not effective in clearing infection. Kordick et
al. (1999), followed a group of cats chronically infected with B. henselae for 454 days.
In this study, cats were intermittently bacteremic without obvious clinical signs except
for one cat with symptoms related to the central nervous system that resolved
spontaneously and did not recur (Kordick et al. 1999). Intervals of 1 to 4 months
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occurred in which cats were culture negative. Recurrent episodes o f bacteremia were
not accompanied with fever and lasted for 454 days in two cats. (Kordick et al. 1999)
Immunological response. The spectrum o f disease seen in humans associated with
Bartonella species is wide. The ability o f Bartonella to elicit such different pathologic
responses is associated with the immune status o f the host. B. henselae infection may
produce either the granulomatous lymphadenitis that is characteristic o f cat scratch
disease in immunocompetent patients or vascular proliferation in patients with defects
in cellular immunity. The most severe manifestations of B. henselae infections occur in
individuals with a depressed cellular immune response. B. henselae in humans is an
intracellular pathogen and multiples within phagocytic cells and is considered a likely
candidate for a Th-1 IFN-y type o f response (Anderson and Neuman 1997). The
persistence of a Th-1 response to an intracellular pathogen is likely to result in an
inflammatory tissue response as seen in infections due to Bartonella.
Results from studies of B. henselae infections in the murine model (BALB/c)
demonstrated granulomatous inflammation in the liver with lesions consisting of
lymphocytes, monocytes, and epithelioid cells (Regnath et al. 1998). Mononuclear cells
were predominately CD4+ lymphocytes or CD1 lb+ monocytes. CD8+ lymphocytes
were found in low numbers. Karem et al. (1999), found B. henselae-specific IgA in
fecal samples of infected BALB/c mice 28 days after infection. In addition, a positive
delayed-type hypersensitivity and IFN response in mice following in vitro stimulation
o f splenocytes indicated B. henselae-specific cellular responses.
Humoral immunity against B. henselae was studied in vitro by Rodriguez-Barradas
et al. (1995). In this study, Bartonella was killed by complement-mediated cytolysis,
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and the presence o f specific antibodies did not increase the serum bactericidal activity
or complement activation. Nonimmune sera killed more than 99.5% o f the inoculum
within 2 hours, suggesting that specific antibodies did not contribute to the bactericidal
activity o f serum. Complement activation proceeded by both classical and alternative
pathways. Activation o f the alternative pathway is explained by the lipopolysaccharides
of gram negative bacteria that activates C3. The classical pathway assays suggested in
this study that B. henselae activated this pathway independent o f the presence of
specific antibodies. In this study phagocytosis and production o f oxygen radicals,
evaluated by flow cytometry, were significantly enhanced in the presence o f bacteria
previously opsonized with immune sera.
The indirect fluorescent-antibody assay (IFA) is widely accepted as a diagnostic
assay for B. henselae infection. The limitation o f the IFA is the inability to differentiate
species-specific serologic reactivity from cross-reactivity with other antigens o f the
same genus i.e. B. quintana. Western blot has been used to dissect the humoral immune
response to B. henselae antigen in patients infected with B. henselae. McGill et al.
(1998) used serum specimens from 69 humans diagnosed with Bartonella infection
(CSD) to investigate subclass level of IgG and other immunoglobulin (Ig) isotypes
using western blot assay. The ranges o f B. henselae-reactive proteins recognized were
17,48, 69, 97, and 116 k-Da and multiple bands at 200 Da. Reactivity to proteins did
not occur in all specimens. In this study, a strong IgG response was detected to total
antigen with the response limited to subclass IgGi. A lack of IgG 3 and high levels of
IgGi activity against B. henselae in CSD infection suggest increased opsonization
activity during CSD rather than complement fixation. Ig isotype differences were
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investigated in this same group o f infected patients, and IgA was detected in 15 o f the
69 patients whereas IgM and IgE antibodies were essentially absent in these patients.
Anderson et al. (1995) identified a strong antibody response in patients with CSD to
a 17 kDa antigen he expressed as a fusion protein. This type o f antigen would have
value as a diagnostic reagent for rapid serologic diagnosis o f Bartonella infections.
A cellular-mediated delayed-type hypersensitivity has been shown to occur in 95 to
98% o f humans with CSD when the Hanger-Rose skin test is used for traditional CSD
diagnostics (Szelc-Kelly et al. 1995). Other implications of cellular immune induction
was seen in immunocompromised humans when they develop severe disease involving
internal organs such as liver, spleen and central nervous system.
The immunological response o f cats to B. henselae is unclear. The different
contributions o f antibody and cellular immunity are difficult to determine. The only
cell in the cat that Bartonella has been associated with is the erythrocyte. An
intracellular location o f Bartonella other than in the erythrocyte has not been
demonstrated in the cat. Other difficulties involved in the present interpretation o f the
immunological response seen in cats are the differences in the route o f inoculation and
the source o f the inoculum. Intravenous, intradermal, intramuscular, and oral routes of
inoculation have been performed in experimental infections o f B. henselae in cats
(Abbott et al. 1997; Guptill et al. 1997; Kordick and Breitschwerdt 1997). Sources of
inoculum used in these studies include infected blood and urine and pure cultures o f B.
henselae (Abbott et al. 1997; Guptill et al. 1997; Kordick and Breitschwerdt 1997;
Regnery et al. 1996). Other difficulties in the interpretation o f the immunological
response seen in cats is the various strains o f B. henselae used to experimentally infect

26

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

cats, and the number o f passages o f the culture before the inoculum was prepared. B.
henselae Houston-1, the prototype strain and a genotype I originally isolated from a
human patient, has been used in many studies but genotype I strains are less commonly
isolated from cats than are the B. henselae genotype II strains (Bergmans et al.1997;
Heller et al. 1997). The seroprevalence o f B. henselae in cats varies throughout regions
o f the United States and in Europe. Seroprevalence ranges from 3.7% to 65.4% in the
United States (Jamerson et al. 1994; Childs et al. 1994; Chomel, 1996). An
understanding o f the role o f humoral antibodies and the cellular responses in cats is
incomplete. High levels o f circulating antibodies to B. henselae can be detected in cats
with bacteremia. Bacteremic cats have been shown to have higher B. henselae antibody
titers than nonbacteremic cats (Chomel et al. 1995). Using an enzyme-linked
immunosorbent assay (ELISA) for detection of B. henselae specific antibodies,
Freeland et al. (1999) demonstrated B. henselae specific IgM and IgG responses in
experimentally infected cats with a pattern of a peak IgM level followed by a rise in IgG
antibodies. Western blot analysis has been performed in infected cats to identify the
immunodominant antigens. Freeland et al. (1999) identified 24 Bartonella-specific
antigens recognized by cats during infection, and antigens o f the 11.3-13.3 kDa and
16.9/18.0 kDa range were common and useful for an antibody screening test. Using the
pathogenic strain B. henselae LSU 16, O’Reilly et al. (1999) demonstrated by ELISA
measurable levels o f IgM at 3 week post exposure and high levels o f IgG by 4 weeks
postinfection. O f interest in this study was the IgM response that began to wane by
week 6 but remained elevated in the infected cats throughout the study, suggesting
continued antigenic stimulation. In the study by Greene et al. (1996), cats infected with
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B. henselae Houston-1 displayed serological response (IgG) that peaked between 3 to
12 weeks after inoculation. The range of the antibodies demonstrated with IFA (B.
henselae Houston-1 antigen) was 128 to 512 with one titer at 4096 in an adolescent cat.
After 11-14 weeks, the antibody titer in five o f the cats was at or below 64. On
rechallenge, the antibody titers increased more rapidly and at a higher level than those
after the primary exposure.
The role o f antibody responses to B. henselae infection in cats has been
demonstrated in several studies. Guptill et al. (1999) compared the immune response o f
neonatal Specific Pathogen Free (SPF) cats experimentally infected to adult cats (SPF)
with a normal mature immune system. Neonates (3-5 days o f age) were inoculated with
B. henselae intradermally or orally and were bacteremic through 12-16 weeks similar to
what occurred in adult cats. Cats inoculated intradermally produced IgG Bartonellaspecific antibodies but orally inoculated neonatal cats did not. Cats with or without IgG
became abacteremic at the same time suggesting that antibodies are not necessary to
clear bacteremia. Parr et al. (1999) demonstrated the role o f antibody in limiting
clinical disease but not in the prevention o f bacteremia and infection with B. henselae.
Parr et al. (1999) demonstrated the effects of passive antibody by decreasing clinical
disease and delayed onset o f bacteremia in experimentally infected cats. The effects of
maternal antibodies were demonstrated in kittens from infected queens with maternal
antibody. Kittens infected at 6 weeks of age became bacteremic but had decreased
clinical disease, whereas kittens from noninfected queens show signs o f clinical disease.
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Guptill et al. (1998), demonstrated maternal anti-5, henselae antibodies in fetuses
and kittens o f infected mothers at 2 weeks post-partum but were not detected at 10
weeks post-partum.
Homologous protection has been shown in several studies with experimentally
infected cats. Regnery et al. (1996) demonstrated homologous protection with B.
henselae by lack o f heterologous protection by B. quintana. In this study, cats infected
with B. henselae failed to develop bacteremia on challenge exposure with B. henselae
but did support B. henselae infection if previously infected with B. quintana. Greene et
al. 1996), also demonstrated homologous protection with B. henselae after secondary
challenge. Cats in this study also had higher and more rapid increase in serum antibody
titers than after primary inoculation. Yamamoto et al. (1998), demonstrated lack o f
heterologous protection by various species and types of Bartonella in SPF cats. In this
study, there was lack of cross protection between B. henselae and B. clarridgeiae and
between B. henselae genotype I and II and the wildlife isolate, ‘Humboldt’.
T herapy and treatm ent. Bartonella isolates from humans are susceptible to
numerous antimicrobial agents including erythromycin, chloramphenicol, rifampin,
gentamicin, trimethoprim-sulfamethoxazole, doxycycline, and ciprofloxacin (Maurin
and Rauolt 1993; Musso et al. 1995). In vitro resistance to penicillin and ampicillin,
tetracycline or vancomycin has been noted (Welch and Slater 1999). There is, however,
a poor correlation between in vitro susceptibility and in vivo responsiveness to
antibiotics. Minimal inhibitory concentration (MIC) results obtained do not appear to
correlate with in vivo antimicrobial efficacy (Maurin et al. 1993). In human infections
numerous individual case reports indicate both successful or unsuccessful treatment of
%
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B. henselae infection (Margileth et al. 1991; Holley et al. 1991). Response of patients
to antibiotics such as trimethoprim-sulfamethoxazole and fluoroquinolones are
inconsistent (Welch and Slater, 1999). Human data suggest that higher doses and
longer periods o f administration o f antibiotics than normal are indicated for treatment o f
Bartonella infections. Patients with extensive hepatic involvement and regional
lymphadenopathy responded to intravenous gentamicin within 48 hours with no
recurrence o f symptoms (Bogue et al. 1989). Treatment o f healthy patients with typical
CSD is supportive because the disease is self-limited. Azithromycin use accelerated the
resolution o f the lymphadenopathy o f typical CSD (Bass et al, 1998; Welch and Slater
1999). In patients with severe multisystemic disease, trimethoprim-sulfamethoxazole,
ciprofloxacin or azithromycin is recommended (Margileth et al. 1998). In
immunodeficient patients, therapy with erythromycin, clarithromycin, azithromycin,
doxycycline, or tetracycline have been found to be effective (Koehler et al. 1997).
Treatment in these patients was for 6-8 weeks with retreatment of 4-6 months in
infections that relapse. Ciprofloxacin has been used successfully to eradicate
Bartonella infection in humans (Margileth et al.1992; Holley 1991). The success o f
ciprofloxacin in treatment of Bartonella infections is attributed to the high drug
concentration achieved in leukocytes, macrophages, and other tissues and organs
frequently colonized by Bartonella organisms, including the spleen, liver, lymph nodes,
heart, and bone (Kordick et al. 1997b).
Antibiotic therapy for control o f B. henselae in infected cats has been investigated
under controlled experimental condition in several studies. Amoxicillin, enrofloxacin,
erythromycin, and tetracycline have been evaluated for efficacy o f B. henselae
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infections in cats. Studies by Regnery et al. (1996) demonstrated reduction in
bacteremia in experimentally infected cats with tetracycline and erythromycin after 3455 days o f treatment. Enrofloxacin-treated cats and amoxicillin-treated cats became
abacteremic by day 98 and 127 after infection, respectively (Regnery et al. 1996).
Greene et al. (1996), treated cats for 1 week with doxycycline and suppressed the
bacteremia but infection was not cleared. These studies are misleading however
because o f the method o f detection o f bacteremia and the relapsing nature o f Bartonella
infections. In the studies by Regnery et al. (1996) and Greene et al. (1996) efficacy o f
treatment was determined by bacteremia as detected by culture, which is not the most
sensitive assay for defining bacteremia. Because relapsing bacteremia can occur in cats
for long periods, a thorough understanding o f the efficacy of antibiotics would involve
following infected cats for long periods. Kordick et al. (1997b), treated cats infected
with Bartonella species using enrofloxacin and doxycycline. In vivo efficacy of both
antibiotics was examined in 18 experimentally infected cats and 25 naturally infected
cats. Treatment success was achieved in 9 of 14 cats receiving enrofloxacin and 2 of 8
cats receiving doxycycline. Treatment was ineffective in some o f the infected cats
despite plasma drug concentrations maintained above the MICs o f enrofloxacin and
doxycycline during each sampling period. Treatment success was based on elimination
of bacteremia detected by culture or PCR. Doxycycline was chosen to treat Bartonella
infected cats because o f its solubility in lipids and ability to cross cell membranes,
whereas enrofloxacin is known to passively diffuse into bacteria and mammalian cells
(Pocidalo 1989). Because cats can be chronically infected with Bartonella, treatment
success may vary depending on the status of infection i.e. acute versus chronic
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infection. Antimicrobial efficacy may be more successful if given to the acutely
infected cats, whereas success in the chronically infected cat may require longer periods
of administration and or higher doses.
L aboratory Diagnosis of Bartonella Species
Available test. Diagnostic tests available for the detection and diagnosis o f B.
henselae in cats include serologic testing, bacterial culture, histopathology with
specialized silver staining, and nucleic acid detection using the polymerase chain
reaction (PCR). In the acute phase of the disease, cats are usually bacteremic and the
organism can be cultured from blood. Clinically, however, cats that are bacteremic
often show no clinical signs of disease (Regnery et al.1992).
B. henselae can be isolated quite easily from a bacteremic cat using common blood
containing media such as chocolate agar and blood agar. Cultures are incubated at 3537°C in an atmosphere o f 5% CO2 . Isolation time varies from 7-35 days. A number of
different solid media have been used, including trypticase soy agar with 5% sheep
blood, chocolate agar, and heart infusion agar with 5% rabbit blood for the isolation of
B. henselae. B. henselae has characteristic colony morphology on initial isolation.
Colony morphology and growth characteristics can be used by those experienced with
handling Bartonella species to recognize the pathogenic species (Clarridge et al.1995).
Colonies are often invaginated, cauliflower-like and imbedded in the agar. It is thought
that this autoadherence is due to the presence o f genotype IV pili on the surface o f the
organism (Batterman et al. 1995). Subculturing o f the organism results in more rapid
colony growth, with visible colonies appearing after 2 to 3 days o f incubation and a loss
of the autoadherent phenotype (Anderson and Neuman 1997).
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Isolation and Culture. For many years microorganisms could be visualized in
patients with CSD and bacillary angiomatosis but could not be grown in the laboratory.
The initial detection o f B. henselae and its laboratory propagation occurred in 1990
(Slater et al. 1990). Using oligonucleotide primers complementary to the 16S ribosomal
RNA genes o f eubacteria, a polymerase chain reaction was used to amplify 16S
ribosomal gene fragments directly from tissue samples of bacillary angiomatosis
(Reiman et al. 1990). The PCR fragments were sequenced and identified as an
uncharacterized microorganism closely related to Rochalimaea quintana (Reiman
1990). The first isolation occurred when a curved gram-negative bacillus was isolated
from several immunosuppressed patients with persistent fever and bacteremia (Slater et
al. 1990). These primary cultures of blood were processed by centrifugation after
blood-cell lysis, and colonies were isolated after 15 days on chocolate agar and sheep
blood agar (Slater et al. 1990). It is now recognized that B. henselae can be cultured on
enriched bacteriologic culture medium containing heme and in the presence o f 5% CO 2 .
Success of isolation o f Bartonella species is variable depending on the time course of
the infection and the choice o f specimen. In general, isolation o f B. henselae from
blood o f patients with CSD who have no evidence o f systemic disease was unsuccessful
(Anderson and Neuman 1997). On the contrary, patients who are immunocompromised
with evidence o f systemic disease usually are culture positive for Bartonella (Anderson
and Neuman 1997). The optimal temperature for growth is 35 to 37°C for B. henselae,
B. elizabethae, and B. quintana. B. henselae has characteristic colony morphology on
initial isolation. Colonies are often imbedded in the agar, and o f a cauliflower-like
appearance. The organism is often autoadherent and difficult to pick from the surface
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o f the agar (Batterman et al. 1995). Upon subculturing o f the organism, the
autoadherent phenotype is lost (Anderson and Neuman 1997). Colony morphology and
growth characteristics are unique to Bartonella species and can be easily recognize by
anyone trained to do so.
Several types o f liquid media have been described that support primary isolation of
B. henselae. A defined RPMI 1640 based medium supplemented with pyruvate, hemin,
and amino acids was used to isolate B. henselae from blood and tissue specimens of
infected patients and a domestic cat (Wong et al. 1995). A blood-free medium with
blood-based components has been shown to support the growth o f B. henselae
(Schwartzman et al. 1993). This medium consists o f brucella agar with 6 to 8% Fildes
solution (BBL), which is a sterile digest o f sheep blood, and 250 pg o f hemin, a
derivative o f heme, which is the iron containing group o f hemoglobin. Several
commercial systems have also been used to identify Bartonella from blood (i.e. SeptiChek biphasic system, BACTEC 460, and the BACTEC NR 660 system) (Larson,
1994). BacT/Alert (Organon Teknika, Durham, NC) using tryptic soy broth with 0.03%
sodium polyanetholesulfonate (SPS) in CO 2 has been used to isolate Bartonella from
the blood of 5 patients who were immunosuppressed (Tiemo et al. 1995).
Direct plating of blood collected in EDTA and lysis centrifugation, using Isolator
Wampole, (Cranbury, NJ) have been used successfully to isolate B. henselae, B.
quintana, and B. clarridgeiae. Freezing o f blood was shown to increase the sensitivity
o f detection o f B. henselae by increasing the number of CFU/ml recovered (Brenner et
al. 1997). It is thought that the freezing lyses erythrocytes and leukocytes and may
serve to liberate intracellular organisms or those organisms that may be on the surface
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or cell membrane (Brenner et al. 1997). Blood collected in tubes containing EDTA,
frozen at -65°C and then plated have been shown to increase the number o f CFU/ml
compared to blood collected in the Isolator tubes (Brenner et al. 1997). Primary
isolation o f Bartonella from tissue has also been accomplished by grinding tissue and
plating on chocolate agar (Dolan et al. 1993).
Cell culture systems have also been used to isolate Bartonella from both blood and
tissue. Endothelial cell lines have been used to cultivate B. henselae and B. quintana
from skin lesions of patients with bacillary angiomatosis (Koehler et al. 1992). Co
cultivation o f B. henselae with Vero cells provide substrate to which the Bartonella do
not autoagglutinate and the cells provide an environment for growth (Dalton et al.
1995). B. henselae is grown in Vero cells for preparation o f antigen to use in the
indirect fluorescent antibody assay (Regnery et al. 1992).
Identification. Bartonella species can be identified to the genus level by
phenotypic characteristics such as growth requirements, gram stain, and colony
morphology. Identification of Bartonella to species level is somewhat more difficult
because in general Bartonella species are biochemically inert. Carbohydrate utilization
cannot be determined by conventional tests but requires methods that may include
genetic analysis. DNA-DNA hybridization and PCR amplification o f various genes
followed by sequencing or restriction endonuclease analysis o f amplicons have been
successful in identification o f Bartonella species.
Serological assays. Serological testing is used frequently for the diagnosis o f B.
henselae in cats because these methods are practical and economical methods that can
be performed by most laboratories. Serologic tests do have limitations and may not be a
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clear diagnostic indicator in some cases. Low antibody levels are detected many times
and are not sufficient evidence to determine active or prior infection. Another
limitation o f some serological tests, is the sensitivity and specificity o f the test
depending on the antigens used in the assay, the time o f specimen collection, the format
o f the assay, and the indicators used to detect the antibody.
The serological response of the cat to B. henselae is not understood partially because
Bartonella antigens recognized by the cat’s immune system have not been fully
identified. Lack o f understanding o f the immunodominant antigens is a controlling
factor for the serological assay used for serodiagnosis o f Bartonella in cats.
Serodiagnostic tools such as indirect immunofluroescent assay (IFA); enzyme-linked
immunoassay (EIA) and the western blot analysis are all used to determine antibody
levels to Bartonella in cats and humans. The IFA is probably the most common
serologic assay used by laboratories and the sensitivity is reported to be 88% and the
specificity is 94% (Regnery et al. 1996). IgG titer of >1:64 in a cat is considered a
positive titer for B. henselae. Studies using the IFA for diagnosis o f cat scratch disease
however, point out possible weakness o f the IFA (Zhinden et al. 1997; Bergmans et al.
1997). In studies by Zhinden et al. (1997); Bergmans et al. (1997) the sensitivity and
specificity of the IFA was shown to be affected by the preparation o f the Bartonella
antigen (with or without cocultivation with Vero cells) and the cutoff titer of the test.
Bergmans et al. (1997) demonstrated that one-point IgG serology is not diagnostic for
B. henselae infection in humans and that two-point serology is necessary to detect
ongoing B. henselae infections. Bergmans et al. (1997) also concluded that IgM
serology was superior to IgG serology in diagnosing B. henselae in CSD patients.
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The serological picture with cats infected with B. henselae varies. Cats with
B. henselae bacteremia were shown to be serologically positive with high titers. Other
stu . ; found bacteremic cats with no detectable antibody levels. Results from a study
by Bergmans et al. (1997) using the ELA to measure antibody to Bartonella, concluded
that 20% o f the 113 cats enrolled in the study were bacteremic and had anti-5, henselae
antibodies whereas 30% o f the 113 cats had antibodies to B. henselae but were not
bacteremic, whereas 2% o f the 113 were bacteremic but were seronegative. This study
concluded that the positive predictive value o f the serologic assay for bacteremia is
39%, and the negative predictive value o f the serologic assay is 96%.
Histopathology and W arth in S tarry silver stain. Before culture, serological
assay or nucleic acid detection became available, histologic findings with silver stains
were used to characterize the causative agent of CSD and bacillary angiomatosis. Early
reports in the literature described Warthin —Starry positive bacteria associated with
cases o f cat scratch disease (Margileth et al. 1984; Kudo et al. 1988). Small
pleomorphic bacilli were seen using the Warthin-Starry silver impregnation stain in
both the skin at primary inoculation sites and in lymph nodes from patients with CSD
(Margileth et al. 1984). Attempts to culture this organism were unsuccessful.
Histologic evaluation o f lesions in patients with CSD and bacillary angiomatosis
revealed similar pleomorphic bacilli on silver stain. The histopathologic findings
associated with infections caused by B. henselae in humans are described in the
literature and are significant. Histopathological findings in lymph nodes depend on the
stage o f the infection. There may be lymphoid hyperplasia, arteriolar proliferation, and
reticulum cell hyperplasia early in the course o f the infection (Sander et al. 1999). In
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the later stages o f the infection, granulomas with central areas o f necrosis,
multinucleated giant cells, and multiple stellate microabscesses are seen (Bass et
al.1997; Kaschula 1996). The histopathologic changes found in CSD are consistent
with granulomatous inflammation with or without central suppuration (Min et al.1993).
The lymph nodes from patients with CSD typically include stellate caseating
granulomas, microabscesses, and follicular hyperplasia (Carithers 1985). The follicular
hyperplasia may be seen with a distinct germinal center and plasmacytosis in the
residual parts o f the lymph node (Kudo et al. 1988). Multinucleated giant cells with the
zone of histiocytes can be seen (Kudo et al. 1988). Min et al, (1993) identified bacilli of
cat scratch disease using a labeled polyclonal rabbit antibody to the outer surface
protein o f B. henselae. The histopathological findings are typical but not specific for
CSD (Sander et al. 1999). Infections caused by other agents, such as lymphogranuloma
inguinale caused by Chlamydia trachomatis, atypical mycobacteriosis, yersiniosis,
tularemia, brucellosis, certain mycotic and chronic granulomatous diseases o f childhood
must be considered in the differential diagnosis (Anderson et al. 1994).
Bacillary angiomatosis is a neovascular disorder with the presence o f bacilli in the
tissue. Cutaneous or subcutaneous lesions are seen in bacillary angiomatosis patients.
Characteristic lobular proliferation o f blood vessels are seen in the lesions with
hematoxylin and eosin stain. Granuloma formation are not seen in patients with
bacillary angiomatosis.
Studies o f cats seropositive to B. henselae report different findings in regards to
histological abnormalities or clinical manifestations. Several studies have shown
histological abnormalities in cats experimentally infected with B. henselae (Guptill et
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al. 1997; Korkick et al. 1999). Guptill et al. (1997) found histopathologic lesions in
multiple organs o f experimentally infected cats 8 weeks after infection. In this study,
cats were described to have generalized peripheral lymphadenopathy with a marked
lymphoid hyperplasia characterized by an expanded paracortex and secondary follicles
with germinal centers. Mild to marked lymphoid hyperplasia o f the spleen with
development of prominent germinal centers was seen in cats infected with a strain o f
B. henselae originally isolated from a cat. Circumscribed aggregates o f neutrophils or
microabscesses were present throughout the red pulp o f the spleen. Two weeks after
infection, the liver from this group of cats contained small foci o f necrosis in the
parenchyma and an increased number of neutrophils in the sinusoids o f the liver. Eight
weeks after infection small foci of granulomatous inflammation in the liver could be
seen. Focal pyogranulomatous nephritis and interstitial myocarditis could be seen in
one cat 4 weeks after infection. Few bacteria were seen on Warthin-Starry stains o f the
spleen of cats examined 2 weeks after infection in this study. In a study done by
Kordick et al. (1999), cats were experimental infected with B. henselae genotype II and
histopathology evaluated after 454 days. In this study peripheral lymph node
hyperplasia was seen in all 13 cats, splenic follicular hyperplasia in 9 cats, lymphocytic
cholangitis in 9 cats, lymphocytic hepatitis in 6 cats, lymphoplasmacytic myocarditis in
8 cats, and interstitial lymphocytic nephritis in 4 cats. Warthin-Starry silver stains were
only suggestive of bacilli in tissue examined in this study.
Polymerase chain reaction (PCR). Polymerase chain reaction (PCR) is an in vitro
method of nucleic acid synthesis by which a particular segment o f DNA can be
specifically replicated. A single nucleic acid target molecule can be amplified until
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sufficient material is present to enable detection and identification. Amplification and
detection can be detected in minutes to hours. PCR replaces the conventional process
o f biologic amplification i.e. growth in culture, with enzymatic amplification o f specific
nucleic acid sequences. The ability to isolate and cultivate microbial pathogens on
artificial medium represents one o f the great diagnostic triumphs o f the last century.
Cultivation o f microbial pathogens from clinical specimens is the mainstay o f the
clinical laboratory today. Despite its established value, however, in vitro cultivation has
many drawbacks. The time required for growth of an organism in culture usually
ranges from days to weeks, and definitive tests introduce additional delays. The number
o f bacterial species that are isolated on bacterial culture m edia is limited. It is
estimated that less than 1% o f the bacteria present on the earth have been described
using cultivation (Reiman et al. 1998).
PCR technology amplifies a selected region of DNA. It involves two
oligonucleotide primers that flank the DNA fragment to be amplified. These primers
hybridize to opposite strands o f the target sequence and are oriented so that the DNA
synthesis occurs across the region between the primers. PCR is based on the functions
o f DNA polymerase to copy and amplify a strand of DNA. DNA polymerase initiates
elongation o f the primer to a longer strand o f DNA. The starting material for PCR is
called the target and is a DNA gene segment. The target sample reacts with a master
mix that contains everything needed to synthesize DNA sequences. The PCR assay
consists o f three steps per cycle which is repeated 20-40 times. Each cycle doubles the
number o f DNA molecules in the previous cycle. Because the copies increase
exponentially, more than 100 million copies can be made in only a few hours. The
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three PCR cycles begin with denaturation, in which double stranded material is
denatured into single-stranded material. The second step involves the annealing o f a
primer pair. The primer is a small piece o f synthetic DNA, an oligonucleotide, known
to complement the DNA sequence o f a particular genetic sequence. The primers flank
the target sequence o f interest. The primer searches out the separated DNA strands and
anneals to its complementary sequence. The third step o f the PCR cycle is extension, in
which the DNA polymerase extends the target sequences between the primers by
addition of bases to the 3’ end o f the strand.
PCR is a sensitive assay that can detect a single DNA molecule. However, a single
protocol is not appropriate for all target sequences. Each PCR design requires
optimization for best performance o f the assay. Factors to consider in the design o f the
PCR assay are the reaction components, the denaturation and annealing temperatures,
and the number o f cycles performed. Concentrations o f reagents in the reaction mixture
such as dNTPs, magnesium chloride, DNA, enzyme, and primers need to be optimized
to maximize efficiency and fidelity o f assay. Denaturation o f the target template is the
first step in the PCR cycle. Strand separation occurs in this step and the correct
denaturation temperature is critical. Primer annealing temperatures are important and
should be approximately 5°C below the true melting temperature (Tm) o f the
amplification primers. The primers used in the assay must be specific only for the DNA
o f the target organism. The specificity o f the primer increases as the temperature
approaches the correct annealing temperature. Increasing the annealing temperature
enhances discrimination against incorrectly annealed primers and reduces miss
extension o f incorrect nucleotides at the 3 ’ end o f the primers.

41

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

Since the development in 1984, PCR assays have been used in research and clinical
applications. Advantages o f nucleic acid techniques include rapid detection o f
fastidious pathogens, detection of nonculturable agents, and discovery o f new organism
types and genotypic analysis. A PCR assay was used to discover and understand
infections caused by B. henselae and to diagnosis cases o f bartoneilosis. Nucleic acid
techniques, including PCR and nucleotide sequencing, were important early in the
characterization o f B. henselae and its association with a variety of disease syndromes.
Reiman et al. (1990), was the first to use broad-range PCR to detect the 16S rRNA gene
sequence o f B. henselae from tissue o f patients with bacillary angitomatosis. B.
henselae bacilli could be seen on silver stains within the lesions o f patients but could
not be isolated by culture techniques. Since that time, PCR has been used as a detection
and identification method for B. henselae. Because o f the fastidious nature o f many
organisms, including Bartonella species, and the limitations o f cultivation technology,
nucleic acid amplification techniques such as PCR are very useful methods to reveal
novel microbes associated with disease. The PCR assay has been used to detect B.
henselae in specimens in multiple human cases involving lymphadenitis, osteomyelitis,
retinitis, postpartum coma, encephalopathy, endocarditis, and Parinaud’s oculoglandular
syndrome in which the cultures were negative (Gottlieb et al. 1999; Robson et al.1999;
Warren et al.1998; McCormack et al. 1998; Wheeler et al.1997; Drancourt et al.1996;
Grando et al. 1999). The discriminatory power in identifying microbes is increased
with genotypic methods as compared to cultivation and use o f phenotypic methods.
Once a microbe is amplified with a PCR assay, the product of that amplification can be
confirmed by sequencing to determine the exact nucleic acid sequence o f the DNA
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fragment. PCR techniques have been used to determine genotypes o f strains involved
in cases o f CSD and bacillary angiomatosis (Bergmans et al. 1997; Heller et al. 1997;
Sander etal. 1999).
Some o f the B. henselae genes amplified by PCR are the 16S rRNA gene, the citrate
synthase gene (gltA), and the htrA gene encoding a 60 kDa heat shock-like protein.
Oligonucleotide primers are designed specifically to be complementary to regions of
these genes.
The 16S rRNA gene is often used in nucleic acid detection methods. Multiple
copies of a gene encoding a 16S rRNA are found in all eubacterium. The 16S rRNA
gene found in these cells is highly conserved with interspersed regions o f hypervariable
sequences. Broad range eubacterial 16S rRNA primers complementary to the
conserved region and flanking the segment o f interest can be used in a PCR design to
amplify the unknown variable region. The primers anneal to conserved region o f
microbial DNA, and the polymerase generates new DNA strands, including the variable
region that can be sequenced for identity. Analysis o f the variable portions permits
determination o f phylogenetic and evolutionary relationships among organisms, and
now forms the basis o f a revised system o f natural classification (Woese 1987).
Because most bacterial genera and species have a unique 16S rRNA gene sequence, this
sequence serves as the molecular fingerprints, and can be used to identify organisms.
Pure cultured organisms can be the source o f the 16S rRNA targets in PCR, or infected
tissue can also be used.
The PCR assay is an extremely sensitive assay and can detect DNA fragments of a
particular microorganism that are below the detection limits o f culture. The levels of
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microbial DNA present in clinical specimens are frequently too low for measurement.
PCR can produce sufficient amounts o f DNA in order for a microbe to be detected and
identified. In theory, the PCR assay can detect as few as one microorganism. The
limitations of culture vary with the range o f 10 to 100 organisms per ml o f fluid.
Because each microorganism has a unique complement o f DNA, this DNA can help
produce an identity o f the microbe and allow for differentiation among microorganisms.
The PCR is a specific reaction when a unique set o f oligonucleotide primers
complementary to regions of the DNA templates are used, and a PCR product o f a
particular size is generated and seen on gel electrophoresis. In addition, confirmatory
methods can be done including sequencing o f the amplified product, annealing o f a
specific oligonucleotide probe to a region o f the amplification product, and restriction
enzyme cleavage o f the amplified product with gel electrophoresis o f the digest and
restriction fragment length polymorphism analysis. Sensitivity and specificity o f the
PCR can be increased further by designing a nested PCR. In the nested PCR two
reaction are performed using products from the first reactions in the second reaction and
increasing the final product. In the nested PCR, products from a primary PCR reaction
are used in a second reaction with primers that anneal to regions o f the same gene, but
at sites internal to the previous priming sites. In a hemi-nested PCR, one primer from
the first PCR reaction is used in the second round reaction along with a different primer.
PCR assays have a high analytical sensitivity. However, high analytical sensitivity
does not necessarily translate into high clinical sensitivity. Clinical performance o f an
assay such as PCR depends on various factors, including the method o f sample
collection, preparation to ensure adequate number o f target molecules, the presence of
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inhibitors of the enzymatic processes of amplification, and the time at which the sample
is collected. The volume o f sample tested has a direct bearing on clinical performance
if the target copy number is low. An analytical sensitivity o f a sample with only one
target copy will be positive in less than 70% o f all reactions performed (Persing 1993).
In this hypothetical system, a sample would have to contain an average o f 10 targets to
ensure that 99% o f all specimens contain a single copy for detection. Sensitivity also
depends on the number o f target molecules in the organism o f interest. If multiple
copies of the target are present in a single organism, the volume of sample may not be
as critical.
A variety of components within clinical specimens may inhibit the PCR by
interacting with components o f the enzymatic reaction. Inhibitors can interact with the
nucleic acid or with the polymerase and inhibit the assay. Heme at 0.8 uM and its
metabolic products are known inhibitors o f DNA polymerase. Cerebrospinal fluid,
urine, and sputum also contain uncharacterized inhibitors o f the Taq DNA polymerase.
Reagents traditionally used in the purification o f nucleic acids such as EDTA,
detergents, sodium dodecyl sulfate, chaotropes, and guanidinium HC1 are inhibitory to
the amplification enzymes.
The fundamental goals o f sample preparation include release o f nucleic acid,
stabilization o f nucleic acid against degradation, removal o f inhibitors, and
concentration o f target molecules. Various protocols for extraction and purification o f
sample DNA are available. A variety of methods to release the nucleic acid from
microorganisms include boiling in distilled water or PCR buffer, detergents, sodium
hydroxide, freeze-thaw, SDS-proteinase K, perchloric acid, enzymes, sonication and
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heat. Additional extraction steps with phenol-chloroform remove amplification
inhibitors. Methods o f concentration usually include use o f alcohol precipitation.
Target capture includes matrices such as magnetic particles, glass, Sephadex, and
diatomaceous earth, which bind nucleic acids in chaotropic solutions. Following
binding o f the nucleic acids to the solid-phase matrix, the impurities and amplification
inhibitors are removed by centrifugation, washing, and elution o f nucleic acids into a
compatible buffer. Commercial kits such as InstaGene matrix Genomic DNA Isolation
Kits (Bio-Rad Laboratories, Inc., Hercules, CA) and Qiagen Blood and Tissue Kit
(Qiagen Inc., Chatsworth, CA) are available for extraction o f DNA and are relatively
simple and automated.
The advantages o f PCR for laboratory diagnosis o f B. henselae can be summarized
in terms o f sensitivity, specificity (identification), and turnaround time. A PCR assay
for B. henselae will detect the microorganism in cases where culture may be negative
because o f detection limits and because of the fastidious nature o f B. henselae.
Identification of B. henselae and the various genotypes can be achieved with a high
discriminatory level using confirmatory methods o f sequencing or Southern blot using a
probe. Identification can be accomplished either from a DNA fragment amplified from
blood or tissue or from an isolate from culture.
Reverse transcription-polymerase chain reaction (RT-PCR). This procedure
involves the reverse transcription o f RNA and PCR amplification. The enzyme reverse
transcriptase converts RNA to complementary DNA (cDNA) and then the cDNA is
amplified in the PCR reaction. The RT-PCR has been widely used in research
laboratories as a rapid and sensitive technique for the detection, quantitation, and
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cloning o f specific mRNA and gene expression. The analysis of RNA expression can
determine if cells are in an active growing state, or in a non-growing state, i.e. dormant
resting state or nonviable state. RT-PCR is the most sensitive technique to determine
the presence or absence of RNA templates or to determine gene expression. RT-PCR is
used in clinical diagnostic laboratories for detection and quantitation o f infectious
microorganisms, cancer cells, and genetic disorders. Two different techniques are
commonly used for RT-PCR: the two step RT-PCR or the one step RT-PCR. In the two
step RT-PCR, cDNA synthesis is performed with reverse transcriptase derived from
avian myeloblastosis virus (AMV) or Moloney murine leukemia virus (MuLV) and Tth
DNA polymerase from the first step. In the second step, a PCR with DNA polymerase
is used. The two step reaction requires that the reaction tube is opened after the cDNA
synthesis and reagents are added for the PCR part o f the procedure. In the one step RTPCR the cDNA and PCR reaction are performed without addition o f reagents between
synthesis o f cDNA and PCR.
Understanding the Pathogenesis o f Bartonella henselae
in the Domestic Cat
Research problem: Bartonella henselae is a serious zoonotic agent and is the
etiologic agent for a wide spectrum o f disease in humans. The domestic cat is the
reservoir for B. henselae and a risk factor for contracting infections in which B.
henselae is the etiologic agent. The pathogenesis o f B. henselae in cats is incompletely
understood. To reduce the risk of contracting B. henselae from a domestic cat, a better
understanding o f the infection in cats is needed. Many aspects of feline bartonellosis
are unclear in particular the persistent nature o f the infection. B. henselae is a fastidious
microorganism that has proven to be difficult to detect by standard bacterial culture.
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Laboratory methods with high sensitivity and specificity are needed to study the acute
and chronic phase of these infections in cats. Understanding the acute and chronic
phase o f the infection in cats will help reduce the risk o f humans contracting Bartonella
from infected cats.
Purpose: Study the pathogenesis of B. henselae in the domestic cat using a
molecular approach. This study will investigate the bacteremic and chronic phase o f B.
henselae genotype I and genotype II infections in cats using a nested polymerase chain
reaction (PCR).
Hypothesis: A molecular assay such as polymerase chain reaction (PCR) is a useful
assay for detecting fastidious microorganisms involved in infectious diseases. In cats
with B. henselae infections, Bartonella DNA persists longer than can be detected by
standard bacterial culture and may explain the chronicity o f these infections.
R esearch objectives: • Design a molecular assay that is sensitive and specific for
the species o f Bartonella that are known to infect cats, i.e. Bartonella henselae
genotype I and genotype II and Bartonella clarridgeiae.
• Determine if PCR assay can be used in biological samples, i.e. blood and tissue
from experimentally infected cats.
• Use PCR assay to follow experimentally infected cats in acute phase (bacteremic
phase), during recurrent episode o f bacteremia and in postmortem tissue.
Compare PCR assay to bacterial culture.
• Determine if B. henselae DNA persists in tissue o f experimentally infected cats
that are abacteremic
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• Determine if there is any histopathology associated with B. henselae infection in
cats.
• Determine the RNA expression of B. henselae found in tissue in cats chronically
infected using RT-PCR.
• Investigate B. henselae genotype differences in experimentally infected cats
during bacteremia, relapsing bacteremia and in tissue.
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CHAPTER TWO
EVALUATION AND USE OF A NESTED PCR IN CATS EXPERIMENTALLY
INFECTED WITH BARTONELLA H E N SE L A E GENOTYPE I AND
BARTO NELLA H E N SE LA E GENOTYPE n
Introduction
The importance o f Bartonella henselae as an emerging pathogen is recognized more
each day by veterinarians, cat owners, and physicians. Bartonella henselae causes a
wide spectrum of diseases and diverse pathology in humans and the domestic cat acts as
a reservoir of this zoonotic disease. Diseases in humans primarily depend on the
immune status o f the patient. Disease ranges from granulomatous features as in cat
scratch disease to vascular proliferative lesions as in bacillary angiomatosis. Cat
scratch disease, the most common disease caused by B. henselae in immunocompontent
patients, is usually a localized self-limiting disease that resolves in time. Sequela to cat
scratch disease occurs in 14% o f cases and manifests in serious clinical conditions
(Regnery and Tappero 1995). Unusual manifestations that have been reported include
cases o f encephalitis, retinitis, conjunctivitis, hepatic granulomas, osteomyelitis,
pulmonary disease, and endocarditis (Regnery and Tappero 1995). Bacillary
angiomatosis and bacillary peliosis, caused by B. henselae in patients whose immune
system is compromised, involve multiple organs and are serious life threatening
diseases. B. henselae has been shown to establish persistent infection with an
intravascular focus displayed as a bacteremia or endocarditis (Reiman 1998).
The domestic cat population in the United States numbers approximately 60 million,
and 15 to 25 million cats may potentially be infected with B. henselae (Kordick et al.
1995). The domestic cat is a common pet in many households and has the potential to
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act as a reservoir for human infections. B. henselae genotype I, B. henselae genotype II,
and B. clarridgeiae have been isolated from cats and are also associated with human
disease (Sanders et al. 1999). Epidemiological studies indicate that a high percentage
o f cats worldwide have been naturally exposed to or are infected with B. henselae
(Childs et al.1994; Jamerson et al. 1995). B. henselae has a worldwide distribution. In
the United States seroprevalence varies and is as high as 65.4% in some regions (Childs
et al. 1994; Jamerson et al. 1995). B. clarridgeiae infections in cats are less common
with isolation rates reported to be approximately 10% in certain regions (Lawson and
Collins 1996; Kordick et al. 1997a).
Clinical disease in cats experimentally infected with Bartonella species varies and is
thought to be strain related (Reiman 1998). In several studies, isolation o f B. henselae
genotype II from cats was more common than isolation o f B. henselae genotype I
(Gurfield et al. 1997; Sander et al. 1998b). Identifying and characterizing the strains or
genotypes of B. henselae would be useful in studies o f the pathogenesis o f feline
bartonellosis. Cats are reported to be coinfected with B. henselae and B. clarridgeiae or
B. henselae genotype I and II (Gurfield et al. 1997). It is not known if there is a
difference in virulence or pathogenicity associated with the various species or
genotypes of Bartonella in cats.
Given the endemicity o f Bartonella infection in cats, understanding feline
bartonellosis is important to those involved in veterinary medicine and human medicine.
Because cats can be persistently and asymptomatically infected with B. henselae with
intermittent bacteremia, recognizing and understanding feline bartonellosis is important
(Regnery et al. 1992c). The bacteremia seen in B. henselae mfection in cats can be of
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significant magnitude in acute or chronic infection, or in chronic infection (Kordick and
Breitschwerdt 1997). The likelihood o f transmission o f B. henselae from cats to
humans is thought to be highest during times when cats are bacteremic (O ’Reilly et al.
1999a).
The pathogenesis of B. henselae in the cat is not understood. Assays currently
available to identify cats infected with Bartonella species include bacterial culture,
serological assay, nucleic acid amplification methods, and Warthin-Starry silver stain.
Bacterial culture for Bartonella species is not ideal and can be limited because o f the
fastidious nature o f organism, the time required for isolation, and the detection limits o f
culture. Kordick et al. (1999) demonstrated the limitations o f culture by amplification
of Bartonella DNA from the blood o f culture negative cats.
The limitations o f serological assays include differentiation of exposure from active
infection, inconsistent results because o f the lack o f understanding of the antigenic
variability within the Bartonella species, and incomplete knowledge o f the feline
immunological response to this pathogen. Immunological responses in cats to B.
henselae vary. Chomel et al. (1995) demonstrated that two percent o f bacteremic cats
in northern California were seronegative. Korkick et al. (1995) observed cats with
relapsing bacteremia in conjunction with variable high antibody titers. Other studies
have demonstrated a relapsing bacteremia without a peak in IgM level or a rise in IgG
level (O ’Reilly et al. 1999a).
Argyrophilic stains such as the Warthin-Starry silver stain have been used to detect
Bartonella in tissue, however, the sensitivity of the test is low (46%) and often fails to
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identify organisms in tissues from which the organism had been cultured and from
bacteremic cats (Brouqui et al. 1997; Slater et al. 1994).
Polymerase chain reaction assays are important diagnostic and research tools
because these assays are highly sensitive and specific. PCR assays are used for the
detection and characterization of pathogenic microorganisms associated with infectious
diseases. PCR assays are useful to amplify DNA from organisms that are difficult to
culture and to detect small amounts of DNA. There are numerous reports in the
literature o f diagnosis o f Bartonella infections in humans in which blood and organ
cultures were negative, but B. henselae DNA was amplified from tissue (Holmberg et
al. 1997; Warren et al.1998; Sander et al. 1998b). The discovery o f Bartonella as the
etiological agent associated with CSD, bacillary angiomatosis was first made with PCR
assays, and these assays continue to be a useful laboratory tool for diagnosing these
infections (Reiman 1993).
A PCR assay for the identification o f species and genotypes would assist in
characterization o f the various strains involved in feline bartonellosis. Our objective
was to develop a tool that could be used to detect Bartonella in numbers below the
limits o f culture and to differentiate the various Bartonella species and genotypes. In
this study, a nested PCR was developed using the 16S rRNA gene o f Bartonella species
that is sensitive and is genus, species, and genotype specific. Experimentally infected
cats were cultured and assayed by PCR during the acute and chronic phases of the
infection. The application o f PCR will assist our understanding o f the pathogenesis o f
Bartonella species in the cat populations
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Materials and Methods
Experimental animals. Specific-pathogen-free (SPF) cats (n=16) were bred at
Louisiana State University (n=4) or were purchased from Liberty Laboratories (Liberty
Comers, NJ) (n=9) or Harlan Sprague-Dawley (Madison, Wis.) (n=3). Cats were
culture negative for B. henselae and antibody negative for B. henselae by western blot
analyses. Cats were housed individually or grouped in an environmentally controlled
setting.
Bacterial strains. Bartonella strains were grown on chocolate agar or blood agar
(TS A w/5% rabbit blood agar plates) (Remel, Lenexa, Kansas) and the other
microorganisms were grown on blood agar (TSA w/5% sheep blood agar plates)
(Remel, Lenexa, Kansas). Bacteria used to evaluate this PCR assay included Bartonella
henselae 87-66 (ATCC 49793), Bartonella henselae Houston-1 (ATCC 49882),
Bartonella quintana (ATCC VR-358), Bartonella clarridgeiae (ATCC 700095), and
Bartonella elizabethae (ATCC 49927) obtained from the American Type Culture
Collection (Rockville, MD). Bartonella henselae LSU 16 (O ’Reilly et al. 1999a) and
Bartonella henselae Baby (Parr et al, 1999) were isolated at Louisiana State University
from naturally infected cats. Escherichia coli, Pseudomonas aeruginosa, Bordetella
bronchiseptica, Brucella abortus, Pasturella multocida, Staphylococcus aureus and
Streptococcus pneumoniae were obtained from the Louisiana Veterinary Medical
Diagnostic Laboratory, School o f Veterinary Medicine, Louisiana State University.
Experimental infections. Cats inoculated with B. henselae LSU 16, Baby, and
Houston-1 strains were given approximately lxlO ?CFU/ml. Cats inoculated with strain
B. henselae 86-77 were given approximately lxlO 9 CFU/ml. All cats were injected
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intradermally with 0.6 ml o f the respective inoculum divided among six sites on the
skin o f the lateral trunk. Animal inoculations were conducted with a second-passage
preparation o f organism. In one group of twelve cats, the cats were divided into 4
groups o f three. Six cats were infected with 5. henselae LSU 16 genotype II, three cats
were infected with B. henselae Baby genotype II, three cats were infected with B.
henselae 87-66 genotype I, and three cats were infected with B. henselae Houston-1
genotype I (Parr et al. 1999). The second group o f 8 cats was in a Bartonella henselae
passive antibody study and were eventually infected with Bartonella henselae LSU 16.
O f this group, four cats were given anti-5, henselae LSU 16 thirty minutes prior to
inoculation with B. henselae LSU 16, one cat was given anti-5, henselae Houston-1 30
minutes prior to inoculation with 5. henselae LSU 16 and three cats were inoculated
with 5. henselae LSU 16 (Brown et al.1998). This group o f 8 cats was challenged a
second time approximately 12 weeks after the first inoculation. Four cats in this group
previously challenged with 5. henselae LSU 16 were given three injections o f 10 mg/kg
o f methylprednisolone (Upjohn, Kalamazoo, MI) intramuscularly at two week intervals.
Experimental infections, passive antibody, and drug administrations were conducted in
the laboratory of Dr. K. L. O ’Reilly.
Collection of blood specimens. Peripheral blood was collected weekly by the staff
from Dr. K. L. O ’Reilly laboratory beginning one week after inoculation and until the
time o f necropsy. A total o f 362 blood specimens were collected in the study. Before
each collection, cats were anesthetized with Telazol (Fort Dodge, Ames, Iowa) at the
recommended dosage. Blood was collected aseptically by jugular puncture and placed
in Vacutainer tubes (Becton-Dickinson, Franklin Lakes, NJ) containing EDTA for PCR
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assay and in pediatric lysis-centrifugation isolator tubes (Wampole Laboratories,
Cranbury, NJ) for culture. Blood collected in EDTA tubes was frozen at -20°C
overnight, and DNA extractions were performed the next day followed by PCR assay.
Blood cultures. Blood cultures were performed by staff in laboratory of K.L.
O’Reilly on blood collected in pediatric Isolator® tubes. A 10-pl aliquot o f blood was
removed from the Isolator® tube and serially diluted. Dilutions (30 pi) were inoculated
onto chocolate agar and incubated at 37°C in 5% CO2 for 7 days. Colony counts were
recorded as the number of CFU per milliliter of blood. Isolates were confirmed to have
phenotypic characteristics consistent with Bartonella henselae.
Defining bacteremia. Bacteremia in experimentally infected cats was determined
by isolation o f Bartonella from a blood specimen (culture-positive) or amplification o f
Bartonella DNA from a blood specimen (PCR-positive).
Extraction of DNA from whole blood specimens. DNA was extracted from 200pl of whole blood collected in a EDTA vacutainer tube using the QIAamp DNA Mini
Kit and QIAamp DNA Blood Mini Kit (Qiagen Inc. Valencia, CA). The Blood and
Body Fluid Spin Protocol was followed according to manufacturer directions.
Extraction of DNA from bacterial strains. Approximately 10 CFU of each
bacterial isolate were taken from the agar with an inoculating loop, placed into 2 ml of
PBS, vortexed and centrifuged. The bacterial pellet was suspended in 180 pi o f Buffer
ATL supplied in the QIAamp DNA Mini Kit and stirred vigorously. Twenty pi of
proteinase K (supplied in kit) was added and the mixture was incubated at 56°C for
approximately 1 hour. The QIAamp tissue protocol was then followed beginning with
the addition o f the AL lysis buffer.
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Extraction controls. A control included all reagents without a DNA sample and
were processed exactly as described above to ensure that extraction buffers and reagents
were not contaminated with target DNA. Blood from negative cats were periodically
extracted and checked for contamination. Blood from positive cats were periodically
extracted as positive controls.
Bartonella genus, species, and type-specific oligonucleotide primers for PCR.
The target gene chosen for amplification was the 16S rRNA gene o f Bartonella. By
identifying conserved and hypervariable regions within the I6S rRNA gene, primers
that are genus specific, that are species specific, and that are type specific were
designed. The oligonucleotide primers were designed by Ron Tapp using an alignment
of the 16S rRNA gene sequence for Bartonella species and other closely related
bacteria (Tapp 2000) (Figure 1).
The primer sequence and nucleotide position are shown in Table 1. For
amplification of genus specific Bartonella DNA, forward primer pair Bhenl6FF and
reverse primer UB16SDR9 were used, generating an 823 bp fragment. A second
reverse primer that is Bartonella genus specific Bhenl6SBBR 5’-CACATGCAA
GTCGAGCACACTCTTTTAGAG-3 ’ was also designed to be used with the forward
Bhenl6FF primer to amplify a 567 bp fragment.
The primer sets for each Bartonella species and genotype and the sizes o f the
amplification products are indicated in Table 2. For amplification o f species and
genotype I-specific Bartonella DNA, the forward primer Bhenl6SGG and reverse
primer Bhenl6SBBR were used. For amplification o f species and genotype II-specific
Bartonella DNA, the forward primer Bhenl6SHH and reverse primer Bhenl6SBBR

57

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

Bartonella I6S rRNA Primer Diagram

I-------477bp—]

Bhenl6SFF

Bhenl6SGG
Bhenl6SHH
BhenI6SCC
I6S rRNA gene

Bhenl6SBBR

UB16SDR9

567 b p ---------------823 bp

Figure i. A map o f the relative positions o f the PCR primers and product
sizes for genus, species, B. henselae and B. clarridgeiae, and
B. henselae genotype I, B. henselae genotype II (Tapp 2000)
(Used by permission from Ron Tapp)
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Table 1. PCR Primer Sequences Bartonella
Primer

Nucleotide
Position*

Sequence (5’-3’)

UB16SDR9
Bhenl6SFF

854-877
52-98

Bhenl6SBBR
Bhenl6SGG

648-673
159-196

Bhenl6SHH

159-197

Bhenl6SCC

159-196

GCCCCCGTCAATTCCTTTGAGTTT
CACATGCAAGTCGAGCACACTCTTTAG
AG
CACTCACCTCTTCCACACTCAAGATA
C AAATTT GT GCT AAT ACCG AATACGTCC
TTAG
GAAATTTGTGCTAAT ACCGAAT ACGTCC
TATTTG
G AAATTT GT GCT AAT ACCGT AT ACGTCC
TACT

* Nucleotide positions are based on the reported 16S rRNA-gene sequence for
E.coli

Table 2. Primer Set and Product Size
Primer Set

PCR Product

Bhen 16SFF-U B16SDR9
Bhen 16SFF-Bhen 16SBBR
Bhen 16SGG-Bhen 16SBBR
Bhen 16SHH-Bhen 16SBBR
Bhen 16SCC-Bhen 16SBBR

823
567
477
477
477

bp
bp
bp
bp
bp

Specificity
Bartonella
Bartonella
Bartonella
Bartonella
Bartonella

genus
genus
henselae Genotype I
henselae Genotype II
clarridgeiae
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were used. For amplification of Bartonella clarridgeiae DNA, the forward primer
Bhenl6SCC and reverse primer Bhenl6SBBR were used. The synthetic
oligonucleotides were purchased from GeneLab (Louisiana State University, Baton
Rouge, LA).
For the nested reaction, PCR primers were used in a primary reaction and a
subsequent second reaction to amplify a region internal to the previous priming site.
The Bartonella genus specific forward primer Bhenl6SFF was used in combination
with reverse primer U B 16SDR9 to amplify an 823 bp fragment. In a second reaction
forward primer BhenI6SFF was used in combination with the inner reverse primer
Bhenl6SBBR to generate a 567 bp Bartonella genus-specific fragment. The species
and type-specific Bartonella nested PCR was done with combinations o f the outer
primers Bhenl6SFF-UB16SDR9 and in the second reaction inner primers Bhenl6SGG,
Bhenl6SHH or Bhenl6SCC and Bhenl6SBBR.
P C R amplification o f DNA. Reaction mixtures were prepared under a hood in a
room separate from the extraction process. A separate set o f pipettes and aerosolbarrier pipette tips were used for reagent preparation. PCR amplification was
performed in a final volume of 50 pi by using a reaction mixture containing
deoxynucleoside triphosphates (200pM each), 1.75 mM MgCk, 0.2pM o f each primer,
2.5 U o f Taq DNA polymerase, AmpliTaq™Gold, (Perkin Elmer), 4 pi o f DNA
template and 32.6 pi o f Perkin Elmer buffer. The PCR amplifications were carried out
on a Model 9600 Thermal-Cycler Perkin-Elmer/Applied Biosystems (Foster City, CA).
Amplification reaction consisted of 10 min. at 95°C; 30 cycles of 94°C for 1 min., 66°C
for 1 min., 72°C for 1 min., and a final elongation step at 72°C for 10 min. A second
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amplification reaction o f 20 cycles with the sample conditions as previously stated was
performed using inner primers and 1 pi of DNA from the first PCR reaction. Amplicon
carryover was prevented by using aerosol barrier pipette tips and by separation of
extraction area, reagent mixture preparation, and amplification and electrophoresis area.
As a negative control, PCR reagents without DNA template were included in each
amplification assay. Positive controls of extracted Bartonella species were also used in
each amplification assay.
Detection o f PC R products. The PCR-amplified products were detected by
electrophoresis on a 2% agarose gel in Tris-borate-EDTA buffer and visualized with
ethidium bromide and UV light transillumination. Sixteen microliters o f the final
product was analyzed in each lane of the gel. A Low DNA Mass™ ladder (Life
Technologies, Gaithersburg, MD) with six blunt-ended DNA fragments o f 2000, 1200,
800, 400, 200, and lOObp was used as the molecular marker.
Sensitivity o f PCR. To determine the minimum amount of Bartonella DNA that
could be detected by this PCR assay specific for the 16S rRNA gene o f B. henselae,
genomic Bartonella DNA was extracted from a B. henselae culture using the QIAamp
DNA Mini Kit (Qiagen, Valencia, CA) protocol for bacteria. The total DNA extracted
from culture was measured by absorbance at 260 nm on a Beckman DU 640
Spectrophotometer (Beckman Instrument, Inc. Hercules, CA) using the WarburgChristian concentration method. Serial ten fold dilutions o f the extracted DNA were
made in the elution buffer from the Qiagen kit. PCR amplification was performed on
each dilution to determine the limits of detection. To determine the minimum number
of organisms that could be detected by PCR assay o f the 16S rRNA gene o f B. henselae,
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serial dilutions of B. henselae organisms diluted in PBS and B. henselae diluted in
sterile cat blood were prepared. Each dilution was extracted using the QIAamp DNA
Mini Kit, and PCR amplification performed. A quantitative culture was performed on
each dilution. The results o f PCR and culture were compared to determine limits of
detection o f PCR.
Specificity of PCR. DNA extracted from Bartonella henselae 87-66 (ATCC
49793), Bartonella henselae Houston-1 (ATCC 49882), Bartonella quintana (ATCC
VR-358), Bartonella clarridgeiae (ATCC 700095), Bartonella elizabethae (ATCC
49927), Bartonella henselae-LSU 16, and Bartonella henselae-Baby, Escherichia
coli, Pseudomonas, Bordetella bronchiseptica, Pasturella multocida, Staphylococcus
aureus and Streptococcus pneumoniae were used as templates in individual PCRs with
primers Bhenl6SDR9, Bhenl6SBBR, Bhenl6SFF, Bhenl6SGG, Bhenl6SHH,
Bhenl6SCC. The specificity o f this PCR was also performed with Brucella abortus
(R B 51 strain) DNA because o f the close phylogenetic relationship to Bartonella species
Sequence analysis. Amplicons derived from isolates o f B henselae LSU 16, B.
henselae Baby, B. henselae 87-66, B. henselae Houston-1, B. clarridgeiae and from
blood o f one infected cat (cat 86) were sequenced by the Louisiana State University
GeneLab using an ABI Prism™ 377 DNA Sequencer (Perkin-Elmer) to confirm the
amplification o f Bartonella DNA.
Results
Specificity of the nested PCR. The primers Bhenl6SFF-Bhenl6SDR9 amplified
the predicted products of the 823 bp DNA in the first amplification from each o f the
Bartonella species (Figure 2). The primers Bhenl6SFF-Bhenl6SBBR amplified the
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Figure 2. Specificity of Bartonella primers Bhenl6SFF-Bhenl6SDR9: PCR products
(2% agarose gel stained with ethidium bromide)
Lane 1: Low DNA Mass™ Ladder (Gibco)
Lane 2: B. henselae LSU 16
Lane 3: B. henselae Baby
Lane 4: B. henselae 87-66
Lane 5: B. henselae Houston-1
Lane 6: B. quintana
Lane 7: B. elizabethae
Lane 8: B. clarridgeiae
Lane 9: E. coli
Lane 10: Pseudomonas aeruginosa
Lane 11: Bordetella bronchiseptica
Lane 12: Pasteurella multocida
Lane 13: Staphylococcus aureus
Lane 14: Streptococcus pneumoniae
Lane 15: Brucella abortus
Lane 16: Reagent control
Lane 17: B. henselae positive control
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567 bp DNA in the second amplification o f PCR with DNA templates from each of the
Bartonella species except B. elizabethae (Figure 3). Products were not amplified with
the other microorganisms and negative controls as shown in Figures 2 and 3. Primers
Bhenl6SGG and Bhenl6SBBR amplified the predicted product o f the 477-bp DNA o f
B. henselae genotype I, and primers Bhenl6SHH and Bhenl6SBBR amplified the
predicted product o f the 477-bp DNA o f B. henselae genotype II, and primers
Bhenl6SCC and Bhenl6SBBR amplified the predicted product o f the 477-bp DNA of
B. clarridgeiae (Figure 4).
Sensitivity o f B. henselae nested PCR. The sensitivity limit o f the assay were
determined as the minimum amount of genomic DNA from an isolate o f B. henselae
and minimum number of B. henselae organisms in spiked cat blood that could be
detected. The sensitivity limits o f B. henselae genomic DNA o f the first reaction with
primers Bhenl6SFF-Bhenl6SDR9 was approximately 6.4 pg or 3.2 x 103 organism
(Figure 5). By using the nested PCR the sensitivity limits o f the assay were increased to
approximately 6.4 fg, which corresponds to 3.2 organisms (Figure 6). To estimate the
quantity of genomic DNA in one cell o f Bartonella, the molecular mass o f Bartonella
bacilliformis (1.76xl0'15g or 1.7 fg or 1.6xl06bp and equal to 1.7 fg) was used.
Applying this method of estimation, one Bartonella cell (2xl06 bp) is equal to
approximately 2 fg. This assay was repeated three times.
Using 200 pi o f each dilution of B. henselae in sterile cat blood, the sensitivity
limits of B. henselae in cat blood was determined to be one ten-fold dilution beyond the
minimal detection limit of culture o f 25 CFU/ml. This assay was repeated three times.
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Figure 3. Specificity o f Bartonella primers Bhenl6SFF-Bhenl6SBBR: PCR products
(2% agarose gel stained with ethidium bromide)
Lane 1: Low DNA Mass™ Ladder (Gibco)
Lane 2: B. henselae LSU 16
Lane 3: B. henselae Baby
Lane 4: B. henselae 87-66
Lane 5: B. henselae Houston-1
Lane 6: B. quintana
Lane 7: B. elizabethae
Lane 8: B. clarridgeiae
Lane 9: E. coli
Lane 10: Pseudomonas aeruginosa
Lane 11: Bordetella bronchiseptica
Lane 12: Pasteurella multocida
Lane 13: Staphylococcus aureus
Lane 14: Streptococcus pneumoniae
Lane 15: Brucella abortus
Lane 16: Reagent control
Lane 17: B. henselae positive control
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Figure 4. Specificity of Bartonella species and genotype primers. PCR products (2%
agarose gel stained with ethidium bromide)
Lane 1: Low DNA Mass™ Ladder (Gibco)
Lane 2-6: Primer Bhenl6SGG-Bhenl6SBBR genotype I specificity
Lane 2: B. henselae 87-66 genotype I
Lane 3: B. henselae LSU 16 genotype II
Lane 4: B. clarridgeiae
Lane 5: Reagent Control
Lane 6: B. henselae 87-66 genotype I positive control
Lane 7-11: Primer Bhenl6SHH-Bhenl6SBBR genotype II specificity
Lane 7: B. henselae 87-66 genotype I
Lane 8: B. henselae LSU 16 genotype II
Lane 9: B. clarridgeiae
Lane 10: Reagent Control
Lane 11:5. henselae-LSU 16 genotype II positive control
Lane 12-16: Primer Bhenl6SCC-Bhenl6SBBR B. clarridgeiae specificity
Lane 12: B. henselae 87-66 genotype I
Lane 13:5. henselae LSU 16 genotype II
Lane 14: 5. clarridgeiae
Lane 15: Reagent Control
Lane 16: 5. clarridgeiae positive control
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Figure 5. Sensitivity of Bartonella primers Bhenl6SFF-Bhenl6SDR9: PCR products
(2% agarose gel stained with ethidium bromide)
Lane 1: Low DNA Mass™ Ladder (G ibco), Lane 2: 640 ng/ml, Lane 3: 64 ng/ml, Lane
4: 6.4 ng/ml, Lane 5: 640 pg/ml, Lane 6: 64 pg/ml, Lane 7: 6.4 pg/ml, Lane 8-13: blank,
Lane 14: B. henselae positive control

Figure 6. Sensitivity o f Bartonella primers Bhenl6SFF-Bhenl6SBBR: PCR products
(2% agarose gel stained with ethidium bromide)
Lane 1: Low DNA Mass™ Ladder (Gibco), Lane 2: 640 ng/ml, Lane 3: 64 ng/ml, Lane
4: 6.4 ng/ml, Lane 5: 640 pg/ml, Lane 6: 64 pg/ml, Lane 7: 6.4 pg/ml, Lane 8: 640
fg/ml, Lane 9: 64 fg/ml, Lane 10: 6.4 fg/ml, Lane 11-12: blank, Lane 13: B. henselae
positive control
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The nested PCR enhanced detection o f organisms from the blood o f cats experimentally
infected with B. henselae. The limit o f detection in cat 87, when using primer set
Bhenl6FF-UB162DR9 in the first reaction, was 19,000 CFU/ml. In the first reaction
using primers Bhen 16FF-UB162DR9, the assay did not detect amplicons in the blood
of cat when the culture results were 1,400 CFU/ml, 1,200 CFU/ml, or 300 CFU/ml. In
the second reaction using the inner primers Bhenl6SFF-Bhenl6SBBR, the nested PCR
assay detected amplicons of B. henselae in cat 87 below the limits o f culture (Figure 7).
In the second reaction, the nPCR amplified Bartonella DNA when the culture results
were 1,400 CFU/ml, 1,200 CFU/ml, 300 CFU/ml, and when the culture was negative
for two consecutive weeks.
Bacteremia in Experimentally Infected Cats. In this study, cats experimentally
infected with B. henselae were followed by PCR and culture beginning one week after
inoculation and until time of necropsy. Over the course of this study, 362 blood
specimens were used to investigate the bacteremic phase o f the infection using PCR
assay and bacterial culture. Fourteen o f the sixteen cats experimentally inoculated with
B. henselae Houston-1 did not become bacteremic. Bacteremia in the cats ranged from
l.OxlO2 to 8.0x105 CFU/ml. The duration o f the bacteremia ranged from 5 weeks to 22
weeks (Table 3). Bacteremia was determined by isolation o f Bartonella from blood or
amplification o f Bartonella DNA from blood. In most samples, the PCR was useful in
detecting Bartonella DNA after the culture became negative. The PCR assays were
positive in 11 o f the 14 cats after culture became negative. The PCR assay was positive
for periods o f 1 to 9 weeks after the culture became negative (Table 3 and Table 5). In
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Figure 7. Bartonella DNA. Comparison o f nPCR assay and bacterial culture from
blood samples from Bartonella henselae experimentally infected cat (87). PCR
products from nPCR (2% agarose stained with ethidium bromide)
Lane 1: Low DNA Mass™ Ladder (Gibco)
Lane 2-7 PCR products with primers Bhenl6SFF-Bhenl6SDR9 and CFU/ml
Lane 2: week-1 Blood sample 19,000 CFU/ml
Lane 3: week-2 Blood sample 1,400 CFU/ml
Lane 4: week-3 Blood sample 1,200 CFU/ml
Lane 5: week-4 Blood sample 300 CFU/ml
Lane 6: week-5 Blood sample 0 CFU/ml
Lane 7: week-6 Blood sample 0 CFU/ml
Lane 8-13 PCR products with primers Bhenl6SFF-Bhenl6SBBR and CFU/ml
Lane 8: week-1 blood sample 19,000 CFU/ml
Lane 9: week-2 blood sample 1,400 CFU/ml
Lane 10: week-3 blood sample 1,200 CFU/ml
Lane 11: week-4 blood sample 300 CFU/ml
Lane 12: week-5 blood sample 0 CFU/ml
Lane 13: week-6 blood sample 0 CFU/ml
Lane 14: Reagent Control
Lane 15: B. henselae positive control
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Table 3. Results o f PCR assay and blood culture from bacteremic cats

Week*
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18-29

Cat 10b
PCR CFU/ml
+
+
+
+
+
-

NDf

2.5x104
8.3xl02
0
0
l.OxlO2
0
0
0
0
0
0
0
0
0
0
0
0

Cat 83b
PCR CFU/ml
+
+
+
+
+
+
-

C at87b
PCR CFU/ml
+
+
+
+
+
+
+

2.0x104
7.0x103
2.3x105
7.0xl02
2.0x103
0
0
0
0
0
0
0
0
0
0
0
0

4-

+
-

NDf

6.2x104
1.9xl04
1.4xl03
1.2xl03
3.0xl02
0
0
0
0
0
0
0
0
0
0
0
0

NDf

C atG 3b
PCR CFU/ml
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
+
-

1.2xl03
1.8xl05
8.0x105
1.3xl05
2.4x104
2.5x104
9.0x103
2.3x104
3.0x102
0
0
0
0
0
0
0
0
0

a post-inoculation
b inoculated with B. henselae LSU 16 Genotype II
c inoculated with Bartonella henselae Baby Genotype II
d inoculated with Bartonella henselae 87-66 Genotype I
c inoculated with Bartonella henselae Houston-1 Genotype I
f ND, not determined

(Table 3 continued)
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Week*
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23-29

Cat L lc
PCR CFU/ml
+
+
+
+
+
+
+
+
+
+
+
+
+
NDf
+
-

+
-

-

-

l.OxlO6
2.4x105
3.0xl02
3.5xl02
0
l.OxlO2
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

Cat 36IC
PCR CFL /ml
+
+
+
+
+
+
+
+
+
+
+
+
+
ND f
-

+
-

-

-

-

3.4x10s
3.5xl04
3.6xl05
7.0x102
l.OxlO2
l.OxlO2
1.5xl02
0
0
0
0
0
0

Cat K3C
PCR CFU/ml

+
4.0x104
+
3.2x104
+
1.5x10s
+
2.0x105
+
6.8x104
+
4.5xl04
+
2.5xl04
+
2.4x104
+
1.3xl04
+
6.7x103
+
4.2x103
+
2.6x103
+
6.6x102
ND
+
2.6x102
+
6.3x102
+
1.3xl02
+
l.OxlO2
+
2.0x102
0
0
0
0
f

0
0
0
0
0
0
0
0
0

-

-

-

C atL 2d
PCR CFU/ml

+
6.8x104
+
4.4x104
+
4.0x105
+
l.lx l 05
+
3.5x10s
+
1.9x19s
+
1.3xl04
+
3.9xl03
+
2.5x103
+
5.0x102
+
5.0x102
+
l.OxlO2
+
8.3xl03
ND f
+
8.6xl03
+
8.3xl03
+
1.5xl04
+
8.0x103
+
7.3xl03
+
5.3x103
+
l.OxlO3
+
l.OxlO3
0
-

a post-inoculation
b inoculated with B. henselae LSU 16 Genotype II
c inoculated with Bartonella henselae Baby Genotype II
d inoculated with Bartonella henselae 87-66 Genotype I
c inoculated with Bartonella henselae Houston-1 Genotype I
fND, not determined

(Table 3 continued)
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Week"
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24-29

C a t K4d
P C R CFU/ml
+
+
+
+
+
+
+
+
+
+
+
+
ND r
-

-

-

9.0x102
4.1xl04
3.0x104
5.1xl04
4.8x104
5.7x104
2.3xl04
6.0x103
4.0x103
4.0x102
l.OxlO2
0
0
0
0
0
0
0
0
0
0
0
0

C at L3e
PCR CFU /m l
+
+
+
+
ND f
-

-

-

-

0
0
0
5.0x102
2.0x103
3.0x102
2.0x102
l.OxlO2
l.OxlO2
0
0
0
0
0
0
0
0
0
0
0
0
0
0

C at F5e
PC R CFU/ml

C at 347*
PCR CFU/m l

.

.

0
0
0
■ 0
0
0
0
0
0
0
0
0
0
f
ND

-

-

-

*

-

-

-

-

-

-

NDf

0
0
0
0
0
0
0
0
0
0

-

-

-

-

-

-

0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

a post-inoculation
b inoculated with B. henselae LSU 16 Genotype II
c inoculated with Bartonella henselae Baby Genotype II
d inoculated with Bartonella henselae 87-66 Genotype I
c inoculated with Bartonella henselae Houston-1 Genotype I
fND, not determined

(Table 3 continued)
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Week*

1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23-29

Cat N2d
PCR CFU/ml
+
+
+
+
+
+
+
+
+
+
+
+
+
NDf
+
-

+
-

-

-

-

-

4.0x103
2.0x103
2.7x104
2.4x104
2.8xI04
2.1xl04
2.2x104
1.6xI04
7.6xl03
5.0x103
2.8xl03
l.OxlO3
l.3x!02

Cat N3b
PCR CFU/ml
+
+
+
+
+
+
+
+
+
+
+
-

-

-

0
0
0
0
0
0
0
0
0

-

-

-

-

-

-

1.2xl03
3.1xl04
2.2x105
2.0x104
3.6x104
2.9x104
6.0x103
2.1xl03
5.0xl02
0
0
0
0
0
0
0
0
0
0
0
0
0
0

a post-inoculation
b inoculated with B. henselae LSU 16 Genotype II
c inoculated with Bartonella henselae Baby Genotype II
d inoculated with Bartonella henselae 87-66 Genotype I
c inoculated with Bartonella henselae Houston-1 Genotype I
fND, not determined
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each o f the cats (n=14) that were followed during the bacteremic phase o f the infection,
the duration o f bacteremia, as defined by culture and PCR, lasted for a longer time
period when the PCR assay was used to detect circulating Bartonella as compared to
culture (Table 3). In three cats, the PCR and culture were negative the same week. The
culture was positive for 1-2 weeks when the PCR was negative in cat L3 and 321. In
two o f the experimentally infected cats there was a 1-week interval when the bacteremia
was below the detection limits o f culture but detected by the PCR assay. In cat 10, the
culture negative interval was 2 weeks during the acute bacteremia when the PCR assay
was positive. In cat LI and 361, Bartonella species were bacteremic 1-3 weeks post
inoculation. Two of the cats during the time when the culture was negative, the PCR
assay were negative one week followed by a positive PCR the next week (Table 3).
Results o f the PCR assay were comparable to culture results in most of the
specimens. The PCR assay was positive in 135 o f the 138 (98%) blood specimens that
were culture-positive. The PCR assay was negative from three blood specimens that
were culture-positive with 100 colony-forming units per milliliter (Table 3 and Table
5). O f the 223 blood specimens that were culture-negative, PCR assay was positive in
40 (18%) o f these specimens (Table 4).

Table 4. Summary of PCR assay and blood culture results (n=362f
PCR positive (%)
Culture positive

135/138

Culture negative

40/223

PCR negative (%)

(98)

3/138

(18)

183/223

(2)
(82)
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Relapsing bacteremia. Two cats, cat 86 and cat 321, infected with B. henselae
LSU 16, a pathogenic strain o f Bartonella in cats, had an episode o f relapsing
bacteremia (Table 5). Cat 86 experienced a culture-negative interval o f 7 weeks
between the two episodes of bacteremia. The second bacteremia in cat 86 lasted for 8
weeks before the blood culture became negative. The PCR assay in cat 86 was positive
for 2 weeks longer than the culture in the first episode o f bacteremia. During the
second bacteremia, both culture and PCR were positive from weeks 13 through 20. Cat
321 was PCR and culture positive from weeks 1 through 6. At week 7, the PCR was
positive and the culture was negative. At week 8, both assays were positive again for 3
weeks. After an 11 -week culture-negative interval, cat 321 became culture and PCR
positive again. The second bacteremia in cat 321 lasted for 4 weeks with positive
culture results for 4 weeks and positive PCR results for only three o f those weeks.
Sequence analysis. The sequence data derived from B. henselae LSU 16 and B.
henselae Baby were that o f a B. henselae genotype II strain with the base pairs ATT
located at positions 172 to 175 o f the 16S r RNA gene identical to B. henselae genotype
II as described by Bergmans et al. (1995) (Figure 8). The sequence data from B.
henselae Houston-1 and B. henselae 87-66 located at positions 172 to 175 o f the 16S r
RNA gene were that o f a B. henselae genotype I with the base pairs TAG as described
by Bergmans et al. (Figure 8). The sequence data derived from the blood o f cat 86 was
a B. henselae genotype II with the base pairs ATT (Figure 8). The sequence data from
the isolate o f B. clarridgeiae was as reported with the base pairs ACT located at
positions 172 to 175 of the 16S rRNA gene (Gene bank X97822) (Figure 8).

75

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

Table 5. Results o f PCR and blood culture from cats with relapsing bacteremia

Weeka
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29

Cat 86b
PCR CFU/ml
4+
+
+
+
+
+
-

+
+
+
+
+
+
+
+
-

-

-

-

-

-

-

6.3x104
1.7xl04
4.3x104
2.2x103
3.0xl02
0
0
0
0
0
0
0
l.lx lO 4
l.OxlO4
6.0x103
1.2xl03
3.3xl02
7.0x102
2.3xl02
l.OxlO2
0
0
0
0
0
0
0
0
0

Cat 321b
PCR CFU/ml
+
+
+
+
+
+
+
+
+
-

2.6x103
3.9xl04
2.0x105
1.7xl04
l.OxlO2
l.OxlO2
0
6.0x102
4.0x102
1.5xl02
0
0

NDC
-

-

-

-

-

+
+
+
-

0
0
0
0
0
0
0
0
0
6.0x102
6.7x102
2.0x102
1.3xl02
0
0
0

a post-inoculation
b inoculated with B. henselae LSU 16 Genotype II
c ND, not determined
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P rim er B hen 1 6 S F F -^
CACATGCCAGTCGAGCACACTCTTTTAGAG
B. henselae LSU 16 genotype II
B. henselae Baby genotype II
B. henselae 87-66 genotype I
B. henselae H ouston-1 genotype I

TAACGCGTGGGAATCTACCCATCT

3. clarridgeiae
P C R p ro d u ct blood cat 86

B.
B.
B.
B.
B.

172-175 bp region
henselae LSU 16 genotype II C T A C G G A A T A A C A C AG A G A A A T T T G T G C T A A T T T A C C G T A T
................................................................. A T T ......................................................
henselae Baby g enotype II
............................................................ T A G .....................................................
henselae 87-66 genotype I
henselae Houston 1 genotype I ............................................................ T A G ............................................
................................................................. A C T ....................................................
clarridgeiae

P C R p ro d u ct blood cat 86

B.
B.
B.
B.
B.

................................................................. A T T ....................................................

henselae LSU 16 genotype II A C G T C C T A T T T G G A G A A A G A T T T A T G G A G A T G G A T G A G C C C
henselae Baby genotype II
henselae 87-66 genotype I
henselae H ouston-1 genotype I
clarridgeiae

P C R p ro d u ct blood cat 86

B.
B.
B.
B.
B.

henselae LSU 16 genotype II G C G T T G G A T T T A G C T A G T T G G T G A G G T A A C G G C T C A C C G A G
henselae Baby genotype II
henselae 87-66 genotype I
henselae H ouston-1 genotype I
clarridgeiae

P C R p ro d u ct blood cat 86

B.
B.
B.
B.
B.

henselae LSU 16 genotype 13 G C G A A A C G A T C C A T A G C T G G T C T G A G A G G A T G A T C A G C C A C
henselae Baby genotype II
henselae 87-66 genotype I
henselae H ouston-1 genotype I
clarridgeiae

P C R p ro d u ct blood cat 86
^
Prim er
B h e n l6 S B B R
ATAGAACTCACACCTTCTCCACTCAC

B.
B.
B.
B.
B.

henselae LSU 16 genotype II A C T G G G A C T G A G A C A
henselae Baby genotype II
..............................................
henselae 87-66 genotype I
..............................................
henselae H ouston-1 genotype I ..............................................
clarridgeiae ..................................... ..............................................

P C R p ro d u ct blood cat 86

..............................................

Figure 8. Partial sequence alignment o f 519-bp fragment amplified from 16S rRNA
gene o f Bartonella henselae LSU 16 genotype II, B. henselae Baby, B. henselae 87-66,
B. henselae Houston-1, B. clarridgeiae, and PCR product from blood o f experimentally
infected cat 86. Region o f 172-175 (ATT, TAG) identifies B. henselae genotype II and
genotype I. Region of 172-176 (ACT) identifies B. clarridgeiae
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Discussion
A PCR assay that is both sensitive and specific is a good tool for studying persistent
infections. The nPCR assay was specific for B. henselae LSU 16, B. henselae Baby, B.
henselae Houston-1, B. henselae 87-66, B. clarridgeiae, and B. quintana, B. elizabethae
was not amplified in the second reaction of the nPCR assay because the reverse primer
Bhenl6SBBR is not specific for B. elizabethae. The sensitivity limits o f the PCR assay
were improved with the nested design and proved useful in detecting low numbers of
organisms. The nested PCR assay was able to detect Bartonella DNA in circulating
blood of cats that were culture negative. The ability o f the PCR to detect Bartonella
DNA in cats that were culture negative is a function o f the sensitivity limits o f the PCR
as compared to culture. In theory, this nested PCR can detect approximately 3.2
Bartonella organisms. The detection limits of culture in this study were approximately
25 CFU/ml, and the limits o f the PCR assay were one ten-fold dilution below 25
CFU/ml. Although the amplification of Bartonella DNA from the blood o f Bartonella
infected cats may represent dead bacteria, the detection of Bartonella DNA in some cats
as long as 9 weeks after blood cultures were negative makes the detection o f dead
bacteria unlikely. Rather, one could postulate that amplification o f Bartonella DNA in
the blood o f infected cats long after the blood culture is negative represents a small
number of viable organisms circulating in the peripheral blood. One also could
speculate that Bartonella DNA in the blood o f these cats is due to the shedding of
microorganisms into the peripheral blood from a sequestered location in the cat such as
the endothelial cells o f the vascular system.
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The PCR assay was able to detect Bartonella DNA in 40 samples that were culture
negative. Again this could be explained by existence o f circulating nonviable
organisms or because the sensitivity of the PCR assay is greater than that o f culture.
The question then becomes the infectious nature o f bartonellosis in cats in this stage o f
the infection. Kordick et al. (1997b) was able to transmit B. henselae from blood
culture negative cat by inoculation of blood into a SPF cat. This observation indicates
that a negative blood culture cannot be used to definitively rule out Bartonella infection
in cats. If cats are infectious after the culture is negative and PCR is positive, the PCR
assay would be a more accurate laboratory assay for detecting cats with Bartonella.
Three blood specimens were culture positive and PCR negative. For unknown
reason, the PCR assay missed three blood specimens that were culture-positive with 100
colony-forming units per milliliter. This may be explained by the cohesion and
aggregation factors that have been reported with Bartonella species. Clarridge (1996)
reported a degree o f cohesiveness in B. henselae and B. clarridgeiae, and this was
correlated with cells existing in a tightly packed array. Despite the fact that the blood
was vortexed before sampling, the PCR could have been negative because o f the
coherent nature o f the organism. The PCR assay results were negative for one week
followed by a positive result the next week in cats, L I, and 361. The results occurred
when the bacteremia was waning and was below the minimum detection limits by PCR
or because the result are representative o f a false positive test.
The PCR assay did not detect Bartonella DNA earlier than the blood culture in the
cats with a recurrent episode o f bacteremia or in the primary infection in cat L3.
Possibly, if blood were taken within the week before the recurrent episode, a positive
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PCR for Bartonella DNA would have been detected. It is not known how the
organisms seed the blood in these infections. If the organism slowly leaks into the
circulating blood from a source like the endothelial lining, the PCR may be positive
before the culture. If the organism seeds the blood suddenly with a number of
organisms large enough for the culture to be positive, the PCR assay would not be
positive any sooner than culture. However, because of the turnaround time of the PCR
assay compared to culture, the detection o f a positive Bartonella cat would be noted at
an earlier time.
Specificity was addressed in this PCR assay with the use o f specific primers in the
first and second reaction of the nested PCR. Specific oligonucleotide primers for
Bartonella genus were used in the first reaction by amplifying an 823 bp fragment or a
567 bp fragment from the 16S rRNA gene o f Bartonella. In the second reaction,
specificity is increased further by the use o f another group o f specific primers that
amplifies a subset from the first reaction because they are complementary to a specific
fragment o f Bartonella. B. clarridgeiae and Bartonella henselae genotype I and
genotype II can be differentiated by the specific primer sets in the second reaction. An
assay that can determine genetic differences in strains of Bartonella will be useful in
studying the pathogenesis o f this organism in cats.
Molecular assays such as PCR give a higher discriminatory power in identification
o f microorganisms than does identification by phenotypic characteristics (Reiman
1993). The products amplified in this PCR reaction were confirmed by sequence
analysis that is a very specific method o f identification and is based on genetic
information, not phenotypic tests as in culture methods. In addition, molecular assays
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such as PCR that will amplify and allow for detection of microorganisms missed
because of the insensitivity of a particular method is a powerful tool in research and
clinical microbiology. This PCR assay has proven to be a useful assay that is both
sensitive and specific and will be used in our laboratory for further studies for the
understanding o f the pathogenesis o f B. henselae in cats.

81

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

CHAPTER THREE
PERSISTENT BARTONELLA DNA IN CATS EXPERIMENTALLY INFECTED
WITH BARTONELLA HENSELAE GENOTYPE I AND BARTONELLA
HENSELAE GENOTYPE II
Introduction
During the past decade, Bartonella species has emerged as an important human
pathogen. Five species, Bartonella henselae, B. quintana, B. clarridgeiae,
B. bacilliformis, and B. elizabethae have been associated with human disease. The
spectrum of diseases produced by Bartonella species is wide and includes
lymphadenopathy, relapsing bacteremia, endocarditis, retinitis, osteolysis,
encephalopathy, hemolytic anemia, bacillary angiomatosis, and bacillary peliosis
(Anderson and Neuman 1997).
Epidemiological studies have shown that ownership o f a cat and being scratched or
bitten by a cat are risk factors for acquiring cat scratch disease (Zangwill et al. 1973).
Following that study, two species, B. henselae and B. clarridgeiae, were isolated from
cats (Gurfield et al. 1997). Prevalence studies have shown that a significant number of
cats are subclinically infected with Bartonella, and that cats are a reservoir for human
infections involving Bartonella species (Childs et al. 1994; Heller et al. 1997; Jamerson
et al. 1995). B. henselae causes the widest spectrum of pathology, depending on the
immune system o f the host, and includes disease with granulomatous features, vascular
proliferative features, and a predominantly intravascular focus (Reiman et al. 1990).
The only known human disease associated with B. clarridgeiae is cat scratch disease.
Our knowledge o f the pathogenesis o f B. henselae in the cat is incomplete. It is
known that the prevalence o f B. henselae infections in cats is high, and that feline
bartonellosis can be a persistent infection in cats (Kordick et al. 1999). What is not
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understood is the persistent phase o f feline bartonellosis. Many aspects o f the persistent
phase such as the mechanisms o f survival, host cell association, or tissue sequestration
are unclear.
Clinically infected cats can be bacteremic and asymptomatic for long periods. The
bacteremia in cats can be o f significant magnitude and duration and can often recur
(Kordick and Breitschwerdt 1997). In a study by Kordick et al. (1997b), cats in
environmentally controlled settings were culture negative for periods up to 4 months
between recurrent episodes o f bacteremia. Kordick et al. (1999) observed recurrent
episodes o f bacteremia for up to 454 days in cats infected with B. henselae or B.
clarridgeiae. In humans, relapsing bacteremia is also a characteristic of Bartonella
infections and many o f these infections evolve into long-term asymptomatic persistent
infections (Welch and Slater 1999). The persistence o f these infections in both cats and
humans is suggestive o f a carrier state with sequestration o f the microorganism within
the host.
During the acute bacteremic phase in cats, B. henselae has been cultured from
lymph nodes, heart, lung, spleen, liver, kidney, pancreas, thymus, and bone marrow
(Guptill et al. 1997). Clinical signs have been described in experimentally infected cats
and include fever, lethargy, and mild neurologic signs consistent with CNS involvement
in one cat (O ’Reilly et al. 1999a; Guptill et al. 1997; Kordick et al. 1999). Within 2 to 6
weeks after infection, enlarged mandibular or popliteal lymph nodes with lymphoid
hyperplasia, a splenic microabscess, and a liver abscess in experimentally infected cats
have been described (Guptill et al. 1997). Bartonella can be cultured from many tissues
o f cats that are bacteremic probably because o f the presence of organisms circulating
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through tissue. Whether Bartonella colonizes or sequesters in tissue after the acute
bacteremic phase is unknown. Tissues from blood culture negative cats are often
culture negative.
In addition to recurrent bacteremia, there is other evidence to support the belief that
Bartonella is a persistent infection in cats. This evidence includes failure to eliminate
infections readily with the use of antibiotics (Kordick et al. 1997b), pathological
changes seen in the tissue o f cats infected for long periods with B. henselae (Korkick et
al. \999), immunological evidence to suggest continued antigenic stimulation (O’Reilly
et al. 1999a) and granulomatous response as seen in some Bartonella infections (Guptill
et al. 1997). Granulomatous inflammation in the liver o f cats infected with B. henselae
was reported in this study but has not been confirmed as a typical cellular response
(Guptill et al. 1997). Granulomatous inflammation has been reported in Bartonella
infections in humans with CSD, in dogs with granulomatous lymphadenitis and
granulomatous rhinitis, and in the liver o f mice (Pappalardo et al. 2000, Regnath et al.
1998).
The immunological response of the cat also suggests that feline bartonellosis can be
a persistent infection. Some cats respond with typical IgM and IgG antibody patterns of
response, while other cats infected with B. henselae have been shown to have IgM
levels which remain elevated above baseline suggesting continued antigenic stimulation
(Freeland et al. 1999). Homologous protection without cross protection by various
species and types has been shown (Yamamoto et al. 1998b). Human and murine
immune responses to B. henselae have been shown to include T-cell activity, IFN-y
production, and macrophage killing activity, suggesting an intracellular location with a
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T hl, CD4 type cytokine response (Karem et al. 1999). Freeland et al. (1999) identified
a number of Bartonella-specific antigens to which strong antibody responses are
generated in both experimentally and naturally infected cats. B. henselae may evade the
cat’s immune system by methods o f promoting uptake by nonimmune cells such as
erythrocytes (Mehock et al. 1998). The strain B. henselae LSU16 was found to be
resistant to killing by neutrophils when compared to the Houston-1 strain of B. henselae
(O’ Reilly etal. 1999b).
In human cases, B. henselae DNA has been detected by PCR in atypical B.
henselae infections involving organs such as heart (endocarditis), brain (encephalitis),
lymph nodes, eye (peripapillary angioma), liver, and spleen (Koehler et al. 1997; Gray
et al. 1998; McGrath, 1998; Wheeler et al. 1997; Baorto et al. 1998; Stuart and Norwick
1998). B. henselae DNA was detected by PCR in the liver o f a dog with peliosis
hepatis (Kitchell et al. 2000). Regnath et al. (1998) showed that B. henselae infected
mice cleared the cultivatable organism within the first 6 days o f infection from liver and
spleen but Bartonella DNA could be detected in the liver for at least 3 months.
Whether Bartonella has an intracellular niche other than the feline erythrocytes is
unknown. An intracellular location of Bartonella in cats would be consistent with the
persistent nature o f feline bartonellosis. In the study by Kordick et al. (1997b), cats
chronically bacteremic with Bartonella were treated for an extended duration o f 25
weeks with enrofloxacin, which is partially converted to ciprofloxacin in the cat, with
elimination of infection in 9 o f 14 infected cats.
Bartonella infections in cats have been reported to cause pathologic changes in
major organs in cats (Kordick et al. 1999). Kordick et al (1999) described cats
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experimentally infected with Bartonella, that had microscopic inflammatory foci in
tissue which represent nonspecific histological changes consistent with systemic
dissemination o f blood-bome infection. Follicular hyperplasia o f lymph nodes and
spleen were seen in experimentally infected cats and thought to represent a tissue
response to chronic antigenic stimulation, which is consistent with chronic Bartonella
infection (Kordick et al. 1999). In another study done by Guptill et al. (1997),
Bartonella-specific antibody-secreting cells were detected in spleen, bone marrow and
peripheral lymph nodes in abacteremic experimentally infected cats thirty-two weeks
post inoculation. The greatest number o f antibody-secreting cells was detected in the
spleen in that study.
Often Bartonella DNA can be amplified from various types o f clinical material in
the absence o f a positive culture. Whether the Bartonella DNA represents
microorganisms that are viable or ncnviable is not fully understood. The amplification
of Bartonella DNA may represent viable organisms lying in a dormant state, viable
organisms in numbers below the detection limits of culture or nonviable (dead)
organism in tissue. One way to determine if a bacterial cell is viable is to measure the
synthesis o f RNA. The RT-PCR, which first produces cDNA from RNA and then
amplifies the cDNA, is one method for analysis of RNA expression.
The purpose o f this study was to determine if persistent Bartonella DNA exists in
the tissue o f abacteremic cats chronically infected with Bartonella. A nPCR assay that
amplifies a 567-bp fragment of the 16S rRNA gene of B. henselae was used to detect
Bartonella DNA in tissue. RNA expression in the tissue o f cats was examined using
two different RT-PCR assays. One assay was designed to amplify a 354-bp fragment o f
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the citrate synthase gene o f B. henselae, and the other RT-PCR was designed to amplify
a 567-bp fragment o f the 16S rRNA gene o f B. henselae. Cats defined as abacteremic
by culture and PCR assay were necropsied and tissues taken for isolation and
amplification o f Bartonella. Results were complied from SPF cats experimentally
infected with B. henselae. The findings of Bartonella DNA detected in tissue after the
bacteremic phase o f the infection are discussed in this study.
Materials and Methods
Experimental animals. Tissue used in this study were taken from twenty-three cat
followed in the study. Sixteen o f the cats were the same as referred to in Chapter 2.
Four additional cats used in this study were bred at Louisiana State University as
specific-pathogen-free cats (SPF) and three additional cat used in this study were
purchased from Harlan Sprague-Dawley (Madison, Wis.) as specific-pathogen-free
(SPF) cats.
Bacterial strains. As described in Chapter 2
Infection in cats. Methods the same as in Chapter 2
Collection o f tissue specimens. Cats were euthanized by cardiac puncture with
overdose o f Beuthanisa (Schering Plough, Canada). Standard necropsies were
performed on all cats. Tissue was collected using a separate set o f sterile instruments
for each tissue. Representative fresh tissue samples were taken for bacterial culture,
PCR analysis, and RNA extraction and formalin fixed tissues were taken for
histopathology. For culture and PCR analysis tissue was placed in a sterile whirpak bag
and placed on ice immediately. Tissue for RNA extraction was immediately frozen in
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liquid nitrogen. Tissue for histopathology was fixed in 10% neutral buffered formalin
for paraffin embedding.
Cultures of tissues. Postmortem tissue specimens were collected aseptically on
each cat at necropsy using a separate set o f sterile instruments for each tissue collected.
Eight tissues including liver, spleen, bone marrow, heart valve, lung, brain, lymph node,
and kidney and blood were taken from each cat. Each tissue was ground in a tissue
grinder and a representative sample was cultured on enriched chocolate agar (Remel,
Lenexa, Kansas) and brucella broth with 6 to 8% Fildes solution and 250 pg o f hemin
per ml (Schwartzman et al 1993). Broth cultures were observed weekly for growth.
Broths were gram stained and subcultured on chocolate agar before discarding. All
cultures were incubated at 37°C in 5% CO 2 for 3 weeks.
Extraction of DNA from tissue. Extraction of DNA from tissue was performed
using the Tissue Protocol within the QLAamp DNA Mini Kit (Qiagen Inc. Valencia,
CA). A representative section o f each tissue was taken from each cat at necropsy. Each
tissue section was ground in a tissue grinder and 25 mg (Mettler PM 460) o f tissue was
used in the Tissue Protocol according to manufacturer directions. The extracted DNA
was used as a template in the PCR assays. Extraction controls included tissue from
Bartonella culture positive and negative cats and a reagent control without a DNA
sample.
PCR amplification o f DNA from tissue. Amplification o f DNA was identical to the
method described in Chapter 2. The PCR assay used in this study was not a quantitative
PCR, therefore, the Bartonella DNA detected in the tissue o f the cats could not be
quantitated. The liver o f cat 1 and spleen o f cat 87 were chosen at random and the
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Bartonella DNA extracted. Extracted DNA was diluted 10-fold in elution buffer and
amplified as described in the PCR assay.
Detection o f PCR products. Methods the same as in Chapter 2
RNA extraction. Tissue that was positive for DNA fragments o f the 16S rRNA
gene o f Bartonella was used for RNA extraction. RNA extractions were done using the
RNAeasy Kit, (Qiagen Inc. Valencia, CA). The procedure recommended by the
manufacturer was followed with the exception o f treatment with RNase-Free DNAase
(Qiagen, Inc. Valencia, CA) for 1 hr at 37°C and a follow-up RNA extraction with the
RNAeasy Kit.
RT-PCR o f the 16S rRNA gene of B. henselae. The RT-PCR reaction mix was
made using the Titan™ One Tube RT-PCR System (Roche Molecular Biochemicals,
Indianapolis, IN) according to the manufacturer direction. This method uses the reverse
transcriptase avian myeloblastosis virus (AVM) for the first strand synthesis and the
Expand™ High Fidelity enzyme blend, which consists of Taq DNA polymerase and
Pwo DNA polymerase for the PCR. Primers used in this assay were designed to
amplify a 567-bp fragment of the 16S rRNA gene o f Bartonella. A nested reaction was
done using 4 pi o f RNA template in the first reaction with forward primers Bhenl6SFF
5’ CAC ATGC AAGTCG AGC AC ACTCTTTT AG AG 3’ and reverse primer
UB16SDR9 5’ GCCCCCGTCAATTCCTTTGAGTTT 3’. The RT-PCR reaction
mixture consisted o f two reaction mixtures each of 25 pi. One reaction mixture
consisted o f 12.5 pi o f sterile RNase and DNase free water, 4 pi o f deoxynucleoside
triphosphates (200 uM each), 2.5 pi dithiothreitol solution (DTT) (100 mM), and 4 pi of
template. The second reaction mixture consisted o f 10 pi of RT-PCR buffer (Titan), 14
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pi o f sterile RNase and DNase free water, and 1 pi o f Titan Enzyme mix (AMV and
Expand ™ High Fidelity). Twenty-five pi of reaction mix one and 25 pi of reaction
mix two were added together for thermocycling. The amplification reaction consisted a
o f reverse transcription step o f 50°C for 30min., 30 cycles at 94°C for 30 s, 66°C for
30s, 68°C for 1 min and a hold cycle for 68°C for 2 min. The second reaction (nested
PCR) mixture consisted o f deoxynucleoside triphosphates (200 pM each), 1.75 mM
MgCH, 0.2 pM of each primer, 2.5 U of Taq DNA polymerase, AmpliTaq™ Gold
(Perkin Elmer), 1 pi o f DNA from the first reaction in PE buffer in a total volume o f 50
pi. In the second reaction the primers were the forward primers Bhenl6SFF and
reverse inner primer Bhenl6SBBR 5’ CACTCACCTCTTCCACACTCAAGATA 3 ’.
Amplification reaction consisted o f 10 min. at 95°C; 20 cycles o f 94°C for lmin., 66°C
for 1 min., and 72°C for 1 min., and a final elongation step at 72°C for 10 min. The
PCR amplification was carried out on a 9600 Thermal-Cycler Perkin-Elmer/Applied
Biosystems (Foster City, CA).
RT-PCR of the citrate synthase gene of B. henselae. A second RT-PCR assay
was designed to amplify a 354 bp fragment o f B. henselae gltA citrate synthase gene
(Regnath et al. 1998). In this assay the outer primer sequences CSN-F1 5’
GGTCCCAACTCTT TGCCGCTATG 3’ and CSN-R1 5’ CAGCCGA
CACTGGGTGCTAATG 3’ were used in the first reaction. The RT-PCR reaction
mixture consisted of two reaction mixtures each o f 25 pi. One reaction mixture
consisted o f 12.5 pi of sterile RNase and DNase free water, 4 pi o f deoxynucleoside
triphosphates (200 uM each), 2.5 pi dithiothreitol solution (DTT) (lOOmM), and 4 pi o f

90

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

template. The second reaction mixture consisted o f 10 pi o f RT-PCR buffer (Titan), 14
pi o f sterile RNase and DNase free water, 1 pi of Titan Enzyme mix (AMV and
Expand Tm High Fidelity). Twenty-five pi o f reaction mix one and 25 pi o f reaction mix
two were added together for thermocycling. The amplification reaction consisted of a
reverse transcription step o f 50°C for 30min., 30 cycles at 94°C for 30 s, 66°C for 30s,
68°C for 1 min., and a hold cycle for 68°C for 2 min. A nPCR was performed with the
inner primers CSN-F2, 5’ ATGCCTAAAAATGTTACAAGA 3 ’and CSN-R2 5 ’
CGTGCTAA TGCAAAAAGAAC 3’. The reaction mixture consisted of
deoxynucleoside triphosphates (200pM each), 1.75 mM M gCk, 0.2pM of each primer,
2.5 U of Taq DNA polymerase, AmpliTaq™ Gold (Perkin Elmer), 1 pi o f DNA from
the first reaction in PE buffer in a total volume of 50 pi. The amplification o f the
second reaction consisted o f denaturation o f 4 min. at 95°C, and 20 cycles o f 1 min at
94°C, 10 sec at 30°C, and lmin. at 72°C and a final extension step of 10 min at 72°C.
PCR amplifications were carried out on a 9600 Thermal-Cycler Perkin-Elmer/Applied
Biosystems (Foster City, CA).
Detection of PC R products. Methods the same as in Chapter 2.
Histopathology. Tissues taken at necropsy included brain, liver, spleen, kidney
heart valve, lung, bone marrow, and peripheral lymph node. Representative sections of
tissues were fixed in 10% neutral buffered formalin for paraffin-embedding, routinely
processed, and 5 um thick sections were stained with hematoxylin and eosin and
Warthin-Starry silver stains for histological examination. Dr. R. Bauer performed all of
the necropsies and examined the histopathology in this study.
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Statistical analysis. The chi-square test was used to evaluate the relationship
between types of tissue and presence o f Bartonella DNA in various tissues. The
analysis was considered significant at a probability of P < 0.05.
Results
Results of culture of tissue. Cats were euthanized from 4 weeks to 17 weeks after
the bacteremic phase o f the infection. At the time of euthanasia, all cats were both
blood culture negative and PCR-negative. A total of 184 tissue specimens were
analyzed in this study from the 23 cats. Agar and broth cultures from 184 tissues were
negative after incubation for 3 weeks.
PCR results from tissue analysis. At the time of necropsy, Bartonella DNA was
not detected from the peripheral blood o f any cat. Although Bartonella was not
cultured from any tissue, Bartonella DNA was amplified in 10 o f the 23 cats in at least
one tissue specimen (Table 6). The distribution o f Bartonella DNA in cats was from 1
tissue to all 8 tissues in one cat. In two cats, Bartonella DNA was detected in the spleen
only. Bartonella DNA was amplified from the brain of 3 (30%), from the liver of 5
(50%), from the spleen o f 9 (90%), from bone marrow o f 7 (70%), from the lung o f 4
(40%), the lymph node o f 6 (60%), from the kidney of 4 (40%) and from the heart value
o f 5 (50%) (Table 7). There were no significant differences among tissue with regard to
finding Bartonella DNA in tissue (x2 = 4.49, P>0.05). Two o f the four cats receiving
passive antibody to Bartonella LSU 16 were found to have Bartonella DNA in at least
five tissue sites. The one cat that received passive antibody to Bartonella henselae
Houston-1 had Bartonella DNA in 7 tissue sites. Three o f the four cats injected with
methylprednisolone were found to have Bartonella DNA in 5 to 8 tissue sites. The cat
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Table 6. Results o f findings o f persistent Bartonella DNA found in various tissues
of cats experimentally infected with Bartonella henselae
Cat #

Strain

AB1* MPd

Necropsy'

Bartonella DNA in Tissue

1
LSU 16*
+ (1 ,2 , 3, 4, 5, 7,
na +
19
+b na
10
LSU 16*
12
+c
81
LSU 16*
na
19
+ (1 ,2 , 3, 4, 5, 6,
+b na
83
LSU 16*
11
84
LSU 16*
na +
19
85
+ (1 ,2 , 3, 4, 6, 7,
LSU 16*
na na
19
+b +
4
+ ( 1 ,3 ,4 , 5, 7,)
86
LSU 16*
+
+b
87
+ (1 ,2 , 3, 4, 5, 6,
LSU 16*
8
182
LSU 16*
>19
na na
184
LSU 16*
>19
na na
223
LSU 16*
na na
>19
G3
LSU 16*
12
na na
+ (2, 7)
321
LSU 16*
4
+ (2, 3)
na na
N3
LSU 16*
na na
18
+ (2)
LI
Baby*
11
na na
+ (2)
361
Baby*
13
na na
+ (2, 3, 8)
FC3
Baby*
10
na na
L2
87-66**
na na
6
N2
87-66**
na na
12
K4
87-66**
na na
16
L3
Houston-1* na na
16
F5
Houston-la
na na
29
347
Houston-la
29
na na
* lx l0 7
* * lx l0 9
a not infected
AB130anti-LSU 16 or anti-Houston-1, passively administered
MPd given three methylprednisolone injections 2 weeks apart
b anti-LSU 16
c anti-Houston-1
dgiven three methylprednisolone injections 2 weeks apart
c weeks post-bacteremia, time o f necropsy
na-negative
1-liver
2-spleen
3-bone marrow
4-heart valve
5-lung
6-brain
7-lymph node
8-kidney

8)

-

7)

-

-

-

-

-

-

-
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8)
7, 8)

Table 7. Results o f culture and PCR assay from 10 of 23 cats with persistent
Bartonella DNA in tissue
Tissue
Brain
Liver
Spleen
Bone marrow
Lung
Lymph node
Kidney
Heart valve
Peripheral Blood

Culture positive

PCR positive

0/10
0/10
0/10
0/10
0/10
0/10
0/10
0/10
0/10

%positive

3/10
5/10
9/10
7/10
4/10
6/10
4/10
5/10
0/10

30%
50%
90%
70%
40%
60%
40%
50%
0%

with all 8 tissues positive had received both passive antibody and methylprednisolone.
Cats 86 and 321, which had a recurrent episode o f bacteremia had Bartonella DNA in 5
and 2 tissues respectively. Six of 14 cats that were infected but did not receive either
passive antibody or methylprednisolone were found to have Bartonella DNA in at least
one tissue. The amplified PCR products of Bartonella DNA from the tissue o f cat 1
liver and cat 87 spleen are shown (Figure 9). Bartonella DNA was amplified in the
undiluted extracted sample from the liver o f cat 1 but was not detected in one 10-fold
dilution o f the extracted DNA. Bartonella DNA was detected in the undiluted and in
one 10-fold dilution o f extracted DNA from the spleen o f cat 87.
RT-PCR results from tissue. Using primer specific for a 567-bp fragment o f the
16S rDNA gene o f Bartonella and primer specific for a 354-bp fragment o f the citrate
synthase gene o f Bartonella, we were unable to detect any cDNA from cats with
persistent Bartonella DNA in tissue. RT-PCR assay using the 16S rRNA primers did
not amplify any cDNA products from the tissue o f the cats but the positive control
Bartonella henselae) was amplified to verify the procedure (Figure 10). The PCR
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Figure 9. Bartonella DNA from tissue of experimentally infected cats. PCR products
amplified from the 16S rRNA gene fragment of Bartonella species.
Lane 1: Low DNA Mass™ Ladder (Gibco)
Lane 2: Liver cat 1
Lane 3-5: Liver cat 1 (10-fold dilutions)
Lane 6: Spleen cat 87
Lane 7: Spleen cat 87 (IO-fold dilution)
Lane 8-13: Spleen cat 87 (10-fold dilutions)
Lane 14: Reagent Control
Lane 15:5. henselae positive control
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1
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3

4

5

6

7

Figure 10. RT-PCR for detection o f cDNA o f Bartonella henselae. PCR products
amplified from 16S rRNA gene fragment o f Bartonella. Tissue samples from cats
experimentally infected with B. henselae
Lane 1: Low DNA Mass™ Ladder (Gibco)
Lane 2: Spleen tissue from cat 87
Lane 3: Liver tissue cat 1
Lane 4: Spleen tissue cat N3
Lane 5: Positive control B. henselae from PCR
Lane 6: Reagent Blank
Lane 7: Positive control B. henselae from RT-PCR
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primers for the citrate synthase (gitA) gene amplified the Bartonella henselae, used as
positive control, but did not amplify cDNA in tissues from infected cats (Figure 11).
We were unable to detect Bartonella specific RNA from the tissue o f cats with
persistent Bartonella DNA. The sensitivity o f either assay was not determined.
Sequence analysis. The PCR product from cat 1 heart valve was sequenced for
confirmation o f Bartonella. The sequence data from the PCR product was identical to
the 16S rRNA fragment o f Bartonella henselae genotype II with the identifying region
ATT. Cat 1 was infected with B. henselae LSU 16 genotype II. (Appendix I).
Postmortem evaluation and histopathology. Gross necropsy results from the
experimentally infected cats were unremarkable except for one cat had multifocal lung
lesions and one cat had hydrocephalus. O f the 23 infected cats tested by PCR and
culture, tissues from 19 cats were processed for histopathologic examination.
Microscopic lesions were seen in the lymph nodes, liver, spleen, kidney, and bone
marrow. Histopathological diagnoses in the infected cats were as follows: lymphoid
hyperplasia o f the lymph nodes in 16 of the 19 cats; lymphocytic pericholangitis in 14
o f the 19; lymphocytic hepatitis in 2 o f the 19 cats; splenic lymphoid hyperplasia in 15
o f the 19 cats; focal interstitial nephritis in 3 o f the 19 cats; focal lymphocytic
interstitial pneumonia in 2 o f the 19 cats; focal eosinophilic pneumonia was seen in one
cat and focal bronchopneumonia was seen in one other cat; bone marrow hyperplasia
was seen in 7 o f the 19 cats and pulmonary edema in 2 of the 19 cats. The lesions
ranged from scant to severe. Bacteria were not visualized in any o f the tissue on routine
staining or with Warthin-Starry stain on a few selected tissues o f some cats.
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354 bp-

1

2

3

4

5

6

Figure 11. RT-PCR for detection o f cDNA o f Bartonella henselae with primers CSNF1 and CSN-R1 and CSN-F2 and CSN-R2. Tissue samples from cats experimentally
infected with B. henselae
Lane 1: Low DNA Mass™ Ladder (Gibco)
Lane 2: Positive control B. henselae
Lane 3: Positive control B. henselae
Lane 4: Spleen tissue from cat 87
Lane 5: Liver tissue from cat 1
Lane 6: Spleen tissue from cat N3
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Discussion
Bartonella DNA was detected in the tissues o f experimentally infected cats although
Bartonella DNA could not be detected in the peripheral blood at the time o f necropsy.
Bartonella DNA was not detected in the blood o f these cats at the time o f necropsy
tissue analysis. Therefore it is doubtful that Bartonella DNA detected in tissues was
from circulating blood. In three cats, there was a 22-week interval between bacteremia
and positive finding of Bartonella DNA in tissue. In cats with relapsing bacteremia,
Bartonella DNA was found in tissues from both cats.
The quantity of Bartonella DNA in the tissues o f these cats is unknown. Bartonella
DNA could be detected in one 10-fold dilution of the extracted DNA from the spleen of
cat 87 but could not be detected from one 10-fold dilution o f extracted DNA from the
liver of cat 1. The sensitivity limits of the nested PCR assay were determined to be 6.4
fg or approximately three organisms. Therefore, the number o f Bartonella organisms in
the tissue in cat 87 and 1 would be approximately 30 and 3 microorganisms respectively
in the tissue of these cats. All cultures from the tissues o f the cats were negative. The
culture results may reflect the minimal detection limits o f culture or possibility o f a
dormant nonculturable state o f the organism in tissue. The absence o f detectable
Bartonella DNA in some tissues may indicate that there was no Bartonella DNA in the
tissue of these cats or the detection limits may have been exceeded. Many aspects of
the pathogenesis of feline bartonellosis are unclear, including entry o f the
microorganism into the cat, interaction with the phagocytic cells, the immunological
Many aspects o f the pathogenesis o f feline bartonellosis are unclear, including entry of
the microorganism into the cat, interaction with the phagocytic cells, the immunological
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response o f the cat, predilection for certain tissue, or sequestration in tissue. The cat
flea is known to play a role in the transmission o f B. henselae from cat to cat. The
spread of the microbe through the body or the events that might occur with the
interaction with phagocytic cells o f the host is open to speculation. Little is known
about the virulence factors associated with Bartonella or mechanisms responsible for
bacterial adherence, colonization, or invasion or the mechanisms o f persistence.
Bartonella infections in cats are characterized by an acute phase in which a
bacteremia o f significant magnitude and duration can be detected by bacterial culture.
Chronic infection with recurrent episodes o f bacteremia is observed in some cats for
long periods. This suggests that there is a subclinical phase o f the infection in which
some cats harbor the organism and remain persistently infected for years. The cyclic
nature of the bacteremia seen in cats infected with B. henselae may represent
sequestration o f Bartonella organisms in tissues with periodic release into peripheral
blood. The nature o f the persistence of this microorganism in cats is in question.
Bartonella may use multiple mechanisms or evasive strategies to ensure prolonged
survival in the cat. In this study, all cultures from the tissues were negative and no
RNA expression was detected although Bartonella DNA could be detected. Does the
Bartonella DNA represent dead organisms; is the organism viable in the tissue of cats
below the detection limits o f culture; is Bartonella in a viable but nonculturable state as
reported with other organisms? A viable but nonculturable state occurs in many
organisms such as Vibro cholerae and Escherichia coli, Salmonella enteritidis. Shigella
sonnei, and Legionella pneumophila, which have lost the capacity to form colonies on
culture media yet, remain viable (Dixon et al. 1998).
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Detection o f Bartonella DNA in tissue that is culture negative is not unusual and is
seen in other hosts infected with Bartonella. In humans infected with B. henselae,
diagnoses o f Bartonella infections are often made by detection o f Bartonella DNA in
culture negative tissue. In cases involving dogs, endocarditis and peliosis hepatis have
been diagnosed by amplification o f Bartonella DNA from culture negative tissue. In a
study by Regnath et al. (1998), B. henselae infected mice were shown to clear the
cultivatable organism within the first 6 days o f infection from liver and spleen but
Bartonella DNA could be detected in liver for at least 3 months. Localization of
Bartonella in tissue certainly seems logical. Mechanism o f localization o f Bartonella in
tissue would depend on cell association. If the microorganisms were free in the plasma,
localization in tissue would depend on the ability o f the organism to adhere to or grow
in vascular endothelial cells. There is evidence that Bartonella does adhere to and
invade endothelial tissue in humans (Dehio et al. 1997). If Bartonella is phagocytized
by monocytes this would be a mechanism to carry the organism through tissue as the
cells move in and out o f the vascular system. The erythrocyte association of Bartonella
would allow travel through tissue on the erythrocyte. An intraerythrocytic location o f a
microorganism could be a protective site from phagocytosis by the reticuloendothelial
system.
In human studies, B. henselae can invade or attach to endothelial cells, macrophages
and neutrophils. In the cat, B. henselae has only been found within feline erythrocytes
(Kordick and Breitschwerdt 1995). An intracellular location that facilitates persistent
infections in cats has not been established. However, the persistent nature o f Bartonella
as well as the lack o f efficacy of antibiotics to clear infections is suggestive o f an
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intracellular location as observed with another intracellular organisms, Brucella, which
is phylogenetically related to Bartonella (Review by Anderson and Neuman 1997). If
Bartonella resides and grows in the macrophage, this mechanism may lead to infection
of the organ harboring the macrophages with reseeding o f bacteria into the blood by
various tissues. In a study by Karem et al. (1999), using the BALB/c mouse as a model,
Bartonella could be cultured from tissue of mice infected intraperitoneally 24 hr after
infection but not after 6 hours or 7 days. Mice infected with B. henselae by the
intraperitoneal route never became bacteremic although Bartonella DNA was detected
within 6 hours in the liver and mesenteric lymph node and up to 7 days in spleen,
kidney, and liver by PCR. This study suggests uptake o f the organism by phagocytes,
which then are filtered by organs such as the liver in the mouse model. In cats infected
with Bartonella, bacteremia is common and circulating organisms in the blood could
localize in organs such as the liver and spleen.
The histopathologic findings in this study are not specific for Bartonella. However,
Kordick et al. (1999) reported similar findings in lymph nodes, spleen, liver, and kidney
in a group of B. henselae infected cats. In a study by Guptill et al. (1997),
histopathologic lesions in multiple organs o f infected cats 8 weeks postinfection were
reported. Necrotizing granulomas were found in lymph nodes in 1 cat at 8 weeks
postinoculation that were similar to what is seen in CSD patient. Guptill et al. (1997)
found mild to marked lymphoid hyperplasia of the spleen, marked lymphoid
hyperplasia in the lymph nodes, and foci of necrosis throughout the liver, focal
pyogranulomatous nephritis, and interstitial myocarditis in a group of Bartonella
infected cats. Bacteria were seen infrequently, were extracellular, and not associated
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with inflammatory lesions. Similar to the study by Kordick et al. (1999), abscesses or
granulomata were not found in tissues from our cats.
Bartonella-induced histopathologic alterations o f affected lymph nodes from human
patients with CSD typically include stellate caseating granulomas, microabscesses, and
follicular hyperplasia (Anderson and Neuman 1997). The histopathologic findings in
the lymph nodes o f patients with CSD depend on the stage o f the infection (Sander et al.
1999). Early in the course of CSD infections, lymphoid hyperplasia is seen, while
granulomas with necrosis and stellate microabscesses are seen later in these infections
(Bass et al. 1997; Kaschula 1996). In human patients with bacillary angiomatosis, a
variety of internal organs including the liver, spleen, bone, brain, lungs, and bowel can
be affected. The liver or the spleen or both are affected in patients with bacillary
peliosis. The affected tissues contain numerous blood-filled partially endothelial celllined cystic structures and fibromyxoid stroma with a mixture o f inflammatory cells,
dilated capillaries, and clumps of bacilli identified by Warthin-Starry staining (Welch
and Slater, 1999). Inflammatory reactions to B. henselae infection without associated
bacillary angiomatosis and or peliosis included granulomatous reactions characterized
by nodular collections o f histiocytes, lymphocytes and aggregates o f neutrophils and
karyorrhexic debris suggestive o f microscopic abscess formation that resemble lymph
node lesions o f CSD (Liston et al. 1996). The hydrocephalus found in one cat and the
multifocal lung lesions found in another cat are non-related findings and likely not
related to the Bartonella infection in the experimentally infected cats. The multifocal
lung lesions with eosinophils seen among the inflammatory cells is likely to be related
to parasite migration or feline asthma.
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Regnath et al. (1998) used the mouse model to demonstrate the progression o f
Bartonella-induced histopathologic alterations. Three days postinfection liver lesions
were characterized by a few small aggregates of lymphocytes and monocytes that
expanded in number and size. In the second week postinfection granulomatous lesions
consisting o f lymphocytes, monocytes and epithelioid cells were observed. Necrosis in
the mouse liver granulomas was not evident as observed in human patients with CSD.
Necrotizing granulomas or abscesses were not found in the cats in this study. The
histologic changes are not specific for Bartonella. However, the follicular hyperplasia
of lymph nodes and spleen as seen in these cats is suggestive o f nonspecific tissue
response to a chronic antigenic stimulation. The cats in this study were not bacteremic
at the time o f necropsy although 10 o f the cats had persistent Bartonella DNA amplified
from various tissues, suggesting chronic infection. Bartonella DNA was amplified
from the spleen of the cats with splenic lymphoid hyperplasia, from the liver o f cats
with lymphocytic pericholangitis and lymphocytic hepatitis and from the lymph node o f
the experimentally infected cats with lymphoid hyperplasia o f lymph nodes. Three cats
had lesions in the kidney, and Bartonella DNA was amplified from the kidney o f four
of the infected cats. Although neurological signs have been observed in cat
experimentally infected with B. henselae LSU 16 (O’Reilly et al. 1999a), significant
lesions were not seen in the brain o f cats in this study which were infected with the
same strain. Kordick et al. (1999) reported similar histopathological findings in a group
of cats experimentally infected with B. henselae. Bartonella DNA was amplified from
the brain o f three o f the cats. Bartonella henselae DNA has been amplified from both
dogs and humans with endocarditis. Cats in this study did not have lesions from the
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heart valve despite the fact that Bartonella DNA was amplified from five cats.
Organisms were not seen in any o f the tissues analyzed in this study. However, other
investigators have reported the difficulty o f demonstrating Bartonella organisms in
tissues. It is difficult to make any correlation between the pathologic changes seen in
the tissues o f these cats and the Bartonella infection. Without locating, Bartonella in
the lesions o f infected cats there is no conclusive evidence that the lesions seen are
related to Bartonella. However, with the high endemicity o f Bartonella infections in
cats, it is possible that the lesions are related to Bartonella. Bartonella may evade the
immune system so that there are no inflammatory responses seen in the cat despite the
fact that the organism is present.
In order to understand the metabolic state or viability o f the persistent Bartonella
DNA found in the tissue o f these cats, attempts to demonstrate RNA expression o f the
citrate synthase gene and the 16S rRNA gene was done. Because there are multiple
copies o f rRNA (104- 106) per cell, it should be possible to extract RNA and amplify the
cDNA o f the rRNA of Bartonella from the tissue o f cats in which persistent Bartonella
DNA was found. Even if the amount o f Bartonella DNA found in tissue was low, using
rRNA as a target seemed to be a reasonable approach to this problem. Detecting RNA
expression o f the rRNA of Bartonella found in the tissue could have given insight to
the metabolic state o f the organism. Using primers specific for the citrate synthase gene
hoping to amplify cDNA from the reverse transcription o f mRNA o f the citrate synthase
gene was also reasonable. Because the half-life o f mRNA is shorter than that o f rRNA,
mRNA is a better marker for growth and viability. Complementary DNA (cDNA) was
not amplified from any of the tissues with either RT-PCR assay. The failure to amplify
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cDNA from the rRNA or mRNA o f the citrate synthase gene could be because of
insufficient numbers o f organisms in the tissue and thus insufficient amount of RNA,
microorganisms in a dormant state, nonviable organisms, or problems with the activity
o f RNases. Whether the Bartonella DNA amplified from the tissue o f the cats in this
study represents viable but nonculturable organisms because o f a dormant state or
because the detection limits of culture remains unknown. All o f the cats in this study
were abacteremic at the time o f necropsy, and some o f the cats that were positive for
Bartonella DNA in tissue had been abacteremic for 19 weeks. In addition, Bartonella
DNAwas amplified from both cats with recurrent episodes o f bacteremia suggesting
that the organisms do persist in the cat. Further work is needed to characterize the
Bartonella DNA found in the tissue o f cats.
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CHAPTER FOUR
COMPARISON OF FINDINGS OF PERSISTENT BARTONELLA DNA IN CATS
EXPERIMENTALLY INFECTED WITH BARTONELLA HENSELAE
GENOTYPE I AND BARTONELLA HENSELAE GENOTYPE n
Introduction
The domestic cat is the reservoir for B. henselae and a risk factor for acquiring cat
scratch disease (CSD) (Zangwill et al. 1993). Cats can be chronically infected with
relapsing bacteremia for long periods o f time (Kordick et al. 1995). Persistent
Bartonella DNA has been detected in the tissue o f cats long after the bacteremic stage
o f the infection, which suggests a harboring o f organism in the tissues o f chronically
infected cats (Chapter 3).
Bartonella are fastidious, slow-growing microorganisms, and distinguishing between
the species is difficult. Definitive identification o f the species requires molecular
techniques. Various molecular methods have been used for identification o f Bartonella
species. Bartonella henselae and B. clarridgeiae presently are the most common
species o f Bartonella isolated from the blood o f cats and the most common species o f
Bartonella isolated from cats is B. henselae (Heller et al. 1997). By partial 16S rRNA
gene sequence analysis, Bergmans et al. (1996), described genotype I and genotype II of
B. henselae that differ from each other in three nucleotides located at positions 172 and
175 o f the 16S rRNA gene. The sequences o f genotype I and genotype II are analogous
to the sequences o f B. henselae Houston-1 described by Regnery et al. (1992) and B.
henselae “BA-TF” described by Reiman et al. (1992), respectively. Two types o f B.
henselae, genotype I and genotype II have been shown to coinfect some cats (Gurfield
et al. 1997). In a study by Heller et al. (1997), blood samples from 94 stray cats found
that 34 % o f the isolates from cats were genotype I, 36% were genotype II and 30%
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were B. clarridgeiae. Bergmans et al. (1996) found that the majority o f the lymph
nodes from patients with CSD contained B. henselae genotype I, while Sander et al.
(1999) found B. henselae genotype I in 59% o f PCR-positive lymph nodes and
genotype II in 23% o f the PCR-positive lymph nodes o f CSD patients. Seven (18%) of
the lymph nodes were negative in both genotype-specific PCRs. Sander et al. (1998b)
found 16 of 17 isolates o f B. henselae from blood culture o f human patinets to be B.
henselae genotype II. These authors have suggested that there may be a difference in
the types of B. henselae and host specificity.
In this study, blood and tissues from cats experimentally infected with B. henselae
genotype I and B. henselae genotype II were tested using a PCR assay designed to
detect both genotypes o f B. henselae using minor sequence differences between the
genotypes in a region o f the 16S rRNA gene of Bartonella.
Identifying strains and types of B. henselae will be useful in understanding the
pathogenesis of these two genotypes
Materials and Methods
Experimental animals. Tissue and blood used in this study was from twenty-three
cats as reported in Chapter 3.
Bacterial strains. Methods the same as in Chapter 3
Infection in cats. Methods the same as in Chapter 2 and 3
Collection of blood and tissue specimens. Blood was collected with the same
methods as in Chapter 2. Tissue was collected with the same methods as in Chapter 3
Blood and tissue cultures. Blood was cultured with the same methods as in
Chapter 2. Tissue was cultured with the same methods as in Chapter 3.
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Extraction of DNA from blood and tissue. Blood was extracted as in Chapter 2.
Tissue was extracted with the same methods as in Chapter 3
PCR amplification of DNA from blood and tissue. A nested PCR was performed
using primers previously described (R. Tapp 2000, Master Thesis, Louisiana State
University, The Institute for Environmental Studies) to amplify a final product o f a 477
bp fragment o f the 16S rRNA gene o f Bartonella. For amplification o f genus specific
Bartonella DNA, forward primer pair Bhenl6FF 5’CACATGCAAGTCGAGCACA
CTCTTTTAGAG 3’and reverse primer UB16SDR9 5’GCCCCCGTCAATTCCTTT
GAGTTT 3’ were used, generating an 823 bp fragment. A second reverse primer that is
Bartonella genus specific Bhenl6SBBR 5’-CACATGCAAGTCGAGCACA
CTCTTTTAGAG-3’ was also designed to be used with the forward Bhenl6FF primer
to amplify a 567 bp fragment.
For amplification o f species and genotype I-specific Bartonella DNA, the internal
forward primer Bhenl6SGG 5 ’G AAATTT GTGCT AAT ACCG AAT ACGT CCTT AG
3’and reverse primer Bhenl6SBBR were used to amplify a 477 bp fragment o f the 16s
rRNA gene o f B. henselae. For amplification of species and genotype II-specific
Bartonella DNA, the forward primer Bhen 1616SHH 5’GAAATTTGTGCTAATAC
CGAATACGTCCTATTTG 3’and reverse primer Bhenl6SBBR were used to amplify a
477 bp fragment. Because genotype I and genotype II fragments were of the same base
pair size both primer sets were performed simultaneously in separate reaction for each
sample. The synthetic oligonucleotides were purchased from GeneLab (Louisiana State
University, Baton Rouge, LA). DNA amplification was carried out in 50-pl reaction
volumes. The PCR amplification was carried out on a Model 9600 Thermal-Cycler
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Perkin-EImer/Applied Biosystems (Foster City, CA). Each reaction mixture consisted
o f deoxynucleoside triphosphates (200pM each), 1.75 mM MgC^, 0.2pM o f each
primer, 2.5 U o f Taq DNA polymerase, AmpliTaq™ Gold (Perkin Elmer), 4 pi of DNA
in PE buffer in a total volume o f 50 pi. Amplification reaction consisted o f 10 min. at
95°C, 30 cycles of 94°C for 1 min., 66°C for 1 min., and 72°C for 1 min., and a final
elongation step at 72°C for 10 min. In the first reaction, primers Bhenl6SFF and
UB16SDR9 or Bhenl6SBBR were added. A second amplification reaction o f 20 cycles
with the sample conditions as previously stated was performed using Bhenl6SGG and
Bhenl6SBBR for genotype I and Bhenl6SHH and Bhenl6SBBR for genotype II and 1
pg of DNA from the previous PCR reaction. As a negative control, PCR reagents
without DNA template were included in each amplification assay. Positive controls of
extracted B. henselae genotype I and genotype II were also used in each amplification
assay.
Detection of PCR products. Methods the same as in Chapter 2 and Chapter 3
Sequence analysis. Methods the same as in Chapter 2
Results
Bartonella henselae genotype I and genotype II DNA detection during
bacteremia and in tissue. The B. henselae primers specific for genotype I and
genotype II were used to determine genotype specificity in the cats during the
bacteremic phase o f the infection and in the tissue analysis (Figure 12). The bacteremic
phase o f the infection was followed in 16 o f the 23 experimentally infected cats. In
nine of the cats, the B. henselae genotype specific primers were used to determine if
there was a genotype switch during periods o f bacteremia. Cats remained infected with

110

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

477 bp-

1

2

3

4

5

6

7

8

9

1

0

11

Figure 12. Bartonella henselae genotype I and genotype II DNA
Lane 1: Low DNA Mass™ Ladder (Gibco)
Lane 2: Cat L2 infected with B. henselae 87-66 genotype I (primers Bhenl6SGG-BBRgenotype I specific)
Lane 3: Cat L2 infected with B. henselae 87-66 genotype I (primers Bhenl6SHH-BBRgenotype II specific)
Lane 4: Reagent Control
Lane 5: B. henselae 87-66 genotype I positive control (primers Bhenl6SGG-BBRgenotype I specific)
Lane 6: B. henselae 87-66 genotype I positive control (primers Bhenl6SHH-BBR-type
II specific)
Lane 7: Cat 321 infected with B. henselae LSU 16 genotype II (primers Bhenl6SGGBBR-genotype I specific)
Lane 8: Cat 321 infected with B. henselae LSU 16 genotype II (primers Bhenl6SHHBBR-genotype II specific)
Lane 9: Reagent Control
Lane 10: B. henselae LSU 16 genotype II positive control (primers Bhenl6SGG-BBRgenotype I specific)
Lane 11: B. henselae LSU 16 genotype II positive control (primers Bhenl6SHH-BBRgenotype II specific)
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the same B. henselae genotype as was inoculated (Table 8). Seven cats were infected
with B. henselae LSU-16 genotype II, and the type specific PCR primers confirmed the
Bartonella DNA detected to be B. henselae genotype II throughout the bacteremia.
Three cats infected with B. henselae Baby genotype II were also confirmed to be B.
henselae genotype II DNA throughout the bacteremia. O f the three cats infected with
B. henselae 87-66 genotype I, all remained infected with B. henselae genotype I and the
one cat infected with B. henselae Houston-1 remained infected with B. henselae
genotype I (Table 8). None o f the cats infected with B. henselae 87-66 genotype I or B.
henselae Houston-1 experienced relapsing bacteremia.
Cat 86 and cat 321 experienced an episode of relapsing bacteremia. Both cats were
infected with B. henselae genotype II, B. henselae genotype II was amplified from both
cats during the relapsing bacteremia (Table 9).
Persistent Bartonella DNA was found in tissue samples from 10 o f 23 of the cats in
this study. O f the 10 cats in which Bartonella DNA was found, all were B. henselae
genotype II. Seventeen cats were infected with B. henselae genotype II. O f the four
cats that became bacteremic with B. henselae genotype I, B. henselae DNA could not be
found in tissues and thus genotype could not be determined (Table 10).
Sequence analysis. The sequence analysis o f the PCR product from blood
specimens o f cat 86 taken during the bacteremic phase o f the infection confirmed the
product was a B. henselae genotype II (Table 11). Cat 86 was experimentally infected
with B. henselae LSU 16 genotype II. The sequence analysis o f the PCR product from
blood specimen o f cat L2 taken during the bacteremic phase o f the infection was typical
a B. henselae genotype I (Table 11). Cat L2 was experimentally infected with
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Table 8. Results of Bartonella henselae genotype from cats during period of bacteremia

Week*
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23-29

Cat L lc
type CFU/ml
II
+
II
+
II
+
II
+

n
+
ii

+
ii

l.OxlO6
2.4x10s
3.0xl02
3.5x102
0
l.OxlO2
0
0
0
0
0
0
0

NDf
II
0
0
II
0
0
0
0
0
0
0

-

Cat 361c
type CFU/ml

n
+

n
+
ii

+
ii

+
ii

+
ii

+

n

3.4x10s
3.5xl04
3.6x10s
7.0xl02
l.OxlO2
l.OxlO2
1.5xl02
0
0
0
0
0
0

NDf
-

n
-

-

-

-

-

-

-

-

-

-

-

-

-

0
0
0
0
0
0
0
0
0

Cat K3C
type CFU/ml

C atG 3b
type CFU/mi

4.0x104 n
1.2xl03
■
f
3.2xl04
1.8x10s
1.5x10s n
8.0x10s
2.0x10s +
1.3x10s
6.8x104 n
2.4x104
n
+
4.5xI04 +
2.5x104
2.5x104 ii
9.0x103
n
+
2.4x104 +
2.3x104
1.3xl04 ii
3.0x102
n
+
6.7x103 +
0
4.2x103 n
0
n
+
2.6xl03 +
0
6.6x102 ii
0
ii
NDf
NDf
2.6x102 n
0
II
+
+
6.3x102
0
1.3xl02 n
0
II
+
+
l.OxlO2
0
2.0x102 ii
0
n
+
0
0
0
0
ii
+
0
0
0
0

n

+
II
+

-

-

a post-inoculation
b inoculated with B. henselae LSU 16 Genotype II
c inoculated with Bartonella henselae Baby Genotype II
d inoculated with Bartonella henselae 87-66 Genotype I
c inoculated with Bartonella henselae Houston-1 Genotype I
f ND, not determined
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Week*
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24-29

Cat K4d
type CFU/ml
I
+

I
+

I
+

I
+

I
+

I
+
-

9.0x102
4.1xl04
3.0xl04
5.1xl04
4.8x104
5.7x104
2.3xl04
6.0x103
4.0x103
4.0x102
l.OxlO2
0
0

-

-

-

-

-

-

-

-

I
+

I
+
-

-

-

-

0
0
0
5.0x102
2.0xl03
3.0xl02
2.0xl02
l.OxlO2
l.OxlO2
0
0
0
0

NDf

ND‘
-

Cat L3*
type CFU/ml

0
0
0
0
0
0
0
0
0
0

-

-

-

-

-

-

-

Cat F5*
type CFU/ml
_
-

*

■

■

-

-

-

-

-

Cat 347*
type CFU/ml
.

0
0
0
0
0
0
0
0
0
0
0
0
0

-

-

-

-

-

-

-

-

NDf

NDf
0
0
0
0
0
0
0
0
0
0

-

-

-

-

-

-

-

-

-

0
0
0
0
0
0
0
0
0
0
0
0
0

0
0
0
0
0
0
0
0
0
0

-

-

-

-

-

-

-

0
0
0
0
0
0
0
0
0
0

a post-inoculation
b inoculated with B. henselae LSU 16 Genotype II
c inoculated with Bartonella henselae Baby Genotype II
d inoculated with Bartonella henselae 87-66 Genotype I
c inoculated with Bartonella henselae Houston-1 Genotype I
fND, not determined
(Table 8 continued)
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Week*

1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23-29

Cat N2d
type CFU/ml

I
4.0x103
+ 2.0x103
I 2.7x104
+ 2.4x104
I
2.8x104
+ 2.1xl04
I
2.2x104
+
1.6xl04
I
7.6x103
+ 5.0xl03
I
2.8x103
+ l.OxlO3
I 1 .3xl02
ND f
I
0
0
+
0
0
0
0
0
0
0
-

Cat N3b
type CFU/ml

n
+
ii

+
ii

+
ii

+
n
+
n
-

-

-

-

-

-

-

-

-

-

-

-

-

1.2xl03
3.1xl04
2.2x105
2.0x104
3.6xl04
2.9x104
6.0x103
2.1xl03
5.0x102
0
0
0
0
0
0
0
0
0
0
0
0
0
0

Cat L2d
type CFU/ml
6.8x104
I
+
4.4x104
4.0x105
I
+
l.lx lO 5
3.5x10s
I
+
1.9xl05
1.3xl04
I
+
3.9xl03
2.5x103
I
+
5.0x102
5.0x102
I
+
l.OxlO2
8.3xl03
I
NDf
+ 8.6x103
I
8.3x103
+
1.5xl04
I
8.0xl03
+ 7.3x103
I
5.3xl03
+
l.OxlO3
I
l.OxlO3

a post-inoculation
b inoculated with B. henselae LSU 16 Genotype II
c inoculated with Bartonella henselae Baby Genotype II
d inoculated with Bartonella henselae 87-66 Genotype I
e inoculated with Bartonella henselae Houston-1 Genotype I
f ND, not determined
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Table 9. Results o f Bartonella henselae genotype from cats with relapsing
bacteremia

Week*
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29

Cat 86b
type CFU/ml
II
+
n
+
ii

+
ii

ii

+
ii

+
ii

+
n
+
-

6.3x104
1.7xl04
4.3x104
2.2x103
3.0xl02
0
0
0
0
0
0
0
l.lx lO 4
l.OxlO4
6.0x103
1.2xl03
3.3xI02
7.0xl02
2.3xl02
l.OxlO2
0
0
0
0
0
0
0
0
0

Cat 321b
type CFU/ml
n
+
n
4ii

+
u
+
ii

+
ND°
-

n
+
ii

+
-

2.6x103
3.9xl04
2.0x105
1.7xl04
l.OxlO2
l.OxlO2
0
6.0x102
4.0x102
1.5xl02
0
0
0
0
0
0
0
0
0
0
0
6.0x102
6.7x102
2.0x102
1.3xl02
0
0
0

a post-inoculation
b inoculated with B. henselae LSU 16 Genotype II
c ND, not determined
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Table 10. Results o f findings of persistent Bartonella DNA in various strains of
Bartonella henselae
Cat

Strain

Type

Bartonella DNA in tissue

1
10
81
83
84
85
86
87
182
184
223
G3
321
N3
LI
361
K3
L2
N2
K4
L3
F5
347

LSU 16*
LSU 16*
LSU 16*
LSU 16*
LSU 16*
LSU 16*
LSU 16*
LSU 16*
LSU 16*
LSU 16*
LSU 16*
LSU 16*
LSU 16*
LSU 16*
Baby*
Baby*
Baby*
87-66**
87-66**
87-66**
Houston-1*
Houston-13
Houston-la

n

+ ( l ,2 , 3 ,4 , 5, 7, 8)

II
II

-

+ ( l ,2 , 3 ,4 , 5, 6, 7)

n
n
n

-

+ (1 ,2 , 3 ,4 , 6, 7, 8)
+ (1 ,3 ,4 , 5,7,)
+ (1 ,2 , 3, 4, 5, 6, 7, 8)

ii
ii

n
n
n

-

+ (2, 7)
+ (2, 3)
+ (2)
+ (2)
+ (2 ,3 , 8)

ii

n
ii

n
ii
ii

-

i
i
i
i
i
i

-

* lx l0 7
* * lx l0 9
3 not infected
1-liver
2-spleen
3-bone marrow
4-heart valve
5-lung
6-brain
7-lymph node
8-kidney
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B. henselae 87-66 genotype I. The Bartonella DNA amplified from the heart valve
tissue o f cat 1 was typical o f a B. henselae genotype II (Table 11). Cat 1 was
experimentally infected with B. henselae LSU 16 genotype II.

Table 11. Partial sequence data of Bartonella henselae strains amplified from
experimentally infected cats
Cat
Cat 86
Cat L2
Cat 1

Specimen
blood
blood
heart valve

Challenge Strain

Sequence data

B. henselae LSU 16 genotype II
B. henselae 87-66 genotype I
B. henselae LSU 16 genotype II

CCTATTTGGA
CCTTA G- GCA
CCTATT- GCA

Discussion
Use o f this PCR assay differentiated between the subtypes o f B. henselae in cats
experimentally infected with Bartonella henselae. It has been shown that cats can be
coinfected with B. henselae genotype I and genotype II and or B. clarridgeiae.
However, whether certain types are predominant over others during coinfection is
unknown. Currently it is not known whether these genotypes are predictive o f
pathogenicity or virulence.
Chronic infection with recurrent episodes of bacteremia is observed in some cats for
long periods. This suggests that there is a subclinical phase o f the infection in which
some cats harbor the organism and remain persistently infected for years. The cyclic
nature o f the bacteremia seen in cats infected with B. henselae may represent
sequestration of Bartonella organisms in the cat with periodic release into peripheral
blood. The nature o f the persistence o f this microorganism in cats is in question.
Bartonella may use multiple mechanisms or evasive strategies such as intracellular
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location, location in sites that are immunologically privileged, or antigenic variation to
ensure prolonged survival in the cat.
There are discrepancies between the results o f Bartonella experimental infections in
cats of various investigators. The differences are in the duration and reoccurrence of
bacteremia experienced in experimentally infected cats. Different parameters o f the
infection process such as dose, route of inoculation, response o f the host, and strain o f
the organism could be reasons for some o f these discrepancies. In the experimental
infection with B. henselae Houston-1 by Regnery et al. (1996) and Greene et al. (1996),
bacteremia o f short duration and without relapse was reported. Kordick et al. (1999)
used B. henselae genotype II from donor cats to induce prolonged bacteremia with
relapse for 454 days in experimentally infected cats. In the study by O’Reilly et al.
(1999a), acute clinical disease was established in cats using B. henselae LSU 16
genotype II isolated from a naturally infected cat.
Identifying and characterizing the strains or subtypes o f B. henselae would be useful
in the studies o f the pathogenesis o f feline bartonellosis. B. henselae strain typing by
genotypic methods will be useful in comparing the diversity o f strains within the cat
reservoirs with the diversity o f strains that cause the various human clinical syndromes.
It has been suggested that the majority o f human clinical samples associated with cat
scratch disease involve B. henselae genotype I, while the majority o f the isolates from
cats are genotype I I B. henselae (Sander et al. 1998; Bergmans et al. 1996).
In this study, all 10 cats with persistent Bartonella DNA detected in tissues were
cats infected with B. henselae genotype II. Bartonella DNA was not found in any o f the
cats infected with B. henselae genotype I despite the fact that the three cats infected
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with B. henselae 87-66 genotype I were inoculated with a higher dose (109 versus 107)
o f organism than the cats infected with B. henselae genotype II. These results suggest
that B. henselae genotype II may be more pathogenic are more adapted in cats because
of the prolong duration o f Bartonella DNA found in tissues of these cats. Bacteremia
was established in all the B. henselae genotype II cats. Bacteremia was established in
cats infected with B. henselae 87-66 genotype I however a higher dose was used. Only
one o f the three cats inoculated with B. henselae Houston-1 became bacteremic.
Episodes of recurring bacteremia were seen in the two cats infected with B. henselae
genotype II. None of the cats infected with B. henselae genotype I had episodes of
recurring bacteremia during the course of this study. Relative differences in virulenceassociated genes and pathogenicity related to strain are still not clear. The finding of
persistent Bartonella DNA in the tissue of cats infected with B. henselae genotype II
and the relapsing bacteremia seen in those same cats is suggestive o f a virulenceassociated strain. The cats with persistent Bartonella DNA in tissue were infected with
two different isolates o f B. henselae genotype II and suggest that persistence and
chronic infections in cats may be associated with genotype II. Use o f genetic tools, to
identify disease-associated genes o f B. henselae will be nice.
Freeland et al. (1999) found differences in absorption antibody profiles with B.
henselae Houston-1 and B. henselae LSU 16 genotype II which may represent
differences in immunodominant antigens expressed by these two types o f Bartonella.
The cats experimentally infected and used in this study were examined by other
investigators (Parr et al. 1999) for comparison of clinical disease in the various strains.
Parr et al. (1999) described differences in clinical disease, bacteremia, antibody
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response, and the number o f circulating antibodies to the various strains o f B. henselae.
In general clinical disease was more severe in B. henselae genotype II than in B.
henselae genotype I as defined by fever, lymphadenopathy, lethargy, diarrhea, and
anorexia. In addition, cats infected with B. henselae LSU 16 displayed neurological
signs not observed in the other cats. The IgM response peaked earlier (3 weeks) in the
B. henselae genotype II strain than in the B. henselae genotype I strain (6 weeks). The
IgG patterns were also different with the peak IgG level appearing at 9-12 weeks in the
genotype II strains and at 7 weeks in the genotype I strains. These results are
suggestive that there may be a difference in virulence and pathogenicity among the
strains o f B. henselae
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CHAPTER FIVE
CONCLUSIONS
Summary o f Results
The nested PCR assay developed was successful in amplifying genus, species, and
genotypes o f Bartonella and was a valuable research tool in this study. The nested PCR
design using outer and inner primer sets amplified an 823 bp fragment, a 567 bp
fragment, and a 477 bp fragment o f the 16S rRNA gene of Bartonella. Sequence
analysis of the PCR products were as predicted and were confirmed to be Bartonella
henselae. Sensitivity limits o f the PCR assay were determined to be 3.2 organisms per
milliliter o f blood and below the detection limits o f culture.
Experimentally infections were established in 23 cats and the PCR assay was able to
detect Bartonella in all of the infected cats and in more samples and for longer periods
than bacterial culture. The PCR assay was positive in 40 of the blood samples in which
the blood culture was negative. The bacteremic phase o f the infection was extended by
1 to 9 weeks as defined by the PCR assay.
The chronicity of Bartonella infections in cats was demonstrated by detecting
persistent Bartonella DNA in 10 o f the 23 cats. Bartonella DNA was detected in 10
cats in multiple tissues. Bartonella DNA were found in the spleen o f 9 o f the 10 cats.
Other tissues in which Bartonella DNA was detected was liver, kidney, brain, lymph
nodes, bone marrow, heart valve, and lung. Chronicity of Bartonella infection was
demonstrated in two cats with episodes o f relapsing bacteremia. Bartonella DNA was
found in tissues from both o f these cats.
Histopathologic analysis o f tissues o f infected cat showed reactions that were typical
o f chronic antigenic stimulation but nonspecific for Bartonella. Lymph nodes from 16
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of the 19 infected cats displayed lymphoid hyperplasia and, in IS of the 19, splenic
lymphoid hyperplasia was observed. Specific diagnostic lesions associated with
Bartonella infections could not be made from these cats.
Determination o f viability o f organism detected in these cats with persistent
Bartonella DNA was not accomplished by RNA express analysis with the RT-PCR
assays. RNA expression o f the citrate synthase gene or the 16S rRNA gene was not
detected in tissue specimens.
The particular B. henselae genotype used to infect the cats did not change over the
course of the acute or chronic bacteremic phase o f the infection. The persistent
Bartonella DNA detected in tissue in the chronic phase o f the infection was determined
to be B. henselae genotype II. B. henselae genotype I was not detected in tissue from
any of the cats infected with that genotype.
F uture W ork
Many aspects o f the pathogenesis of Bartonella henselae are still unclear. Research
designed to investigate virulence factors, strain variability, cell association o f the
organism, and mechanisms of persistence are needed. Understanding the nature of the
persistence by determining viability of Bartonella DNA detected in tissue is an
interesting area. Is the organism viable but dormant in tissue and the source o f
relapsing episodes o f infection? Moreover, what are the factors that allow the
bacteremia to reoccur? Whether B. henselae DNA found in the tissue o f cats long after
the acute phase of the infection represents sequestration o f a viable organism which has
lost the capacity to form colonies on culture media or is nonviable and not the source of
recurring infection is unknown. The concepts o f culturability and viability are
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confusing. An organism that is culturable is able to reproduce and an organism that is
viable is alive but not necessarily reproducing or culturable in the present state or
environment. There are over 30 bacterial species in which a viable but nonculturable
response occurs when exposed to adverse environmental factors (Oliver 1999). There is
a great deal o f study necessary to understand the molecular and physiological basis of
dormancy in microorganisms. Understanding the sensing mechanisms used by
organisms in various environments inside and outside o f the host and the responses
generated to modify metabolism is a dominant theme in studying pathogenesis.
Determining if the Bartonella DNA found in the cat is a source of clinical bacteremia
when sequestered in the host and if there is a tissue predilection for sequestration will
help in the understanding of the course o f Bartonella infection in cats. Therapeutic
decisions may evolve around the determination of persistence. Chronic infections may
be eliminated by treatment of cats in the acute phase o f infection to avoid sequestration.
Using RNA expression as an indicator for growth and metabolism o f prokaryotic cells
requires adequate amounts of RNA. The amount o f Bartonella DNA detected in the
tissue of cats is probably low and a limiting factor in the recovery o f detectable RNA.
Another approach to characterizing the Bartonella DNA in terms of viability would be
to inoculate tissue with detectable Bartonella DNA into other animals and observe for
signs of infection.
From this research, Bartonella DNA was detected by PCR from culture-negative
blood of infected cats. The infectious nature o f PCR positive and culture negative
blood would be interesting to know and could be determined by infecting cats with this
blood or using fleas for transmission.
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Knowledge of strain variability involved in Bartonella infections will allow for
comparison of the diversity o f strains within cat reservoirs with the diversity o f strain
that causes various human clinical syndromes. There may be strains that are more
pathogenic similar to the strain B. henselae LSU-16. Using molecular strain typing
methods such as pulsed-field gel electrophoresis o f endonuclease-restricted
chromosomal DNA or restriction fragment length polymorphism (RFLP) o f the
intergenic transcribed spacer region may help identify the strains o f Bartonella.
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APPENDIX A
PILOT EXPERIMENT: CULTURE TECHNIQUES FOR ISOLATION OF
BARTO NELLA H E N SE LA E
Cat ID**

Date infected*

Date necropsied

HIAb

BBC

VCd

1

1/97

6/97

-

-

-

10

1/97

6/97

-

-

-

33

1/97

6/97

-

-

-

43

1/97

6/97

-

-

-

46

1/97

6/97

-

-

-

48

1/97

6/97

-

-

-

55

1/97

6/97

-

-

-

57

1/97

6/97

-

-

-

61

1/97

6/97

-

-

-

62

1/97

6/97

-

-

-

63

1/97

6/97

-

-

-

+

+

+

B. henselae positive control

** cats were blood culture negative
a Cats were infected with B. henselae Houston-1. Cats were necropsied and tissue taken
for culture. Tissue sampled for culture included; lung, liver, spleen kidney, lymph node,
bone marrow, tonsil, brain, uterus, ovary, blood, buffy coat, plasma. Blood was
collected in Dupont Isolator tube, EDTA vacutainer tube.
b Heart Infusion Agar with 5%Rabbit blood. Cultures were incubated at 37% C in 5%
CO 2 for 3 weeks
c Brucella broth with Fildes 250 ug/ml and Hemin 6-8%. Cultures were incubated at
37% in 5% CO 2 for 3 weeks and subcultured on HI A agar
d Vero Cells-tissue was placed in tissue grinder for processing. Subcultures were made
from vero cell culture on to HIA agar.
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APPENDIX B
SUMMARY OF RESULTS OF EXTRACTION TECHNIQUES

Sample_________________ Extraction technique_____ FFDR9*______ FFBBRb
Bartonella henselae 87-66 genotype I
Bartonella henselae Houston-1 type
Bartonella henselae LSU 16
Bartonella henselae Baby
Bartonella clarridgeiae
ICM-3 (20 cfu/ml)c
ICM-3 (20 cfu/ml)c
Cat 351-2 (90 cfu/ml)c
Cat 351-2 (90cfu/ml)c

Qiagen*
Qiagen*
Qiagen*
Qiagen*
Qiagen*
CTAB**
Qiagen*
CTAB**
Qiagen*

+
+
+
+
+
-

+
-

+

+
+
+
+
+
+
+
+

*Qiagen Kit for Tissue and Blood Extraction (Qiagen Inc., Chatsworth, CA)
** Preparation o f Genomic DNA from Bacteria Phenol chloroform CTAB extraction
with ethanol precipitation (Current Protocols in Molecular Biology, 1994)
a primers used in the first reaction o f the nPCR
b primers used in the second reaction o f the nPCR
c 200ul o f blood used as sample
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APPENDIX C
COMPARISON OF BLOOD SPECIMENS COLLECTED FROM CATS
EXPERIMENTALLY INFECTED WITH BARTO NELLA H E N SE LA E
Collection tube

Culture"

Dupont Isolator™
Vacutainner Hepamin
Vacutainer EDTA
Vacutainer EDTA frozen

+
ND
+
++

PCR1b

+

“blood was cultured on Heart Infusion Agar with 5% rabbit blood at 37°C in 5%
CO2 for 3 weeks
bpolymerase chain reaction done using Bartonella genus and species specific primers in
50 pi volume using reaction mixture containing deoxynucleoside triphosphates (200
pM each), 1.75 mM MgCh, 0.2 pM of each primer, 2.5 U o f Taq DNA polymerase,
AmpliTaq TM Gold, 4 pi o f DNA template and 32.6 pi o f Perkin Elmer buffer. The
PCR amplifications were carried out on a 9600 Thermal-Cycler Perkin-Elmer/Applied
Biosystems (Foster City, CA). Amplification reaction consisted o f 10 min. at 95°C; 30
cycles of 94°C for 1 min.; 66° C for 1 min., 72°C for 1 min.; and a final elongation step
at 72° C for 10 min.
+ low numbers
++ high numbers
ND not determined
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APPENDIX D
RESULTS OF VARIOUS SPECIMENS FOR PCR ASSAY FOR DETECTION
OF BARTONELLA HENSELAE
Specimen
Serum3
Mouth swabb
Whole blood0

Number positive by PCR*
0/39
0/22
12/39

"polymerase chain reaction done using Bartonella genus and species specific primers in
50 pi volume using reaction mixture containing deoxynucleoside triphosphates (200
pM each), 1.75 mM MgCI2, 0.2 pM o f each primer, 2.5 U o f Taq DNA polymerase,
AmpliTaq TM Gold, 4 pi o f DNA template and 32.6 pi of Perkin Elmer buffer. The
PCR amplifications were carried out on a 9600 Thermal-Cycler Perkin-Elmer/Applied
Biosystems (Foster City, CA). Amplification reaction consisted o f 10 mins. at 95°C; 30
cycles o f 94°C for 1 min.; 66° C for 1 min., 72°C for I min.; and a final elongation step
at 72° C for 10 min.
3 blood drawn in serum vacutainer tube and separated. 12 o f the 39 were positive using
whole blood.
b sterile cotton swabs were used to swab the mouth o f cats. Swabs were placed in sterile
phosphate buffered saline for 1 hour and concentrated for PCR assay. All cats in this
group were bacteremic as defined by PCR and culture.
0blood was drawn in EDTA vacutainer tube and frozen before PCR assay performed.
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APPENDIX E
BACTERIAL SPECIES AND REFEREN CE STRAIN S
Genus, Species and S train

Bartonella henselae Houston-1
Bartonella henselae 87-66
Bartonella henselae LSU 16
Bartonella henselae Baby
Bartonella clarridgeiae
Bartonella quintana
Bartonella elizabethae
Pseudomonas aeruginosa
Escherichia coli
Bordetella bronchiseptica
Pasturella multocida
Staphylococcus aureus
Streptococcus pneumoniae
Brucella abortus

Genotype

I
I
II
n

Source

ATCC #49882
ATCC #49793
LAVMDL*
LAVMDL*
ATCC #700095
ATCC #VR-358
ATCC #49927
ATCC #25330
ATCC #11303
LAVMDL*
LAVMDL*
LAVMDL*
LAVMDL*
LAVMDL*

^Louisiana Veterinary Medical Diagnostic Laboratory
**Not applicable
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G ene B ank
Accession M
AJ223780
AJ223780
NA**
NA**
X97822
M73228
L01260
X06684
E05133
NA**
NA**
NA**
NA**
NA**

APPENDIX F
INDIRECT FLUORESCENT ANTIBODY ASSAY (IFA) FOR BARTONELLA
HENSELAE
Antigen preparation:
1. Bartonella henselae LSU 16 grown in Vero Cells for 5 days or until > 80%
infected. Antigen for IFA testing was prepared by pelleting and resuspending
the microorganisms in 0.5% bovine serum albumin in phosphate-buffered
saline (FBS).
Slide preparation
1. 12 well Teflon coated slides were washed with glass washing detergent and rinsed
and soaked in 95% ethyl alcohol prior to use.
2. 5 pi o f antigens are spotted on slide with capillary tube
3. Antigen is allowed to completely air-dry and are fixed to slides by immersion in
clean acetone for 15 minutes, then air-dried.
4. Slides are wrapped and stored in freezer.
IFA Procedure
1. Sul o f patient serum is added to 155 pi o f Vero cells and allowed to incubate for 30
minutes at 37°C.
2. Twofold dilutions o f serum ranging from 1:32to 1:1024 were made in skim milk..
3. 25 pi o f each dilution is added to antigen spot well with positive and negative
controls.
4. Incubate slides for 30 minutes at 37°C in a covered dish.
5. Rinse slides in (PBS) for five minutes. Repeat once and rinse in distilled water.
Allow slides to air dry.
6. Cover each antigen spot well with 25 pi o f FITC-conjugated goat anti-cat conjugate
(Kirkegaard and Perry Laboratories, Gaithersburg, MD).
7. Incubate slides for 30 minutes at 37°c.
8. Rinse slides in PBS for five minutes. Repeat once and rinse in distilled water.
9. Slides are examined at 40x with a fluorescence microscope.
Interpretation o f Results: Slides are examined for fluorescing bacilli. A positive titer is
taken as 1:64 or greater.
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APPENDIX G
PERSISTENT BARTONELLA DNA FOUND IN VARIOUS TISSUES BY PCR
C a t#

Strain

AB ^ M Pd

Necropsy*

Bartonella DNA in Th

1
10
81
83
84
85
86
87
182
184
223
G3
321
N3
LI
361
K3
L2
N2
K4
L3
F5
347

LSU 16*
LSU 16*
LSU 16*
LSU 16*
LSU 16*
LSU 16*
LSU 16*
LSU 16*
LSU 16*
LSU 16*
LSU 16*
LSU 16*
LSU 16*
LSU 16*
Baby*
Baby*
Baby*
87-66**
87-66**
87-66**
Houston-1*
Houston- l a
Houston-la

+
na
+b na
+c
na
+b na
+
na
na na
+b +
+b +
na na
na na
na na
na na
na na
na na
na na
na na
na na
na na
na na
na na
na na
na na
na na

19
12
19
11
19
19
4
8
>19
>19
>19
12
4
18
11
13
10
6
12
16
16
29
29

+ (1 ,2 , 3 ,4 ,5 , 7, 8)
-

+ (1,2, 3, 4, 5, 6, 7)
-

+ (1 ,2 , 3,4, 6, 7, 8)
+ ( 1 ,3 ,4 , 5, 7,)
+ (1,2, 3,4, 5, 6, 7, 8)
-

+ (2, 7)
+ (2,3)
+ (2)
+ (2)
+ (2,3, 8)
-

* lx l0 7
* * lx l0 9
a not infected
AB1* anti-LSU 16 or anti-Houston-1
MPd given three methylprednisolone injections 2 weeks
banti-5, henselae LSU 16
c anti-5, henslelae Houston-1
c weeks post-bacteremia, at time o f necropsy
na-not applicable
1-liver
2-spleen
3-bone marrow
4-heart valve
5-lung
6-brain
7-lymph node
8-kidney

148

Reproduced with permission of the copyright owner. Further reproduction prohibited without permission.

APPENDIX H
L ETTER OF PERM ISSION
Alma Roy
School o f Veterinary Medicine
Louisiana State University
Baton Rouge, LA 70803
Dear Mrs. Roy,
You have my permission to use Figure 2.1: Primer Design, page 14, that is published
my thesis titled: DNA DIAGNOSTICS FOR THE DETECTION AND
IDENTIFICATION OF CAT SCRATCH DISEASE CAUSING AGENTS.
Sincen

Ronald Aaron Tapp Jr.
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APPENDIX I
SEQUENCE ANALYSIS O F PCR PRODUCT FR O M HEART VALVE O F CAT
ONE. CAT ONE WAS EXPERIM ENTALLY IN FECTED W ITH B. H E N SE L A E
LSU 16 GENO TYPE H.
TACCC ATCTCT ACGG AAT AAC AC AG AG AAA

45

46

TTTGTGCT A ATTT ACCGT AT ACGTCCT ATTTGGAGAAAGATTTATC

91

92

GGAGATGGATGAGCCCGCGTTGGATTAGCTAGTTGGTGAGGTAAC

136

1

137 GGCTCACCGAGGCGACGATCCATAGCTGGTCTGAGAGGATGATCA 181
182 GCCACACTGGGACTGAGACACGGCCCAGACTCCTACGGGAGGCA

225

316 GTG AAG AT AATG ACGGT AACCGG AG AAGAAGCCCCGGCT AACTT 359
405 G ATTT ACTGGGCGT AAAGCGC AT GT AGGCGG AT ATTT AAGTC AG A 449
450 GGTGAAATCCC AGGGCTCAACCCTTGAACTGCCTTTGATACTGGG 494
495 T ATCTTGAGTGTGG AAGAAGGG AG
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